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Foreword
Welcome to the 2017 Annual Perinatal Mortality Report from the National 
Perinatal Epidemiology Centre (NPEC). 
This year 2019, marks a significant year for the NPEC. The Centre is high-
lighting ten years of data and audit in the maternity services. The NPEC have 
always strategically aimed to close the audit loop and since the establishment 
of the National Women and Infants Health Programme (NWIHP) in January 
2017, a number of the NPEC recommendations have been progressed. The 
NPEC works in collaboration with the NWIHP and acknowledges the key rela-
tionship that has developed between the two organisations. We look forward 
to continuing this relationship with the NWIHP.
The NPEC actively encourages the use of data in the units through individual 
hospital reports and the use of the national data set. The NPEC appreciates 
the importance of working with the units to ensure they know their data and 
understand how this data can be used in their units. 
I sincerely thank all my colleagues in the maternity services in Ireland who 
continue to engage with the NPEC and produce data of which we are proud. 
We must now ensure that we turn that data into information, and then intelli-
gence, to ensure the maternity services in Ireland continue to grow and lead 
in audit and change-management initiatives.
Lastly, I would like to thank the staff in the NPEC for their ongoing dedication 
to the mission of the Centre: by assessing the outcomes of care, learning from 
the data and working with all the stakeholders involved, the NPEC continues 
its mission to improve the care of mothers and babies in Ireland. 
Richard A Greene, Director, NPEC
National Perinatal Epidemiology Centre
5th Floor, Cork University Maternity Hospital
Wilton, Cork, Ireland
Email: npec@ucc.ie
Tel: +353 (21) 420 5017 
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Introduction
This is the seventh report of the national clinical audit on Perinatal Mortality in 
the Republic of Ireland (ROI), using the NPEC data collection tool and classifi-
cation system. It provides information on perinatal deaths arising from births 
occurring in the ROI during 2017. 
Since 2009, the NPEC, in collaboration with the multidisciplinary Perinatal 
Mortality Group (see Appendix B), has conducted a national clinical audit of 
Perinatal Mortality annually. The fundamental aim of this clinical audit, and a 
core function of NPEC, is to improve the care of mothers and babies in Ire-
land through the provision of key epidemiological evidence and monitoring 
of adverse perinatal outcomes. It is acknowledged that ongoing monitoring 
of quality and safety data is essential to continually drive improvements in 
the maternity services. The information provided in this report contributes 
to a body of evidence that will guide: future clinical practice; the counselling 
of bereaved parents; public-health interventions; and inform policy makers 
within the health services.
The report is divided into seven sections (Figure I) with additional information 
provided in the Appendices.
Figure I: Sections of this 2017 Perinatal Mortality Report 
 Section 1 contains the main findings including:
•  National and international comparison of Perinatal Mortality Rates (PMR) and the 
impact of in-utero transfer on individual unit’s PMR.
•  Distribution of Perinatal Deaths by the Robson Ten Group Classification System.
•  Maternal and infant characteristics impacting on adverse perinatal outcomes.
•  Management of delivery in women experiencing perinatal loss.
•  Investigations to determine the cause of perinatal death.
 Section 2 contains the invited expert commentary: 
•  “The Impact of Prematurity on our Perinatal Mortality Rate” by Dr Anne Twomey.
 Sections 3, 4, 5 and 6 provide findings specific to (respectively): 
• Stillbirths
• Early neonatal deaths
• Perinatal deaths associated with intrapartum events
• Late neonatal deaths
  Section 7 presents data on early neonatal deaths with a birthweight <500g 
and a gestational age at delivery of <24 weeks.  
• These deaths are not included in the PMR
8 PERINATAL MORTALITY IN IRELAND 
This is the seventh report of the national 
clinical audit on Perinatal Mortality in 
Ireland, using the NPEC data collection 
tool and classification system on cause 
of death. All 19 Irish maternity units 
reported anonymised data on 381 deaths 
arising from 62,076 births occurring in 
2017, of at least 500g birthweight or at 
least 24 weeks gestation. 
Stillbirths, early-neonatal and late 
neonatal deaths accounted for 235 
(61.7%), 111 (29.1%) and 35 (9.2%) of the 
381 deaths, respectively. The Perinatal 
Mortality Rate was 5.6 deaths per 
1,000 births; corrected for Congenital 
Malformation, the rate was 3.5 per 1,000 
births. The stillbirth rate was 3.8 per 
1,000 births; and, the early neonatal 
death rate was 1.8 per 1,000 live births. 
Among mothers experiencing perinatal 
death, the proportion of women 
attending their first antenatal visit at 
20 weeks gestation or later was almost 
eight percent (7.7%). This was slightly 
higher compared to almost five percent 
(4.8%) in 2016. 
The care of pregnant mothers was 
transferred in utero to another maternity 
unit in 8.1% of the perinatal deaths, most 
commonly to a tertiary referral maternity 
unit. 
The rate of autopsy uptake following 
perinatal death in 2017 (54.4%) is 
higher than the 47.8% reported in 2016, 
and is also higher than rates reported 
in previous years. Similar to previous 
years, a post-mortem examination was 
performed more often in stillbirths 
(60.0%) than in neonatal deaths (42.5%). 
There continues to be a high rate 
of placental histology examinations 
performed following perinatal death 
(99.1 % in stillbirths and in 92.7% of early 
neonatal deaths).
Specific placental conditions was the 
primary cause of death in over thirty 
percent (n=76, 32.3%) of the 235 
stillbirths that occurred in 2017. Major 
congenital anomaly was the second 
most common cause of death in 
stillbirths (n=64, 27.2%). The cause of 
death was unexplained in eleven percent 
of stillbirths (n=26, 11.1%); this is slightly 
lower than the fifteen percent (15.2%) 
in 2016. Infection was the main cause 
of death in less than three percent of 
stillbirths (n=6, 2.6%); this represents a 
decrease compared to previous years. 
Intra-uterine growth restriction was 
the main cause of death in one case of 
stillbirth (n=1, 0.4%). 
Executive summary
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Major congenital anomaly was the 
primary cause death in over half of 
the 111 neonatal deaths in 2017 (n=62, 
55.9%). Respiratory disorder was the 
second most common cause of death, 
accounting for more than one in five 
(n=24, 21.6%) of early neonatal deaths of 
which more than half (n=13, 54.2%) were 
due to severe pulmonary immaturity.
Low birthweight was associated with 
perinatal deaths, particularly with 
stillbirths. Forty percent (40.3%) 
of all stillbirths were classified as 
severely small for gestational age 
(<3rd customised birthweight centile) 
compared to a third (34.2%) of early 
neonatal deaths.
An association between maternal age 
and perinatal mortality was identified. 
Compared to mothers aged between 
25-29 years, women aged less than 20 
years had 2.7 times the rate of perinatal 
mortality and women aged greater than 
40 years had at 1.8 times the rate of 
perinatal mortality.
In terms of ethnicity and occupation, 
while the numbers involved were small, 
ethnic minorities and the unemployed 
were over-represented in the mothers 
who experienced perinatal deaths; this is 
similar to findings in 2016. 
Perinatal deaths from multiple births 
accounted for 12.4% of all perinatal 
deaths. This is over three times the 
proportion of multiples among all births 
in 2017.
While on-going clinical audit is essential 
to identify key factors influencing 
adverse perinatal outcomes, the 
opportunity to learn from the tragic 
event of a perinatal death would be 
greatly enhanced by the establishment 
of an enquiry into perinatal deaths.
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Recommendations 
Recommendations from previous reports being 
progressed by the National Women and Infants 
Health Programme.
•  The establishment of an enquiry for stillbirth and 
neonatal deaths should be considered in order 
to enhance the lessons which may improve care. 
An initial step would be the establishment of a 
standardised review of a case series of unexpected 
perinatal deaths associated with intrapartum 
events.
•  The resourcing of perinatal pathology services on 
a regional and national basis, as recommended 
by the Faculty of Pathology, would provide equal 
access to review for all perinatal deaths nationally 
and would facilitate an agreed approach to 
classification of autopsy, placental histology and 
cytogenetics. See further recommendation below.
•  As recommended by the Institute of Obstetrics 
and Gynaecology, second trimester fetal anomaly 
ultrasound scanning should be universally available 
for all pregnant women in Ireland. The NPEC 
Perinatal Mortality Advisory Group supports the 
NWIHP as they work with the Hospital Groups 
Chief Executive Officers to ensure that each 
maternity hospital/unit provides all pregnant 
women with access to dating and anomaly scans.1
Based on the findings of this and previous reports, 
the NPEC Perinatal Mortality Advisory Group makes 
the following recommendations:
•  Standardised approach to improved antenatal 
detection of fetal growth restriction (FGR) with 
timely delivery is a preventative strategy to reduce 
perinatal mortality.2 
  –  Again, we recommend the generation of 
customized birth weight centile charts for every 
woman during pregnancy and concomitantly, 
staff should be trained in risk assessment, 
plotting of symphysial fundal height (SFH) 
and scan weight estimates in order to reduce 
stillbirths in Ireland.
  –  Based on feedback to the NPEC, other 
methodologies could be considered. A 
multidisciplinary working group should be 
developed to address a national standardised 
approach to the detection of FGR. A national 
approach should also evaluate the use of 
a standard growth curve across all Irish 
maternity units. The Institute of Obstetrics and 
Gynaecology would be well placed to facilitate 
this working group.
•  Anonymised placental histology reports on 
perinatal death should be submitted to the 
NPEC as part of this audit; this would facilitate 
standardised interpretation and classification of 
placental conditions.
•  The Hospital Groups should examine the allocation 
of funding for the perinatal pathology service 
to ensure that a structured approach is taken to 
recruit staff in a timely manner. 
•  Further research exploring factors impacting on 
autopsy rates, particularly in the case of neonatal 
deaths, is warranted.
•  Consideration should be given to the 
establishment of a national working group to 
include Obstetricians, Neonatalogists, Midwives 
and Allied Health Professionals whose remit is 
to look at the problem of preterm birth (PTB) 
in Ireland at a national level and how it is best 
addressed.
•  The NPEC Perinatal Mortality Advisory Group 
suggests that the NWIHP engage with the 
Coroner Service of Ireland regarding the clinical 
management of cases in order to allow timely 
reporting to families and hospitals of provisional 
information on cause of death e.g. draft autopsy 
report as per other jurisdictions. 
•  A public health education programme on perinatal 
deaths and modifiable risk factors should be 
developed.3, 4
•  Funding should be provided by the Health Service 
Executive (HSE) to ensure that staffing levels allow 
protected time for clinical audit. Robust clinical 
audit of perinatal outcomes in all maternity units 
in Ireland is vital for patient care, but such audit 
requires the protected time of clinical staff.
1  National Women and Infants Health Programme, (2017) National 
Maternity Strategy Implementation Plan Launched. https://www.
hse.ie/eng/services/publications/corporate/national-maternity-
strategy-implementation-plan.pdf 
2  Clinical Practice Guideline No 29 (2014). Fetal Growth Restriction 
Guideline - Recognition, Diagnosis and Management: Institute of 
Obstetricians and Gynaecologists, Royal College of Physicians 
of Ireland and Directorate of Strategy and Clinical Programmes, 
Health Service Executive.
3 Nuzum D, Meaney S, O’Donoghue K. The public awareness of 
stillbirth: an Irish population study. BJOG 2018;125:246–252
4 O’Keeffe LM, Dahly DL, Murphy M, et al Positive lifestyle changes 
around the time of pregnancy: a cross-sectional study BMJ Open 
2016;6:e010233. doi: 10.1136/bmjopen-2015-010233 
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Figure II: Map of maternity units and hospital groups in the Republic of Ireland 
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Methods
Data collection and management
In 2017, there were 19 maternity units 
in Ireland. Within each maternity, unit 
coordinators with the responsibility of 
submitting perinatal mortality data to the 
NPEC have been identified. Pseudonymised 
data on perinatal deaths from births that 
occurred between January 1 and December 
31 2017 were submitted to the NPEC by all 19 
units using a standardised notification dataset 
either electronically, via the secure online 
NPEC database, or alternatively by paper 
format (see Appendix E). The notification 
dataset is completed using data on fetal 
and maternal characteristics recorded in 
the clinical records. Implemented nationally 
in 2011, the NPEC notification dataset was 
based on the validated Centre for Maternal 
and Child Enquiries (CMACE) Perinatal Death 
Notification Form5 and has been endorsed by 
the Clinical Advisory Group at the Institute of 
Obstetrics and Gynaecology, the Faculty of 
Paediatrics and the HSE National Obstetric 
Programme Working Group. 
Figure III illustrates the NPEC data collection 
and management processes. There has been 
a steady improvement in the overall quality 
of data reported by all maternity units since 
the implementation of the NPEC perinatal 
mortality notification dataset in 2011. To ensure 
completeness and accuracy of information, all 
data is validated directly with the respective 
maternity units. The NPEC also undertakes 
extensive reconciliation of its annual perinatal 
mortality dataset with that of the National 
Perinatal Reporting System (NPRS). This 
consolidation with the NPRS is in response 
to recommendations by the Chief Medical 
Officer6 and ensures that both agencies 
datasets represent the most accurate record 
of perinatal mortality annually.
Figure III: NPEC data collection and management processes 
5 Centre for Maternal and Child Enquiries (CMACE) (2010) Perinatal Mortality 2008: United Kingdom. London: CMACE
6 Holohan, T. (2014) HSE Midland Regional Hospital, Portlaoise Perinatal Deaths (2006-date). Dublin: Department of Health. 
Available at: http://www.lenus.ie/hse/bitstream/10147/313524/1/portlaoiseperinataldeaths.pdf
13ANNUAL REPORT 2017
The 2017 birth cohort
In this 2017 report, perinatal deaths are 
presented for births from 1 January 2017 to 31 
December 2017; thus allowing, neonatal deaths 
of December 2017 births which occurred in 
January 2018 to be included. The NPEC has 
been reporting on the perinatal mortality for a 
birth cohort in both the 2015 and 2016 perinatal 
mortality reports. This method of reporting 
perinatal mortality for a birth cohort allows 
more accurate estimates of mortality rates to 
be produced as appropriate denominators are 
available. The MBRRACE-UK Perinatal Mortality 
Surveillance Reports are based on perinatal 
mortality for a birth cohort also.7 The NPEC 
Perinatal Mortality Reports for the years 2014-
2011 were based on deaths in a calendar year. 
Therefore, in this 2017 report, 2014-2011 figures 
have been revised to adjust for this.
Rate calculations
To assess perinatal mortality, overall and 
unit-specific perinatal mortality rates (PMRs) 
per 1,000 births and corresponding 95% 
confidence intervals based on the Score 
Confidence Interval methodology were 
derived.8 Stillbirth, neonatal and corrected 
PMRs, which exclude deaths associated 
with or due to a congenital malformation, 
were also calculated. Denominator data on 
the number of live births and stillbirths was 
provided directly by the Healthcare Pricing 
Office (HPO) for all but one of the nineteen 
maternity units. Birth data for this unit was 
sourced from the unit’s published annual 
clinical report.9 At the time of writing this 
report, only provisional national data on births 
in 2017 was available from the Irish Healthcare 
Pricing Office.10
Perinatal deaths are included in a maternity 
unit’s rate if the baby was delivered in the 
maternity unit or if the unit was the intended 
place of delivery but the baby was born before 
arrival. Of the reported perinatal deaths in 2017, 
there was only one case that was not included 
in the rate of a maternity unit. This was a case 
where the mother had not received antenatal 
care from a maternity unit or a self-employed 
community midwife but presented to a unit 
after unattended delivery in the community.
Funnel plots
Variations in PMRs between maternity units 
could potentially be due to random chance or 
reflect differences in baseline characteristics 
of the childbearing population. For this reason, 
funnel plots were used to assess performance 
outcomes for individual units in comparison 
to the overall average.11 In brief, the plot is a 
scatter diagram of individual maternity unit 
mortality rates against the number of births 
within that unit. The national rate is indicated 
by the solid straight line. The 95% confidence 
interval is indicated by the curved dashed 
line. The dashed lines represent the limits 
within which 95% of units are expected to 
lie (i.e. within two standard deviations). The 
99.8% confidence interval for the national 
rate is plotted using solid lines. These solid 
lines represent the limits within which 99.8% 
of units are expected to lie (i.e. within three 
standard deviations). The width of the 
confidence interval is adjusted to allow for 
meaningful comparison between unit-specific 
rates and the national rate. The confidence 
interval is wider for smaller units reflecting 
the lack of precision in rates calculated based 
on small numbers. The confidence interval 
narrows for larger maternity units, giving the 
diagram a ‘funnel’ shape. Maternity unit rates 
outside the 95% and 99.8% confidence interval 
are statistically significantly different from the 
national rate. In general, one in 20 units would 
be expected to lie outside the 95% confidence 
8 Agresti, A. and Coull, B. (1998) Approximate Is Better than Exact for Interval Estimation of Binomial Proportions.  
The American Statistician, 52, 2.
9 The Rotunda Hospital Dublin (2018). The Rotunda Hospital Dublin Annual Report 2017. Dublin
10 Healthcare Pricing Office. Perinatal Statistics Report 2017. Dublin: Health Service Executive. Provisional data [in press]
11 Spiegelhalter D. (2002) Funnel plots for institutional comparison. Quality and Safety in Health Care; 11(4):390-91.
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limits by chance alone whereas an observation 
outside the 99.8% confidence limits is 
especially rare, i.e. there is a 0.2% chance of 
this happening.
Birthweight centile
As with previous reports, we have produced 
charts to highlight the issue of failure of fetal 
growth in utero in relation to the stillbirths and 
early neonatal deaths that occurred in Ireland 
in 2017. To do so, we used the Gestation 
Related Optimal Weight (GROW) software12 
and coefficients derived from the multiple 
regression analysis of data on 11,072 births in 
six maternity units in Dublin, Galway, Limerick 
and Belfast in 2008-2009.13
The regression analysis determined the Term 
(i.e. 40 weeks) Optimal Weight (TOW) in 
Ireland to be 3,490.7g. The normal range 
(i.e. the range from the 10th centile weight 
to the 90th centile weight) around the TOW 
was then calculated and the recommended 
proportionality growth function was applied to 
the TOW, the 10th centile term weight and the 
90th centile term weight in order to determine 
the optimal weight and normal range at all 
gestations (21-44 weeks for the stillbirths and 
early neonatal deaths in Ireland in 2017). These 
steps are described in detail in the GROW 
documentation.
Customised birthweight centiles were also 
derived using the GROW software. There was 
missing data for maternal height (n=49, 14.2%) 
and weight (n=48, 13.9%). For these cases, 
we used the median height and weight of 
the mothers with complete data. The GROW 
software also provides estimated customised 
birthweight centiles in cases with missing 
data. Ultimately, customised birthweight 
centiles were calculated for 344 of the 346 
perinatal deaths.
Classification of abnormal placental 
histology
Abnormal placental findings have been 
classified and presented under the following 
broad categories: maternal vascular 
malperfusion, fetal vascular malperfusion, 
cord pathology, cord pathology with distal 
disease, delayed villous maturation defect, 
Figure IV: Diagram outlining the interpretation of a Funnel Plot 
12 Gardosi J, Francis A. Customised Weight Centile Calculator. GROW version 6.6, 2013 Gestation Network, www.gestation.net
13 Unterscheider J, Geary MP, Daly S, McAuliffe FM, Kennelly MM, Dornan J, Morrison JJ, Burke G, Francis A, Gardosi J, Malone FD. 
The customized fetal growth potential: a standard for Ireland. Eur J Obstet Gynecol Reprod Biol 2013; 166(1):14-7
99.8% confidence interval (CI). 
Rates above the 99.8% CI are 
markedly higher than the national 
rate.
95% confidence interval (CI).
One in 20 maternity units would be 
expected to lie outside the 95% CI by 
chance alone
National Rate
































Total births in unit (≥500g or ≥24 weeks)
Unit-specific rate Overall rate      95% confidence limits 99.8% limits
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chorioamnionitis, villitis and ‘other placental 
condition’ (Appendix F). This is in keeping 
with recommendations in a publication 
from an international consensus meeting 
of pathology.14 It is envisaged that this will 
optimise classification of placental conditions 
causing or contributing to perinatal loss.
Classification of death
The NPEC data collection form requests 
contributors to identify maternal, fetal and 
neonatal conditions, using specific categories, 
which caused or were associated with the 
death. The unit contributor is also requested 
to assign the principal cause of death with 
reference to the post mortem and placental 
pathology if performed. Guidance and 
definitions for completing specific categories 
are described in Appendix G. Briefly described, 
categories include both pathophysiological 
entities and clinical conditions present at 
time of death including placental pathology 
and Intra-Uterine Growth Retardation (IUGR). 
Classification of stillbirths was made using 
the NPEC maternal and fetal classification 
system. In the case of neonatal deaths, the 
NPEC neonatal classification system was used 
to attribute the main neonatal cause of death 
and the NPEC maternal and fetal classification 
system was used to identify the underlying 
obstetric condition/sentinel event associated 
with the death. 
Robson Ten Group Classification 
System
In 2017, 14 of the 19 units that participated in 
the perinatal mortality audit also provided 
data on all deliveries classified according 
to the Ten Group Classification System 
(Appendix H).15 This facilitated perinatal 
deaths to be classified according to the Ten 
Groups for these 14 units.
Recommendation: Funding should be 
provided by the Health Service Executive 
(HSE) to ensure that staffing levels allow 
protected time for clinical audit. Robust 
clinical audit of perinatal outcomes in all 
maternity units in Ireland is vital for patient 
care, but such audit requires the protected 
time of clinical staff.
Definitions and terminology
While individual units define perinatal cases 
similarly, there is some variation. To allow for 
comparison across all units the NPEC used the 
following definitions for the current report:
Stillbirth: The NPEC seeks to apply a 
definition of stillbirth in accordance with 
the Irish Stillbirths Registration Act, which 
specifies stillbirth as a child born weighing 
500 grammes or more or having a gestational 
age of 24 weeks or more who shows no sign 
of life.16 In previous reports, we considered 
delivery ≥24 gestational weeks to be 
coterminous with having a gestational age 
of 24 weeks or more. However, cases of fetus 
papyraceous, where one of twin fetuses died 
early in development, were not included as 
stillbirths. From 2016, cases of intrauterine 
death diagnosed before 24 gestational weeks 
with a birthweight <500g are not considered 
to have reached a gestational age of 24 weeks 
or more and thus are not included as stillbirths 
in this audit.
Early neonatal death: Death of a live born 
baby occurring within 7 completed days of 
birth. 
Late neonatal death: Death of a live born 
baby occurring after the 7th day and within 28 
completed days of birth. 
14 Khong TY, Mooney EE et al: Sampling and definition of placental lesions. Arch Pathol Lab Med
15 Robson MS (2001). Classification of caesarean sections. Fetal and Maternal Medicine Review, 12, pp 23-39 doi:10.1017/S0965539501000122
16 Stillbirth Registration Act, 1994. Available at: http://www.irishstatutebook.ie/eli/1994/act/1/enacted/en/print 
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Live birth: Live birth refers to the complete 
expulsion or extraction from its mother of 
a product of conception, irrespective of the 
duration of the pregnancy, which, after such 
separation, breathes or shows any other 
evidence of life - e.g. beating of the heart, 
pulsation of the umbilical cord or definite 
movement of voluntary muscles - whether 
or not the umbilical cord has been cut or the 
placenta is attached. Each product of such a 
birth is considered live born.17
Total births: For the purpose of calculating 
perinatal mortality rates, the denominator 
used was the number of births (live birth 
and stillbirths) from 24 weeks gestation or 
birthweight >500g. At the time of writing this 
report, only provisional national data on births 
in 2017 was available from the Irish Healthcare 
Pricing Office.18 For this report, data on the 
number of births was provided by the HPO 
for all but one of the nineteen maternity units; 
birth data for this unit was sourced from the 
unit’s published annual clinical report.19
Stillbirth rate: Number of stillbirths per 1,000 
births (live births and stillbirths from 24 weeks 
gestation or weighing >500g). The reporting 
guideline used by the Irish Healthcare Pricing 
Office perinatal statistics report on stillbirths 
uses the criterion of birthweight >500g.20 For 
consistency, we also report the stillbirth rate 
using the criterion of birthweight >500g.
Neonatal death rate: Number of early 
neonatal deaths per 1,000 live births (from 
24 weeks gestation or weighing >500g). 
The Irish Healthcare Pricing Office perinatal 
statistics report on early neonatal deaths with 
a birthweight >500g. For consistency, we also 
report the early neonatal death rate using the 
criterion of birthweight >500g.
Overall perinatal mortality rate (PMR): 
Number of stillbirths and early neonatal 
deaths per 1,000 births (live births and 
stillbirths from 24 weeks gestation or weighing 
>500g). Again for consistency with the 
Irish Healthcare Pricing Office reporting of 
perinatal statistics, we also report the neonatal 
death rate using the criterion of birthweight 
>500g. Late neonatal deaths are not included 
in the PMR.
Corrected PMR: Perinatal mortality rate 
excluding perinatal deaths associated with or 
due to a major congenital malformation.
Booking: Some data sought by the NPEC 
Perinatal Death Notification Form relate to the 
time of booking. Booking in this regard relates 
to the mother’s first antenatal visit at the 
maternity unit.
In utero transfer: From January 2016, the 
NPEC Perinatal Death Notification Form 
contains a specific question on whether the 
obstetric care of the mother was transferred 
to another maternity unit with the fetus in 
utero. The identity of the transferring unit and 
gestational age at time of in-utero transfer are 
also captured.
Parity: The number of completed pregnancies, 
whether live birth or stillbirth, of at least 24 
weeks gestation or with a birthweight ≥500g. 
We refer to parity prior to the pregnancy that 
resulted in a perinatal loss in 2016.
Gravida: The number of times the mother has 
been pregnant, irrespective of duration. We 
refer to gravida prior to the pregnancy that 
resulted in a perinatal loss in 2017.
 
17 World Health Organisation. Available at: http://www.who.int/healthinfo/statistics/indmaternalmortality/en/
18 Healthcare Pricing Office. Perinatal Statistics Report 2017. Dublin: Health Service Executive. Provisional data [in press]
19 The Rotunda Hospital Dublin (2018). The Rotunda Hospital Dublin Annual Report 2017. Dublin
20 Healthcare Pricing Office. Perinatal Statistics Report 2017. Dublin: Health Service Executive. Provisional data [in press]
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21 Health Information and Quality Authority. Guidance on a data quality framework for health and social care 2018. : HIQA; 2018 
[cited 2019]. Available from: https://www.hiqa.ie/sites/default/files/2018-10/Guidance-for-a-data-quality-framework.pdf. 
Data Quality Statement
In the National Perinatal Epidemiology Centre the maintenance of data at high quality 
standards is a priority. The purpose of this data quality statement is to support the 
interpretation and quality of the information contained in this report.
This quality statement, presented in Appendix I, has been developed in line with the 
Health Information and Quality Authority (HIQA) guidance on data quality framework 
for health and social care.21 The statement describes the quality of the data according 
to five data quality dimensions as defined by HIQA: 
1. Relevance 
2. Accuracy and reliability 
3. Timeliness and punctuality 
4. Coherence and comparability 
5. Accessibility and clarity
The National Clinical Audit of Perinatal Mortality adheres to following national and 
international legislation and standards: 
• The European Union General Data 
• Protection Regulation 2016 
• The Data Protection Act 1988 and the 
• Data Protection (Amendment) Act 2003
• Data Protection Act 2018 (Section 36(2)) (Health Research) Regulations 2018
• Information Management Standards for National Health and Social Care Data (2017)
• National Office of Clinical Audit Standards for National Clinical Audit 
• National Standards for Safer Better Healthcare (2012) 
• FAIR (Findable, Accessible, Interoperable, and Re-usable) Data Principles. 
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1. Main findings
Perinatal mortality rate
This section of the report provides details of 
the perinatal mortality rate (PMR), maternal 
and infant characteristics and autopsy uptake. 
In line with previous reports, the findings 
provided in this section relate to stillbirths and 
early neonatal deaths only. Separate sections 
are then provided for stillbirths, early neonatal 
deaths and late neonatal deaths describing 
clinical management and the main cause 
of death based on the NPEC Classification 
System.
The 19 Irish maternity units reported 
62,076 births with a birthweight >500g or 
gestational age >24 weeks. Of these, 381 were 
subsequently classified as perinatal deaths. 
Stillbirths, early neonatal and late neonatal 
deaths accounted for 235 (61.7%), 111 (29.1%) 
and 35 (9.2%) of the 381 deaths, respectively.
The reporting guideline used by the Irish 
Healthcare Pricing Office (HPO) in their 
publication of national perinatal statistics, uses 
the criterion of birthweight >500g. In 2017, 
there were 360 perinatal deaths reported from 
an estimated 62,051 babies born weighing 
>500g. Stillbirths, early neonatal and late 
neonatal deaths accounted for 216 (60.0%), 
109 (30.3%) and 35 (9.7%) of the 360 deaths, 
respectively.
As detailed in Table 1.1, the stillbirth rate 
associated with the criteria of birthweight 
>500g or gestational age >24 weeks was 3.8 
per 1,000 births and the early neonatal death 
rate using the same criteria was 1.8 per 1,000 
live births compared respectively to 3.5 and 1.8 
per 1,000 births based on birthweight >500g. 
The overall PMR was 5.6 deaths per 1,000 
births and when corrected for congenital 
malformation was reduced to 3.5 whereas the 
respective rates based on birthweight >500g 
were 5.2 and 3.4 per 1,000 births. 
Table 1.1: Frequency and rate of perinatal mortality outcomes, 2017
BWT ≥500g or gestational age ≥24 weeks BWT ≥500g
Number Rate (95% CI) Number Rate (95% CI)
Total births 62,076 62,051
Stillbirths 235 3.8 (3.3-4.3) 216 3.5 (3.0-4.0)
Early neonatal deaths 111 1.8 (1.5-2.2) 109 1.8 (1.4-2.1)
Perinatal deaths 346 5.6 (5.0-6.2) 325 5.2 (4.7-5.8)
Corrected perinatal deaths 220 3.5 (3.1-4.0) 208 3.4 (2.9-3.8)
Note: BWT=Birthweight; Rate per 1,000 births; 95% CI=95% Score confidence interval;  
Corrected perinatal deaths exclude deaths due to a congenital malformation. 
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European comparison of the rate of 
stillbirth
In 2018, Euro-Peristat published a report entitled, 
the ‘European Perinatal Health Report’ which 
compared the stillbirth rate across countries in 
Europe in 2015.22 The criterion for the stillbirth 
rate was gestational age ≥28 weeks. Based on 
this criterion, Figure 1.1 illustrates the 2017 Irish 
total stillbirth rate and the corrected Irish stillbirth 
rate, which excludes cases due to a congenital 
malformation in comparison to the reported 
stillbirth rate for the other countries in Europe. 
Figure 1.1: Irish stillbirth rate in 2017 compared to the stillbirth rate in other countries in Europe
Note: Rates based on stillbirths among births with ≥28 completed weeks of gestation. The Irish stillbirth rate, 
when corrected by excluding cases due to a congenital malformation, is adjusted to 2.1
22 Euro-Peristat Project. European Perinatal Health Report. Core indicators of the health and care of pregnant 
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Comparison of perinatal mortality, 
2012-2017
Table 1.2 compares the perinatal mortality 
outcomes for 2017, based on the criteria of 
birthweight ≥500g or gestational age ≥24 
weeks, with those of the previous five years. 
As stated in the Definitions and Terminology 
section of this report, cases of intrauterine 
death diagnosed before 24 gestational weeks 
and born after 24 gestational weeks with 
a birthweight <500g were not included as 
stillbirths in 2016 and 2017. These cases were 
included as stillbirths in the previous annual 
reports and there were on average 5-7 such 
cases each year, accounting for approximately 
2% of the annual number of stillbirths reported. 
Revised figures, excluding these cases, are 
provided for 2012-2015 in Table 1.2 and Figure 
1.2 below. Thus, a meaningful assessment 
of changes over time can be made as the 
application of case definitions is the same 
across the period.
Perinatal mortality rates were higher in the 
period before 2012-2016. There was a notable 
decrease in perinatal mortality in 2016 
compared to 2015, the largest year-to-year 
change observed during 2012-2016. In 2017, 
the perinatal mortality rate, corrected perinatal 
mortality rate, stillbirth rate and neonatal rate 
were similar to rates in 2016.
The time trend in each of the perinatal 
mortality rates is illustrated in Figure 1.2. The 
notable decreases in the rates in 2017 have 
reversed the effects of the smaller increases 
observed since 2012.
Table 1.2: Comparison of perinatal statistics, 2012-2017
2012 2013 2014 2015 2016 2017 RR (95% CI)
Total births N 71,755 69,146 67,663 65,904 64,133 62,076
Stillbirths
n 299 294 324 287 250 235
0.97 (0.81-1.16)
rate 4.2 4.3 4.8 4.4 3.9 3.8
Early neonatal deaths
n 141 162 142 166 124 111
0.92 (0.72-1.19)
rate 2 2.4 2.1 2.5 1.9 1.8
Perinatal deaths
n 440 456 466 453 374 346
0.96 (0.83-1.11)
rate 6.1 6.6 6.9 6.9 5.8 5.6
Corrected perinatal 
deaths
n 292 296 315 279 228 220
1.00 (0.83-1.20)
rate 4.1 4.3 4.7 4.2 3.6 3.5
Note: Rates are per 1,000 births; RR=Rate ratio comparing rate in 2017 versus rate in 2016; 95% CI=Exact Poisson 95% confidence 
intervals; Corrected perinatal deaths exclude deaths due to a congenital malformation. 
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Variation by maternity unit
Based on birthweights ≥500g and/or gestation at 
delivery ≥24 weeks, the uncorrected PMR across 
the Irish maternity units ranged from 1.9 to 12.2 
per 1,000 births (Table 1.3); the corrected PMR 
ranged from 0.7 to 9.2 per 1,000 births. This level 
of variation across units is higher compared to 
2016. There was little correlation between the 
unit-specific corrected PMR in 2016 and 2017.
As reported earlier, the national perinatal 
mortality rate was similar in 2017 compared to 
2016, but there is variation when comparing at 
the individual unit level. Year-to-year changes at 
the level of individual units are volatile due to the 
smaller numbers involved. 
The profile of mothers delivered may differ 
across Irish maternity units and this may 
explain variation in perinatal mortality rates. 
However, establishing this requires more detailed 
information on all mothers delivered at Irish 
maternity units than is currently available. 
Figure 1.2: Trend in perinatal mortality rates in Ireland, 2012-2017
Note: Rates per 1,000 births; PMR = perinatal mortality rate; Corrected PMR excludes deaths due to a congenital malformation.
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Table 1.3: Perinatal mortality rates across Irish maternity units in 2017 and 2016
Unit Uncorrected PMR (95% CI) Corrected PMR (95% CI) 
2017 2017 2016
1 12.2 (7.0-21.3) 9.2 (4.8-17.3) 2.9 (1-8.5.0)
2 7.2 (5.6-9.2) 5.0 (3.7-6.7) 3.8 (2.7-5.3)
3 6.8 (3.9-11.9) 5.1 (2.7-9.7) 3.3 (1.5-7.3)
4 6.6 (3.9-11.1) 5.2 (2.9-9.3) 3.3 (1.6-6.8)
5 6.5 (5.0-8.5) 3.9 (2.8-5.5) 5.2 (3.9-7.0)
6 6.2 (4.7-8.2) 3.1 (2.1-4.5) 2.6 (1.7-3.9)
7 6.1 (3.3-11.1) 4.9 (2.5-9.6) 4.4 (2.2-8.7)
8 5.6 (3.0-10.7) 3.1 (1.3-7.3) 3.6 (1.6-7.8)
9 5.4 (4.0-7.4) 3.7 (2.5-5.3) 2.5 (1.6-3.9)
10 4.9 (2.9-8.2) 3.2 (1.7-6.0) 3.7 (2.0-6.5)
11 4.9 (2.6-9.3) 3.3 (1.5-7.1) 4.6 (2.4-8.8)
12 4.6 (2.1-10.0) 2.3 (0.8-6.7) 5.9 (3.0-11.6)
13 4.3 (2.8-6.7) 2.3 (1.2-4.2) 1.8 (0.9-3.5)
14 3.3 (1.8-6.0) 2.6 (1.3-5.2) 4.7 (2.9-7.8)
15 3.3 (1.4-7.6) 2.0 (0.7-5.7) 2.7 (1.0-6.9)
16 3.2 (1.4-7.5) 1.3 (0.4-4.7) 3.1 (1.3-7.1)
17 3.0 (1.3-7.0) 3.0 (1.3-7.0) 4.0 (2.0-8.3)
18 2.9 (1.1-7.5) 0.7 (0.1-4.1) 2.8 (1.1-7.3)
19 1.9 (0.6-5.5) 1.2 (0.3-4.5) 3.1 (1.3-7.2)
All 5.6 (5.0-6.2) 3.5 (3.1-4.0) 3.6 (3.1-4.0)
Note: Rates per 1,000 births based on birthweights ≥500g or gestational age ≥24 weeks; PMR=perinatal mortality rate; 95% 
CI= 95% Score confidence interval; Corrected PMR excludes deaths due to a congenital malformation; One perinatal death 
was born outside of the maternity care and, therefore, were not included in the rates of any of the 19 units.
In utero transfer
In Ireland, women with high risk pregnancies may 
be transferred to the care of tertiary maternity 
units with facilities for specialist fetal medicine 
and high-level neonatal intensive care. Of the 
346 perinatal deaths in 2017, there were 28 cases 
(8.1%) where the care of the pregnant woman 
was transferred in utero.
The 28 in utero transfer cases in 2017 resulted in 
10 stillbirths (35.7%) and 18 early neonatal deaths 
(64.3%). All but one of the 28 in utero transfer 
cases were transferred to one of the country’s 
four large maternity hospitals. For these hospitals 
in 2017, 13.0% (n=27) of their 208 perinatal 
deaths arose from in utero transfer cases. This 
proportion varied across the four large maternity 
hospitals from 2.5% for one hospital, 9.8% for 
another rising to 10.9% for the third hospital 
and 24.2% for the fourth. This shows the impact 
on perinatal mortality rates for these hospitals 
associated with in utero transfer.
The solid horizontal line in Figure 1.3 represents 
the national total or uncorrected PMR in 2016 
(5.6 deaths per 1,000 births) and the curved 
dashed lines represent the 95% confidence 
interval around the national rate which should 
include the corrected PMR of individual units. 
Statistically, one in 20 observations can be 
expected to be outside the 95% confidence 
range. None of the maternity units had an 
uncorrected PMR outside the limits of the 
confidence interval indicating their consistency 
with the national rate.
In Figure 1.3, the blue diamonds represent 
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each unit’s PMR. The red squares represent 
each unit’s PMR if there had been no in 
utero transfer cases, i.e. if all mothers who 
experienced perinatal loss after their care had 
been transferred in utero had still experienced 
perinatal loss whilst in the care of the maternity 
unit where she had intended to deliver at the 
time of her first antenatal visit. Without these in 
utero transfer cases, almost all of the country’s 
small maternity units would have had a higher 
PMR while the four large maternity hospitals 
would have had a lower PMR. 
Figure 1.3: Funnel plot of the uncorrected perinatal mortality rate (PMR) for Irish maternity units, 2017
Note: The blue diamond markers indicate the unit-specific PMR that was observed in 2017 and the red square markers the PMR 
that would have been observed if in utero transfer cases had remained at the unit where the booking appointment had taken place.
Total births in unit (≥500g or ≥24 weeks)
































Total births in unit (≥500g or ≥24 weeks)
          
Corrected perinatal mortality rate
The solid horizontal line in Figure 1.4 represents 
the national corrected PMR in 2017 (3.5 deaths 
per 1,000 births). The curved dashed blue lines 
represent the 95% confidence limits around the 
national rate and the curved blue lines represent 
the 99.8% confidence limits. Statistically, one 
in 20 observations, i.e. 5%, can be expected to 
be outside the 95% confidence limits whereas 
an observation outside the 99.8% confidence 
limits is especially rare, i.e. approximately one in 
500 observations. Three units had a corrected 
PMR rate below the lower 95% confidence limit 
and one of these units had a rate of 0.73 per 
1,000 births, which was below the lower 99.8% 
confidence limit. 
One of units with a rate that is still within the 
within the 95% confidence limits but is just below 
the upper 95% confidence limit was one of the 
maternity hospitals noted earlier as having a 
high proportion of perinatal deaths following 
in utero transfer. If perinatal deaths following in 
utero transfer were excluded from the corrected 
PMR for this unit, it would be reduced by 
approximately forty percent and would be well 
within the 95% confidence limits. 
Figure 1.4: Funnel plot of the corrected perinatal mortality rate for Irish maternity units, 2017 
Note: Two units have similar rates of 1.24 and 1.29 (represented by overlapping diamonds). 
Figure 1.5 is a replicate of the funnel plot in Figure 
1.4 as it also illustrates variation in the corrected 
PMR across Irish maternity units in 2017. For each 
unit, we have added errors bars to illustrate the 
range in the unit’s annual corrected PMR since 
2011 when the NPEC perinatal notification form 
came into use. Considering this six-year period, 
most of the units with over 2,000 births had their 
lowest corrected PMR in 2016 and 2017.
The expected greater volatility in the rate 
associated with smaller units is evident. The plot 
also indicates how rarely a unit’s corrected PMR 
falls outside the limits of the 95% confidence 
interval or conversely it illustrates that the units 
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Figure 1.5: Funnel plot of the corrected perinatal mortality rate and its variation for the years 2011-2017 
in Irish maternity units 
Note: The error bars illustrate the variation in each unit’s annual corrected PMR since 2011.
In Figure 1.6, the solid horizontal line represents the national stillbirth rate of 3.8 per 1,000 births. 
Four units had a stillbirth rate below the lower 95% confidence limit and one of these units had 
a rate of 0.73 per 1,000 births, which was below the lower 99.8% confidence limit. This indicates 
that all these four units had a stillbirth rate that was lower than the national rate in 2017. 
Figure 1.6: Funnel plot of the stillbirth rate for Irish maternity units, 2017
Note: Two units have similar rates of 1.20 and 1.24 (represented by overlapping diamonds).
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Total live births in unit (≥500g or ≥24 weeks)
The solid horizontal line in Figure 1.7 represents the overall early neonatal mortality rate of 1.8 per 1,000 
live births. The neonatal mortality rate for all but two units were within the limits of the 95% and 99.8% 
confidence intervals. These two units did not have any neonatal death cases, indicating that these units 
had a rate that was lower than the national rate in 2017. The data for these units was verified with the 
Healthcare Pricing Office.
Figure 1.7: Funnel plot of the early neonatal mortality rate for Irish maternity units, 2017
Note: Three units have similar rates of 0.60, 0.63 and 0.64 (represented by overlapping diamonds).
Distribution of Perinatal Deaths by 
Robson Ten Group Classification 
System
This is the second year that NPEC have presented 
data on the distribution of perinatal deaths by 
Robson Classification. The Robson Classification, 
also referred to as the Ten Group Classification 
System (TGCS), is a method providing a common 
starting point for further detailed analysis within 
which all perinatal outcomes can be measured 
and compared.23 The system classifies all pregnant 
women into one of 10 categories that are mutually 
exclusive and, as a set, totally comprehensive (see 
Appendix H).24 The categories are based on five 
basic obstetric characteristics that are routinely 
collected for all maternities: parity, gestational 
age, onset of labour, foetal presentation and 
number of foetuses.
In cases of antepartum stillbirth, the baby is 
usually delivered following induction of labour 
or by pre-labour caesarean section. This places 
the vast majority of women who experience 
antepartum stillbirth into Group 2 or Group 4, 
depending on parity. It thereby causes these 
groups to have relatively high perinatal mortality 
rates compared to groups 1 and 3, which is a 
consequence of care after the perinatal loss 
event rather than reflecting valid differences in 
23 Robson M et al. The 10-Group Classification System (Robson classification), induction of labor, and cesarean delivery. International Journal of 
Gynecology and Obstetrics 131 (2015) S23–S27 
24 Robson MS (2001). Classification of caesarean sections. Fetal and Maternal Medicine Review, 12, pp 23-39 doi:10.1017/S0965539501000122.
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risk. To address this issue, we report perinatal 
mortality data for Groups 1 and 2 combined and 
Group 3 and 4 combined.
In 2017, 14 Irish maternity units collated data on 
all births by each of the groups in the TGCS. The 
number of deliveries of infants in these units 
(n=51,472) constituted 84% of the total number 
of deliveries in the 19 Irish maternity units in 2017. 
These 14 units accounted for a similar proportion 
of the country’s 346 perinatal deaths in 2017 
(n=294, 85.0%) and their overall PMR was 5.7 per 
1,000 babies delivered. 
The TGCS of women who delivered in the 14 
units during 2017 and their perinatal deaths 
are detailed in Table 1.4. On account of the 
small number of cases per category and the 
limited power of analysis in a small cohort, 
rates per stillbirths and early neonatal deaths 
are not appropriate and as such not presented 
separately. Groups One through Five accounted 
for 87.8% of the deliveries in that year (n=45,212) 
but represented only one in four of the perinatal 
deaths (n=79, 26.9%). 
Groups Six through Ten accounted for 12.2% of 
deliveries whereas almost three in four perinatal 
deaths were associated with one of these groups 
(n=215, 73.1%). Each of these groups had a 
greatly elevated PMR, ranging from 11.4 per 1,000 
for Group Nine women to 50.9 per 1,000 babies 
delivered for Group Ten. 
Prematurity is strongly associated with perinatal 
mortality. This is made especially clear by the 
TGCS. Group Ten contains all single cephalic 
pregnancies delivered preterm. This group 
contained 4% of the maternities, it had the 
highest PMR and contributed 2.1 per 1,000 babies 
delivered to the overall PMR of 5.7 per 1,000 
babies delivered.
Table 1.4: Incidence of perinatal death by Robson Group in fourteen Irish maternity units, 2017











All* 51,472 100% 294 5.7 (5.1-6.4) 5.7
1 Nulliparous, singleton, cephalic, 
>37/40, spontaneous labour
17,350 33.7% 39 2.2 (1.6-3.1) 0.8
2 Nulliparous, singleton, cephalic, 
>37/40 induced or elective CS
3 Multiparous (excluding previous 
CS), singleton, cephalic, >37/40, 
spontaneous labour
20,211 39.3% 28 1.4 (0.9-2.0) 0.5
4 Multiparous (excluding previous 
CS), singleton, cephalic, >37/40 
induced or elective CS
5 Previous CS, singleton, cephalic, 
>37/40, induced or elective CS
7,651 14.9% 12 1.6 (0.8-2.7) 0.2
6 All nulliparous deliveries with a 
single breech pregnancy
1008 2% 32 31.7 (21.8-44.5) 0.6
7 All multiparous breech (including 
previous CS)
884 1.7% 33 37.3 (25.8-52) 0.6
8 All multiple pregnancies 
(including previous CS)
2,032 3.9% 38 18.7 (13.3-25.6) 0.7
9 All deliveries with a single 
pregnancy with a transverse or 
oblique lie, including women with 
previous uterine scars
176 0.3% 2 11.4 (1.4-40.4) 0.0
10 All singleton, cephalic, <37/40 
(including previous CS)
2,160 4.2% 110 50.9 (41.9-61.4) 2.1
Note: Rate is per 1,000 babies delivered; 95% CI=Exact Poisson 95% confidence intervals. CS=Caesarean section. 
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Maternal characteristics
The findings presented below relate to 
characteristics of mothers of stillbirths and early 
neonatal deaths born with a birthweight ≥500g 
or having achieved a gestational age ≥24 weeks.
Age
The age of mothers experiencing perinatal loss 
was known for 344 of the 346 perinatal deaths 
in 2017 (99.4%). The mothers who experienced 
perinatal loss in 2017 ranged in age from teenage 
years (the youngest being 17 years of age) 
through to mid forties (46 years of age). Their 
age distribution broadly reflected that of the 
population of mothers who gave birth in Ireland 
in 2017 (Table 1.5). Over half of the population 
(52.4%) who gave birth in 2017 were aged 25-
34 years, whereas a slightly lower proportion 
of mothers who experienced perinatal loss 
were in this age group (42.7%). The age profile 
of mothers who experienced a stillbirth was 
similar to that of mothers who experienced early 
neonatal death. 
An association between maternal age and 
perinatal mortality was identified (Table 1.6). 
Compared to mothers aged between 25-29 
years, women aged less than 20 years had 2.7 
times the rate of perinatal mortality and women 
aged greater than 40 years had at 1.8 times the 
rate of perinatal mortality.
Table 1.5: Age distribution of mothers experiencing perinatal loss in 2017



















<20yrs 12(3.3) 14(4.1) 1.7% 11(4.7) 3(2.7)
20-24yrs 39(10.6) 41(11.9) 8.3% 28(12) 13(11.7)
25-29yrs 43(11.7) 52(15.1) 17.4% 36(15.5) 16(14.4)
30-34yrs 136(36.9) 95(27.6) 35.0% 63(27) 32(28.8)
35-39yrs 101(27.4) 105(30.5) 30.6% 72(30.9) 33(29.7)
>40yrs 38(10.3) 37(10.8) 7.0% 23(9.9) 14(12.6)
Note: Values are shown as n (%) unless otherwise stated. Maternal age unknown for two stillbirths in 2017 and five cases in 2016. 
Table 1.6: Comparing the relative risk of perinatal mortality by age group among mothers in 2017
Age group Rate per 1,000  
(95% CI)
Relative Risk  
95% CI
P-Value
<20yrs 13.4 (7.3-22.5) 2.7 (1.5-4.9) 0.001
20-24yrs 8.1 (5.8-11) 1.7 (1.1-2.5) 0.015
25-29yrs 4.9 (3.7-6.4) 1.00 (reference)
30-34yrs 4.4 (3.6-5.4) 0.9 (0.6-1.3) 0.567
35-39yrs 5.6 (4.6-6.8) 1.1 (0.8-1.6) 0.425
>40yrs 10.8 (7.9-14.4) 1.8 (1.2-2.7) 0.007
Note: Maternal age unknown for two cases in 2017. 95% CI=Exact Poisson 95% confidence intervals. 
25 Healthcare Pricing Office. Perinatal Statistics Report 2017. Dublin: Health Service Executive. Provisional data [in press] 
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26 Centre for Maternal and Child Enquiries (CMACE) (2010) Perinatal Mortality 2008: United Kingdom. London: CMACE
27 Healthcare Pricing Office. Perinatal Statistics Report 2017. Dublin: Health Service Executive. Provisional data [in press]. 
28 Healthcare Pricing Office. Perinatal Statistics Report 2017. Dublin: Health Service Executive. Provisional data [in press]. 
Ethnicity
Assessment of risk of perinatal loss associated 
with ethnic group is impeded by the absence 
of national data on ethnicity for the pregnant 
population in Ireland. The majority of mothers 
who experienced perinatal loss were of white 
Irish ethnicity (74.0%) (Table 1.7). This is close 
to the proportion of white Irish women in the 
female population aged 15-49 years enumerated 
by the National Census 2016. While the numbers 
involved were small, Irish Traveller, Asian and 
Black ethnicities were overrepresented in the 
mothers who experienced perinatal deaths 
in 2017 (12.1%) compared to 5% of the female 
15-49-year-old population. 
Table 1.7: Ethnicity of mothers experiencing perinatal loss in 2017
Ethnicity Perinatal deaths  
2017 N(%)
15-49 year-old female  
population, 2016 (%)
White Irish 256(74.0) 77.1
Irish Traveller 13(3.8) 0.7
Other white background 37(10.7) 13.3
Asian/Asian Irish 15(4.3) 1.6
Black/Black Irish 14(4.0) 2.7
Other/Mixed 11(3.2) 1.8
Not recorded/Missing - 2.7
Note: Values are shown as n(%) unless otherwise stated. Population data from the National Census 2016. 
Employment Status
Lower socio-economic status has been shown to 
be associated with poor pregnancy outcomes.26 
In the NPEC national clinical audit, data on the 
mother’s and father’s employment status at 
booking was sought. Data was not recorded for 
34 (9.8%) of the 346 women who experienced 
perinatal loss; this was slightly higher than the 
proportion of unrecorded employment status 
in 2016 (8.6%). Table 1.8 provides a high-level 
overview of the data that were provided on 
mother’s occupation alongside data available for 
the most comparable occupation categories for 
mothers of all births in Ireland (from the Perinatal 
Statistics Report 2016)27 and for the 15-44 year-
old female population from the National Census 
2016.
Employment status was specified for 90.2% 
of the mothers for whom data were recorded 
(Table 1.8). It can be seen that unemployment 
status was recorded for 9.9% of the mothers 
experiencing perinatal loss compared to 4.7% of 
all mothers and 8.2% of the female population 
aged 15-44 years. The proportion of mothers 
engaged in home duties who experienced 
perinatal loss (16.0%) was slightly lower than the 
percentage of all women engaged in home duties 
who gave birth (18.6%) in 2017.
Table 1.8: Employment status at booking of mothers experiencing perinatal loss in 2017
Employment Status Perinatal deaths  
2017 N=312 
N(%)
All births*28  
(%)
15-44 year-old female 
population** 
(%)
Employed 218(69.9) 72.9 57.8*
Unemployed 31(9.9) 4.7 8.2
Home duties 50(16.0) 18.6 10.4
Student 11(3.5) n/a 21.1
Others not in labour force 2(0.6) n/a 2.5
Note: Data not known on employment status for 34 perinatal deaths. *Employment status was not stated or not classifiable for 
3.8% of all births in 2017. **Population data from Census 2016.
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Gestation at booking
Gestation at the time of the mother’s first antenatal visit to the maternity hospital was not recorded for 
36 cases of perinatal death in 2017 (10.4%). Of those with data, almost thirty percent (29.0%) booked 
into hospital before 12 weeks gestation, over sixty percent (61.9%) attended for antenatal care between 
12 and 19 weeks gestation (Table 1.9). The proportion of women presenting for first antenatal visit at 20 
weeks gestation or later was slightly higher in 2017 (7.7%) compared to 2016 (4.8%) (Figure 1.8).
Table 1.9: Weeks gestation at date of first hospital booking in 2017








Less than 12 Weeks 85(25.2) 90(29.0) 56(25.8) 34(36.6)
12-19 Weeks 235(69.7) 192(61.9) 138(63.6) 54(58.1)
20 Weeks or Later 16(4.8) 24(7.7) 21(9.7) 3(3.2)
Not Booked 1(0.3) 4(1.3) 2(0.9) 2(2.2)
Note: Gestation at booking unknown for 36 cases in 2017; in 2016, gestation at booking was unknown for 32 cases and not 
recorded for five cases. 
Figure 1.8: Proportion attending first booking appointment ≥20 weeks gestation among women who 
experienced perinatal loss in 2013-2017 
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Anatomy scan
For the first year of this audit, the NPEC have 
collected data on whether a woman underwent an 
anatomy scan. As recommended by the Institute of 
Obstetrics and Gynaecology, second trimester fetal 
anomaly ultrasound scanning should be universally 
available for all pregnant women in Ireland. 
Data on whether a woman received an anatomy 
scan was recorded for 310 of 346 woman who 
experienced perinatal loss in 2017. Of these 310 
women, more than three quarters (n=266, 76.9%) 
received an anomaly scan. Rates varied across 
the maternity units, with some units having rates 
of 100% and other units having rates of 40% and 
below.
Fertility treatment 
Currently in Ireland there is no national data on the 
number of births as a result of fertility treatment. 
The NPEC Notification Form contains a specific 
question on whether the pregnancy resulting in 
perinatal loss was the result of fertility treatment. 
In 2017, information was available for 321 of the 346 
(92.8%) cases of perinatal death. In 28 of these 321 
cases (8.7%) the pregnancy was reported to be the 
result of fertility treatment (n=18 of 220 stillbirths, 
8.2%; n=10 of 101 early neonatal deaths, 9.9%). 
Twelve of these 28 pregnancies (42.9%) were 
associated with multiple births ending in perinatal 
loss of one or more infants. 
The method of treatment was specified for 25 
of the 28 (89.3%) pregnancies resulting from 
fertility treatment. In order of frequency, the 
methods were: in vitro fertilisation (including egg 
donation and Intracytoplasmic Sperm Injection 
(ICSI) and other types) (n=20), and other (n=4). 
Body Mass Index
Increased maternal Body Mass Index (BMI) 
has been associated with an increased risk 
of congenital anomaly and stillbirth.29, 30 The 
recording of BMI in maternity records is a key 
recommendation of the Obesity and Pregnancy 
Clinical Practice Guideline. While this may be 
common practice in maternity units, no national 
data on the BMI of the pregnant population are 
available.31
Body Mass Index (BMI) was available for 312 of 
the 346 of women who experienced perinatal 
loss in 2017 (Table 1.10). The BMI of 43.3% of 
these mothers was in the healthy range (18.5-
24.9kg/m2), which is similar to the previous 
years. In each of the six years, 2012-2017, over 
fifty percent of the mothers (56.1% in 2017) 
who experienced perinatal loss were either 
overweight or obese albeit with fluctuation in the 
distribution of these two groups. The pattern of 
BMI in the mothers who experienced perinatal 
loss remains similar to that in the women from 
the general population who participated in the 
2015 Health Ireland Survey.32




















Underweight (<18.5) 5(1.4) 7(1.8) 5(1.2) 6(1.8) 2(0.6) 3%
Healthy (18.5-24.9) 161(45.4) 181(45.3) 179(43.8) 140(42.0) 135(43.3) 44%
Overweight (25.0-29.9) 99(27.9) 108(27) 128(31.3) 114(34.2) 103(33) 31%
Obese (≥ 30.0) 90(25.4) 104(26) 97(23.7) 73(21.9) 72(23.1) 22%
Note: Values are shown as n(%) unless otherwise stated; *Percentage refers to the total 312 cases for which BMI was obtained in 2017.
29 Rasmussen SA, Chu SY, Kim SY, Schmid CH, Lau J. Maternal obesity and risk of neural tube defects: a metaanalysis.  
Am J Obstet Gynecol 2008;198:611-9. 
30 Chu SY, Kim SY, Lau J, Schmid CH, Dietz PM, Callaghan WM, et al. Maternal obesity and risk of stillbirth: a metaanalysis. 
Am J Obstet Gynecol 2007;197:223-8.
31 Clinical Practice Guideline No 2 (2011). Obesity and Pregnancy: Institute of Obstetricians and Gynaecologists, Royal 
College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, Health Service Executive.
32 Ipsos MRBI (2015). Healthy Ireland Survey 2015. Dublin: The Stationery Office.
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Smoking and substance misuse
Smoking status of the mothers at their time of 
booking was recorded for 320 (92.5%) of the 346 
women. Of these, 52 (15.0%) were smokers at 
the time of booking. Twenty-three were smoking 
between one and nine cigarettes per day (n=23 of 
52, 44.2%) and twenty-nine were smoking at least 
up to 10 cigarettes per day (n=29 of 52, 55.8%). 
Information on smoking in late pregnancy was 
available for 38 of the 52 smokers (73.1%) and only 
four (7.7%) stopped smoking during pregnancy. 
The prevalence of smoking during pregnancy or in 
the last trimester is not routinely known for all Irish 
pregnancies but rates of 12%, 15%, 16% and 19% 
have been reported for England, Northern Ireland, 
Wales and Scotland, respectively.33
Three women had a documented history of 
alcohol misuse prior to pregnancy and two 
women had a documented history of alcohol 
misuse during pregnancy. Seven women had 
a documented history of drug misuse prior to 
pregnancy and six women had a documented 
history of drug misuse during pregnancy.
Previous pregnancy 
Two thirds of mothers who experienced perinatal 
loss in 2017 had at least one previous pregnancy 
(gravida > 0; 230 of 346, 66.5%). Table 1.11 
specifies gravida/parity for the 346 women who 
experienced perinatal loss in 2017. One third of 
women (n=116, 33.5%) had never been pregnant 
before (gravida = 0). Of the 230 women who had 
been pregnant (gravida > 0), over half (n=129, 
56.1%) had pregnancies exceeding 24 weeks or 
500g birthweight (gravida = parity, indicated 
by green shading). Over one third of these 230 
mothers (n=70, 30.4%) experienced at least 
one pregnancy exceeding 24 weeks or 500g 
birthweight and at least one pregnancy less than 
24 weeks gestation and under 500g birthweight 
(gravida > parity > 0, indicated by yellow 
shading). Additionally, for 13.5% (n=31) these 
women’s previous pregnancies never exceeded 
24 weeks gestation or 500g birthweight (gravida 
> parity = 0, indicated by orange shading).








0 1 2 3 4 5 7 9 Total
0 116 0 0 0 0 0 0 0 116
1 23 67 0 0 0 0 0 0 90
2 8 17 47 0 0 0 0 0 72
3 0 4 16 5 0 0 0 0 25
4 0 2 5 4 8 0 0 0 19
5 0 1 0 4 5 2 0 0 12
6 0 0 0 3 0 1 0 0 4
7 0 0 0 1 1 1 0 0 3
8 0 0 1 0 1 0 1 0 3
10 0 0 0 0 0 0 0 1 1
11 0 0 0 0 0 0 0 1 1
Total 147 91 69 17 15 4 1 2 346
Note: We refer to gravida and parity prior to the pregnancy ending in perinatal death in 2017. Green represents women with 
previous pregnancies that were all ≥24 weeks or ≥500g; yellow represents women who had experienced pregnancy ≥24 weeks 
or ≥500g and also pregnancy <24 weeks and <500g; and, orange represents women whose previous pregnancies were always 
<24 weeks gestation and <500g birthweight. 
33 EURO-PERISTAT Project with SCPE and EUROCAT. European Perinatal Health Report. The health and 
care of pregnant women and babies in Europe in 2010. May 2013. Available www.europeristat.com
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Of the 230 women who had a previous 
pregnancy, 41.3% (n=95) were reported to have 
had a previous pregnancy-related problem 
(unknown for two women). Caesarean section 
delivery was the most common previous 
pregnancy-related problem with over twenty 
percent of mothers (n=52, 22.6%) having a 
previous caesarean section delivery (Table 
1.12). Pre-term birth or mid-trimester loss was 
the second most common, with (n=13, 5.7%) 
of mothers experiencing this in a previous 
pregnancy. 











Previous caesarean delivery 61(18.9) 64(19.3) 71(22.1) 69(26.1) 52(22.6)
Pre-term birth or mid-trimester loss 14(4.3) 29(8.7) 24(7.5) 24(9.1) 13(5.7)
Three or more miscarriages 14(4.3) 16(4.8) 24(7.5) 21(8) 7(3.0)
Baby with congenital anomaly 10(3.1) 7(2.1) 10(3.1) 7(2.7) 7(3.0)
Infant requiring intensive care 4(1.2) 14(4.2) 13(4) 11(4.2) 6(2.6)
Stillbirth 9(2.8) 7(2.1) 12(3.7) 9(3.4) 5(2.2)
Neonatal death 5(1.6) 6(1.8) 3(0.9) 5(1.9) 5(2.2)
Pre-eclampsia 12(3.7) 18(5.4) 8(2.5) 11(4.2) 5(2.2)
Placental abruption 1(0.3) 4(1.2) 4(1.2) 3(1.1) 2(0.9)
Placenta praevia 1(0.3) 2(0.6) 1(0.3) 2(0.8) 1(0.4)
Post-partum haemorrhage requiring transfusion 3(0.9) 4(1.2) 5(1.6) 5(1.9) 1(0.4)
Other 39(12.1) 46(13.9) 35(10.9) 43(16.3) 26(11.3)
*Note: Percentage relates to total number of mothers who had a previous pregnancy (n = 230). 
In terms of parity, women who experienced 
perinatal loss in 2017 were broadly similar to the 
population of women who gave birth in 2017 
although there was an overrepresentation of 
women with at least three previous deliveries 
among those who experienced perinatal loss 
(Table 1.13). The risk of perinatal death increased 
with parity, women who had three or more 
previous deliveries had over a sixty percent higher 
risk of perinatal death compared to women who 
had one previous delivery. (Table 1.14).



















Nulliparous 170(37.3) 180(38.6) 172(38) 135(36.2) 147(42.5) 38.6%
Para 1 136(29.8) 140(30) 148(32.7) 128(34.3) 91(26.3) 34.3%
Para 2 87(19.1) 84(18) 84(18.5) 62(16.6) 69(19.9) 17.9%
Para 3+ 62(13.6) 62(13.3) 49(10.8) 48(12.9) 39(11.3) 9.1%
Note: Values are shown as n(%) unless otherwise stated. 
34 Healthcare Pricing Office. Perinatal Statistics Report 2017. Dublin: Health Service Executive. Provisional data [in press] 
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Table 1.14: Comparing the relative risk of perinatal mortality by parity among mothers in 2017
Parity





Nulliparous 6.2 (5.3-7.3) 1.44 (1.11-1.87) 0.006
Para 1 4.3 (3.5-5.3) 1.00 (reference) -
Para 2 6.3 (4.9-8) 1.45 (1.06-1.99) 0.019
Para 3+ 7.0 (5.0-9.5) 1.61 (1.11-2.34) 0.013
Note: 95% CI=Exact Poisson 95% confidence intervals. 
Pre-existing medical problems
Information about pre-existing medical 
conditions was available for 337 of the 346 
mothers who experienced perinatal loss in 
2017 (97.4%). Over thirty percent of these 337 
women had a pre-existing medical problem 
(n=107, 31.8%). This represents a slight decrease 
compared to 2016 (n=123, 35.4%).
The most common type of pre-existing medical 
problems were the Psychiatric disorders with 
8.0% of mothers (n=27 of 336 women) suffering 
from conditions of this type (Table 1.15). This 
was followed by Endocrine disorders which had 
second the highest percentage of occurrence 
(n= 22, 6.5%). Under the “Other” category a 
wide range of problems were captured, such as 
gynaecological issues, asthma, musculoskeletal 
and hepatic issues. 











Psychiatric disorder 24(5.5) 34(7.7) 31(7.0) 40(11.5) 27(8.0)
Endocrine disorder 17(3.9) 30(6.8) 24(5.4) 26(7.5) 22(6.5)
Diabetes 13(3.0) 16(3.6) 16(3.6) 8(2.3) 7(2.1)
Cardiac disease 11(2.5) 9(2.0) 6(1.4) 6(1.7) 6(1.8)
Hypertension 7(1.6) 10(2.3) 13(2.9) 9(2.6) 6(1.8)
Renal disease 5(1.2) 7(1.6) 4(0.9) 3(0.9) 4(1.2)
Haematological disorder 3(0.7) 8(1.8) 5(1.1) 9(2.6) 4(1.2)
Inflammatory disorder 3(0.7) 6(1.4) 17(3.9) 3(0.9) 2(0.6)
Epilepsy 4(0.9) 1(0.2) 5(1.1) 1(0.3) 0
Other 90(20.7) 105(23.6) 65(14.7) 62(17.9) 61(18.1)
Any pre-existing medical problem 143(32.9) 175(39.4) 138(31.3) 123(35.4) 107(31.8)
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Delivery
Labour was induced in almost a third of women 
who experienced a stillbirth (n=150 of 235, 63.8%) 
and 15.3% of those who experienced a neonatal 
death (n=17 of 111). A caesarean section was the 
planned mode of delivery for 10.3% of the women 
who experienced a stillbirth (n=24 of 234, unknown 
for one case) and 24.3% of the women who 
experienced an early neonatal death (n=27 of 111).
The type of care received at delivery was known 
for all of the mothers who experienced perinatal 
loss (n=346). The vast majority of the babies 
(n=339, 98.0% of 346) were delivered under 
obstetric-led care which is the predominant model 
of care in Ireland. Three babies (0.9%) were born 
before arrival at the maternity unit. 
Presentation at delivery was known for almost 
all mothers who experienced perinatal loss 
(n=344 of 346, 99.4%). Over seventy percent 
of presentations at delivery were vertex 
presentations (n=251 of 344, 73.0%), over one 
in four were breech presentation (n=90 of 344 
26.1%) and in just three cases, the presentation 
was compound (n=3 of 344, 0.9%).
Mode of delivery was known for all of mothers 
who experienced perinatal loss (Table 1.16). 
Spontaneous vaginal cephalic delivery was the 
mode of delivery for almost sixty percent of 
stillbirths (n=139 of 235, 59.1%) and for thirty-
five percent of the babies who died in the early 
neonatal period (n=39 of 111, 35.1%). Over half of 
the deliveries in cases of neonatal death involved 
caesarean section (n=58, 52.3%), usually pre-
labour (n=45, 40.5%). Approximately fifteen 
percent of stillbirths involved caesarean section 
(n=37, 15.7%), again predominantly pre-labour 
(n=29, 12.3%). Among stillbirths delivered by 
caesarean section, over thirty percent of the 
mothers (n=12 of 37, 32.4%) had a previous 
caesarean delivery. 
In comparison to the proportion of all births 
occurring with assisted breech delivery in 2017 
(0.5%), this type of delivery is relatively more 
common in stillbirths (5.5%) and neonatal deaths 
(4.5%). The higher rate of breech delivery in 
stillbirths may be explained by the fact that these 
were a planned delivery. 




Neonatal deaths  
(N=111)  
N(%)
All births 201735 
(%)
Spontaneous vaginal cephalic 139(59.1) 39(35.1) Vaginal birth
52.5%Spontaneous vaginal breech 40(17.0) 5(4.5)
Pre-labour caesarean section 29(12.3) 45(40.5) Caesarean section
32.7%Caesarean section after the onset of labour 8(3.4) 13(11.7)
Assisted breech 13(5.5) 5(4.5) 0.5%
Ventouse 5(2.1) 2(1.8) 10.8%
Forceps 1(0.4) 2(1.8) 3.5%
Note: Values are n(%) unless otherwise stated. 
The type of caesarean section was known for 
all but one stillbirth case delivered by caesarean 
section (n=94 of 95). A similar proportion 
of caesarean sections were categorised as 
emergency caesarean section delivery (n=36 of 
94, 38.3%) and urgent caesarean section delivery 
(35 of 94, 37.2%). One in four were categorised as 
elective caesarean sections (n=23 of 94, 24.5%). 
Urgent caesarean delivery was the most common 
type of caesarean delivery in stillbirths (n=14 of 
36, 38.9%) and emergency caesarean delivery 
was the most common type of caesarean 
delivery in neonatal deaths (n=25 of 58, 43.1%).
35 Healthcare Pricing Office. Perinatal Statistics Report 2017. Dublin: Health Service Executive. Provisional data [in press] 
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Level of care for mothers  
post-delivery 
For women who experienced perinatal loss in 
2017, 3.8% (n=13 of 341, unknown for five cases) 
were admitted to a high dependency unit (HDU) 
and only one case (n=1 of 344, 0.3% unknown 
for five cases) was admitted to an intensive care 
unit (ICU). Similar admission rates were reported 
for the years between 2013 and 2016 (Table 1.17). 
Admission to HDU for the mother was more 
common in cases of early neonatal death than in 
stillbirths.
Deliveries by emergency caesarean section were 
associated with higher levels of admission to 
the HDU (17.1%, n=6 of 35 cases of this type of 
caesarean section, unknown for one case).




























Admitted to HDU 29(6.4) 26(5.7) 41(9.2) 20(5.4) 13(3.8) 6(2.6) 7(6.3)
Admitted to ICU 6(1.3) 16(3.5) 9(2) 7(1.9) 1(0.3) 0(0) 1(0.9)
Note: Values are n(%) unless otherwise stated. *Admission data unknown for five women in 2017. 
Infant characteristics
The findings presented below are based on stillbirths and early neonatal deaths born with a birthweight 
≥500g or having achieved a gestational age ≥24 weeks.
Sex 
There were four perinatal deaths for which the sex of the baby was indeterminate (Table 1.18). Of the 346 
perinatal deaths, 53.2% were male (n=184). In the overall population of births in 2017, 51.4% were male 
and 48.5% female.36 Male babies outnumbered female babies among stillbirths and early neonatal deaths.
Table 1.18: Sex of baby in stillbirths and neonatal deaths in 2017





There was an association between perinatal death and multiple pregnancies. There were 43 perinatal 
deaths from multiple births, making up 12.4% of all perinatal deaths in 2017 (Table 1.19). This is over three 
times the proportion of multiples among all births in 2017 (3.8%).
Table 1.19: Perinatal deaths from singleton and multiple births in 2017
Perinatal Deaths N(%) Stillbirths N(%) Early Neonatal Deaths N(%) All births  
201737 (%)
Singleton 303(87.6) 214(91.1) 89(80.2) 96.3%
Twins 40(11.5) 19(8.0) 21(18.9)
3.7%Triplet 3(0.9) 2(0.9) 1(0.9)
Other Multiple (0) (0) (0)
36 Healthcare Pricing Office. Perinatal Statistics Report 2017. Dublin: Health Service Executive. Provisional data [in press] 




























Gestational age at delivery (weeks)
Stillbirths Early Neonatal Deaths
The 43 perinatal deaths from multiple births 
comprised 21 stillbirths and 22 early neonatal 
deaths. The majority (n=12, 54.5%) of the 22 
early neonatal deaths from multiple births were 
due to respiratory disorders, most often severe 
pulmonary immaturity, the remaining ten deaths 
were due to major congenital anomalies (n=8, 
36.4%) and neurological disorders (n=2, 9.1%). 
The main cause of death for the 21 stillbirths from 
multiple births were specific placental conditions 
(n=8, 38.1%), specific fetal conditions (n=5, 
23.8%), major congenital anomalies (n=2, 9.5%) 
and associated obstetric factors (n=1, 4.8%). The 
main cause of death was unexplained for five 
stillbirths (n=5, 23.8%).
Chorionicity was reported for 41 of the 43 
perinatal deaths from multiple births. The vast 
majority were cases with dichorionic diamniotic 
(n=29, 67.4%) and the remaining cases were 
monochorionic diamniotic (n=9, 20.9%) and 
trichorionic (n=2, 4.7%). 
There were 28 cases where one twin died, 
six pairs of twins where both twins died and 
three cases where one triplet died, indicating 
a total of 43 perinatal losses involving 37 
pregnancies. It was reported that ten of these 
multiple pregnancies were the result of a fertility 
treatment (10 of 35 pregnancies, 28.6%, unknown 
for two cases).
Gestation 
Almost seventy percent of perinatal deaths in 2017 were associated with delivery before 37 weeks 
gestation (n=241 of 346, 69.7%). This was the case for 66.4% of stillbirths (n=163 of 235) and 70.3% of 
early neonatal deaths (n=78 of 111). A higher proportion of extremely pre-term delivery, i.e. delivery at 
22-27 weeks gestation, was more often associated with cases of early neonatal death than cases of 
stillbirth (Figure 1.9).
Figure 1.9: Distribution of gestational age at delivery in stillbirths and neonatal deaths in 2017 




































The most represented birthweight in cases of perinatal death was in the range of 500-999 grams (n=85 
of 346, 24.6%) (Figure 1.10). In over seventy percent of perinatal deaths (n=246, 71.1%) the birthweight 
was less than 2,500 grams. For stillbirths, 68.9% had a birthweight below 2,500g (n=162 of 235) and 
75.7% of neonatal deaths (n=84 of 111) also registered weight below this value. 
Figure 1.10: Distribution of birthweight in stillbirths and neonatal deaths in 2017
Birthweight centiles
An increased risk of perinatal death has been 
associated with failure of fetal growth in utero. We 
have produced two charts to highlight this issue 
in relation to the stillbirths and early neonatal 
deaths that occurred in Ireland in 2017. To do so, 
we used the Gestation Related Optimal Weight 
(GROW) software38 and coefficients derived from 
the multiple regression analysis of data on 11,072 
births in six maternity units in Dublin, Galway, 
Limerick and Belfast in 2008-2009.39
The regression analysis determined the Term 
(i.e. 40 weeks) Optimal Weight (TOW) in Ireland 
to be 3,490.7g. The normal range (i.e. the range 
from the 10th centile weight to the 90th centile 
weight) around the TOW was then calculated 
and the recommended proportionality growth 
function was applied to the TOW, the 10th centile 
term weight and the 90th centile term weight 
in order to determine the optimal weight and 
normal range at all gestations (21-44 weeks for 
stillbirths and early neonatal deaths in Ireland in 
38 Gardosi J, Francis A. Customised Weight Centile Calculator. GROW version 6.7.6.5(IE), 2015 Gestation Network, www.gestation.net
39 Unterscheider J, Geary MP, Daly S, McAuliffe FM, Kennelly MM, Dornan J, Morrison JJ, Burke G, Francis A, Gardosi J, Malone FD. 
The customized fetal growth potential: a standard for Ireland. Eur J Obstet Gynecol Reprod Biol 2013; 166(1):14-7
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2017). These steps are described in detail in the 
GROW documentation.
The optimal weight and normal range for 
all gestations are plotted with the actual 
birthweights of the stillbirths in Figure 1.11 and 
with the birthweights for cases of early neonatal 
death in Figure 1.12. For stillbirths across all 
gestational ages, a high proportion were below 
the lower limit of the normal range (10th centile). 
In cases of early neonatal death, the birthweight 
was often below the normal range for births after 
32 weeks gestation. However, low birthweight was 
observed less often than for cases of stillbirth.
Figures 1.11 and 1.12 have the limitation of plotting 
actual birthweights against the optimal weight 
and normal range adjusted only for gestational 
age. There is no adjustment for other factors 
affecting birthweight, namely, maternal height, 
weight, parity and ethnic group and infant sex. 
The use of centiles customised for maternal 
and infant characteristics affecting birthweight 
identifies small babies at higher risk of mortality 
better than population centiles.40 Small-for-
gestational-age (SGA) refers to birthweights 
below the 10th centile and severely SGA refers to 
birthweights less than the 3rd centile.41
40 Clausson B, Gardosi J, Francis A, Cnattingius S. Perinatal outcome in SGA births defined by customised versus population–based 
birthweight standards. BJOG 2001;108:830–4.
41 Royal College of Obstetrics and Gynaecologists. The investigation and management of the small-for-gestational age fetus.  
RCOG Green Top Guideline 2013 (No.31). Available at: www.rcog.org.uk/files/rcog-corp/22.3.13GTG31SGA_ExecSum.pdf
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Figure 1.12: Optimal birthweight and normal range compared to actual birthweights in early neonatal deaths, 2017
Customised birthweight centiles were derived 
using the GROW software.42 There was missing 
data for maternal height (n=49, 14.2%) and 
weight (n=48, 13.3%). For these cases, we used 
the median height and weight of the mothers 
with complete data. The GROW software also 
provides estimated customised birthweight 
centiles in cases with missing data. Ultimately, 
customised birthweight centiles were calculated 
for all 344 of the 346 perinatal deaths. 
The distribution of customised birthweight 
centiles at all gestations is illustrated for 
stillbirths in Figure 1.13 and for early neonatal 
deaths in Figure 1.14. At all gestations, there were 
cases spanning the full range of birthweight 
centiles (i.e. 0-100th) but there was a clear 
overrepresentation of cases below the median 
and far more at or near centile zero than would 
be expected in the population of all births.





































































Figure 1.13: Distribution of customised birthweight centiles for stillbirths, 2017
Figure 1.14: Distribution of customised birthweight centiles for early neonatal deaths, 2017
42 PERINATAL MORTALITY IN IRELAND 
Table 1.20 details the number and percentage 
of stillbirths and early neonatal deaths within 
specific ranges of customised birthweight 
centiles. Low birthweight was associated with 
both groups but particularly with stillbirths. Forty 
percent (40.3%) of all stillbirths were classified 
as severely SGA (<3rd customised birthweight 
centile) and over almost fifty percent (49.8%) 
were SGA (<10th customised birthweight centile) 
compared to 34.2% and 45.0% of the cases of 
early neonatal death, respectively. SGA may be 
more prevalent among stillborn babies because 
they may have died some days or weeks before 
being delivered. We do not record whether there 
was evidence of maceration in cases of stillbirth 
but there was support for this hypothesis. The 
customised birthweight centile of the stillborn 
baby was lower when there was more than 
one week between confirmation of death and 
delivery.
Table 1.20: Distribution of customised birthweight centiles, 2017




< 3rd 94(40.3) 38(34.2)




*Includes cases from the category <3rd Centile. Centiles could not be calculated for two stillbirths.
Cases of stillbirth and early neonatal death were 
at significantly lower birthweight centiles when 
the cause of death was attributed to major 
congenital anomaly (Table 1.21). Over half of the 
63 stillbirths due to congenital anomaly (n=35, 
55.6%) were severely SGA in comparison to 
35% of the stillbirths due to other causes (n=59, 
34.7%). Similarly, almost fifty percent of the 62 
early neonatal deaths due to congenital anomaly 
(n=30, 48.4%) were severely SGA compared to 
just sixteen percent (n=8, 16.3%) of the 49 early 
neonatal deaths due to other causes.
Table 1.21: Distribution of customised birthweight centiles of perinatal deaths due and not due to major 
congenital anomaly, 2017
Centile Stillbirth (N=233 of 235) Neonatal death (N=111)









< 3rd 35(55.6) 59(34.7) 30(48.4) 8(16.3)
< 10th 3(60.3)* 19(45.9)* 9(62.9)* 3(22.4)*
10-49th 7(11.1) 52(30.6) 11(17.7) 17(34.7)
50-89th 8(12.7) 26(15.3) 10(16.1) 10(20.4)
90th+ 10(15.9) 14(8.2) 2(3.2) 11(22.4)
Note: Values are n (%) unless otherwise stated. *Includes cases from the category <3rd Centile.
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Diagnosis of fetal growth restriction (FGR)
Data on diagnosis of fetal growth restriction 
(FGR) were recorded for 337 of the 346 perinatal 
deaths. A diagnosis of FGR was reported 
for 88 (26.1%) of the 337 deaths, 65 (28.4%) 
stillbirths and 23 (21.3%) early neonatal deaths. 
An antenatal diagnosis of FGR (as opposed 
to diagnosis based on observation at delivery 
or post-mortem) was reported for 61 perinatal 
deaths (18.1%), 39 stillbirths (17.0%) and 22 early 
neonatal deaths (20.4%).
For stillbirths and cases of early neonatal death 
that were severely SGA (<3rd customised 
birthweight centile), approximately 38.6% (n=49 
of 127) had an antenatal diagnosis of FGR (Table 
1.22). The level of antenatal diagnosis of FGR was 
lower for stillbirths and early neonatal death that 
were SGA (stillbirths = 28.8%, neonatal deaths = 
42.0%) compared to stillbirths and early neonatal 
death that were severely SGA (stillbirths = 34.8%, 
neonatal deaths = 47.4%). 
Table 1.22: Antenatal diagnosis of fetal growth restriction (FGR) for small-for-gestational-age (SGA) and 
severely SGA perinatal deaths in 2017
Antenatal diagnosis of FGR 
n of N (%)
Stillbirth
Severely SGA (<3rd centile) 31 of 89 (34.8%)
SGA (<10th centile)* 32 of 111 (28.8%)*
Neonatal death
Severely SGA (<3rd centile) 18 of 38 (47.4%)
SGA (<10th centile)* 21 of 50 (42.0%)*
Note: SGA cases include severely SGA cases; FGR diagnosis unknown for nine stillbirths. 
Recommendation: Improved antenatal 
detection of fetal growth restriction (FGR) 
with timely delivery is a preventative strategy 
to reduce perinatal mortality. 
–  Again, we recommend the generation of 
customized birth weight centile charts 
for every woman during pregnancy and 
concomitantly, staff should be trained in 
risk assessment, plotting symphysial fundal 
height (SFH) and scan weight estimates in 
order to reduce stillbirths in Ireland.
–  Based on feedback to the NPEC, other 
methodologies could be considered. A 
multidisciplinary working group should 
be developed to address a national 
standardised approach to the detection 
of FGR. A national approach should also 
evaluate the use of a standard growth 
curve across all Irish maternity units. The 
Institute of Obstetrics and Gynaecology 
would be well placed to facilitate this 
working group.
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Investigations to determine the cause of death
Autopsy
Current practice guidelines recommend that 
parents should be offered a full post-mortem 
examination of the stillborn infant to help explain 
the cause of death.43 Data on autopsy uptake 
was reported for 338 of the 346 perinatal deaths, 
of which 54.4% (n=184) underwent an autopsy. 
The rate of autopsy uptake in 2017 is higher than 
the 47.8% reported in 2016 and is higher than 
rates reported in previous years. The trend in the 
perinatal autopsy rate is illustrated in Figure 1.15. 
The autopsy uptake rate in stillbirths continues to 
be higher than in cases of early neonatal death.
In Ireland in 2017, an autopsy was undertaken 
following 60.0% of stillbirths (n=138 of 230, 
unknown for five cases) and 42.5% of early 
neonatal deaths (n=46 of 108, unknown for three 
cases), see Figure 1.17. These figures are higher 
than in the United Kingdom as a whole in 2016 
(full autopsy for 44.5% of stillbirths and 26.3% of 
early neonatal deaths).44
Figure 1.15: Autopsy uptake percentage, 2011-2017 
43 Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: Institute of 
Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, 
Health Service Executive.
44 Draper ES, Gallimore ID, Kurinczuk JJ, Smith PW, Boby T, Smith LK, Manktelow BN, on behalf of the MBRRACE-UK Collaboration. 
MBRRACE-UK Perinatal Mortality Surveillance Report, UK Perinatal Deaths for Births from January to December 2016. Leicester: 























Total number of perinatal deaths in unit (≥500g or ≥24 weeks)
Unit-specific rate Overall rate      95% Confidence interval
The variation in the rate of autopsy across the 19 maternity units in 2017 is illustrated in the funnel plot 
(Figure 1.16). This may reflect variation in access to dedicated perinatal pathology services across units. 
There was some variation found across the four large maternity units, with rates of 51.0%, 53.6%, 55.6% 
and 77.5% being found across the four units.
Figure 1.16: Funnel plot of autopsy uptake in the 19 Irish maternity units in 2017 
Note: Autopsy uptake unknown for eight cases of perinatal death.
Figure 1.17 details the autopsy-related steps 
taken following the 346 perinatal deaths in 2017 
(autopsy uptake unknown for eight cases). A 
total of 184 autopsies were performed on cases 
of perinatal death and there were 121 cases that 
did not receive an autopsy.
Forty-four of the deaths became coroner cases 
(13.1% of 338 cases for which autopsy status was 
known) and, at the time data were reported to 
the NPEC, the maternity unit had received the 
autopsy report from the coroner’s office in 31 of 
these cases (72.1%, unknown if report received 
for one case). For the 292 deaths which were 
not coroner cases, there were 138 autopsies 
undertaken.
Forty-six percent of the perinatal deaths did 
not receive an autopsy (n=154, 45.6%). For the 
majority of these cases an autopsy was offered 
and presumably declined by parents (n=121, 72.1% 
of the cases without autopsy). This represents a 
decrease in the rate of autopsy offered in 2016 
(88.7%). Such an offer was made more often in 
cases of stillbirth (80 of 121 autopsies offered, 
66.1%) than for early neonatal deaths (41 of 121, 
33.9%). Consequently, in 2017 of the 338 cases 
where data on autopsy uptake was reported, 
there were 33 perinatal deaths for which an 
autopsy was not offered (n=22 of 338, 9.8%). 
This represents a slightly higher proportion than 
in 2016, when 5.9% of perinatal deaths were not 
offered an autopsy. 
46 PERINATAL MORTALITY IN IRELAND 
 
Figure 1.17: Flowchart outlining autopsy-related steps taken after 346 perinatal deaths in 2017
Note: Autopsy unknown for five stillbirths and three early neonatal deaths. It was also not known if coroner’s report had been 
returned from coroner’s office for one stillbirth case. 
The decision not to offer to undertake an autopsy may be influenced by the clinical scenario and 
the antenatal diagnosis. There was evidence to support this in relation to major congenital anomaly. 
The proportion of cases not offered an autopsy was higher if the perinatal death was due to a major 
congenital anomaly than if it the death was due to another cause (Table 1.23). 
Table 1.23: Uptake and offer of autopsy of perinatal deaths due and not due to major congenital anomaly, 2017
Autopsy Stillbirth (N=230 of 235) Neonatal death (N=108 of 111)









Performed 24(38.1) 114(68.3) 23(39.0) 23(46.9)
Offered 30(47.6) 50(29.9) 22(37.3) 19(38.8)
Not offered 9(14.3) 3(1.8) 14(23.7) 7(14.3)
Note: Data on whether autopsy was performed and/or offered was incomplete for five cases of stillbirth and two cases of early 
neonatal death. Values are n (%) unless otherwise stated. 
Recommendation: Further research exploring factors impacting on autopsy rates, 
particularly in the case of neonatal deaths, is warranted. 
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Placental examination 
The value of placental examination in determining 
cause of perinatal death is well documented.45 
In 2017, placental histology examinations were 
conducted for almost all stillbirths (n=233 of 235, 
99.1%, unknown for two cases) and for 92.7% of 
early neonatal deaths (n=102 of 110, unknown 
for one case). Thus, there has been a very 
slight increase in the rate of placental histology 
examination for stillbirths from 96.8% in 2016 to 
99.1% in 2017 and a similar rate for early neonatal 
deaths in 2016 (93.4%) and in 2017 (92.7%). 
In 2016, lower levels of placental histology 
examinations were reported for stillbirths in the 
United Kingdom as a whole (89.9%).46
Specific placental conditions 
Abnormal placental findings have been classified 
in line with recommendations from the publication 
from the international consensus meeting of 
pathology.47 These are presented under the 
following broad categories: Maternal vascular 
malperfusion, Fetal vascular malperfusion, Cord 
pathology, Cord pathology with distal disease, 
Delayed villous maturation, Chorioamnionitis, 
Villitis, Fetal Vasculitis and other. 
Of the 234 stillbirths and 102 early neonatal 
deaths for which placental examinations were 
conducted, specific placental pathology was 
present in 182 (77.8%) of stillbirths and 69 (67.6%) 
of early neonatal deaths (Table 1.24). More than 
one placental condition was present for some 
cases. 
Specific placental conditions were generally 
more prevalent among stillbirths than among 
cases of early neonatal death. In the case of 
stillbirths, conditions within the maternal vascular 
malperfusion, fetal vascular malpersuion and 
cord pathology categories were most commonly 
reported (n=81, 34.6%, n=60, 25.6% and n=54, 
23.1% respectively).
Submission of anonymised placental histology 
reports to the NPEC as part of this audit would 
facilitate standardised interpretation and 
classification of placental conditions at national 
level. 
45 Korteweg FJ, Erwich JJ, Timmer A, van der Meer J, Ravise JM, Veeger NJ, Holm JP. Evaluation of 1025 fetal deaths: proposed 
diagnostic workup. Am J Obstet Gynecol 2012 206:53.e1-53.e12
46 Draper ES, Gallimore ID, Kurinczuk JJ, Smith PW, Boby T, Smith LK, Manktelow BN, on behalf of the MBRRACE-UK Collaboration. 
MBRRACE-UK Perinatal Mortality Surveillance Report, UK Perinatal Deaths for Births from January to December 2016. Leicester: 
The Infant Mortality and Morbidity Studies, Department of Health Sciences, University of Leicester. 2018.
47 Khong TY, Mooney EE et al (2016). Sampling and definition of placental lesions. Arch Pathol Lab Med 2016 Jul;140 (7):698-713
Table 1.24: Placental histology findings for stillbirths and early neonatal deaths, 2017 
Stillbirth (n=234 of 235) 
N(%)
Neonatal death (n=102 of 111) 
N(%)
Maternal vascular malperfusion 81(34.6) 35(34.3)
Fetal vascular malperfusion 60(25.6) 16(15.7)
Cord pathology 54(23.1) 11(10.8)
Delayed villous maturation 22(9.4) 6(5.9)
Chorioamnionitis 21(9.0) 23(22.5)
Cord pathology with distal disease 19(8.1) 3(2.9)
Villitis 10(4.3) 8(7.8)
Other placental condition* 35(15.0) 9(8.8)
Any placental condition 182(77.8) 69(67.6)
Note: More than one placental condition was present for some cases. *Includes conditions such as Placental disease due to 
massive perivillous fibrin deposition, Mesenchymal dysplasia, Diffuse chorionic hemosiderosis and Chronic histocytic intervillositis.
Recommendation: Anonymised placental histology reports on perinatal death should be submitted 
to the NPEC as part of this audit: this would facilitate standardised interpretation and classification 
of placental conditions.
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Other examinations performed 
External examinations were performed for over 
forty-seven percent of the perinatal deaths in 
2017 (n=160, 46.4%, unknown for one case) 
compared to forty-one percent (41.3%) in 2016 
(Table 1.25). Performing X-Ray, similarly to the 
trend in previous years, has continued to increase 
as it was reported to have been performed 
slightly more often following perinatal death in 
2017 (40.3%) than in 2016 (34.0%). Computerised 
tomography scans (CT scan) and magnetic 
resonance imaging (MRI) tests were rarely 
undertaken. External examination and X-ray were 
carried out more often following cases of stillbirth 
in 2017 than for cases of early neonatal death.

























External 211(45.6) 219(48.6) 154(41.3) 160(46.4) 116(49.6) 44(39.6%)
X-Ray 147(31.7) 152(33.7) 127(34.0) 139(40.3) 112(47.9) 27(24.3)
CT scan 1(0.2) 1(0.2) 2(0.5) 5(1.4) 5(2.1) 0(0)
MRI 2(0.4) 1(0.2) 3(0.8) 11(3.2) 7(3.0) 4(3.6)
Note: Values are n (%) unless otherwise stated. CT=Computerised tomography, MRI=magnetic resonance imaging. Data on 
whether other examination was performed was missing for one stillbirth case. 
Cytogenetic analysis is an important investigation 
in the diagnosis of chromosomal abnormalities. 
Some abnormalities are potentially recurrent 
and can be tested for in future pregnancies.48 
In the event of a chromosomal disorder, a 
specific question on the NPEC Perinatal Death 
Notification form (Appendix E) asks how the 
diagnosis was made. A chromosomal disorder 
was the most commonly reported major 
congenital malformation causing death in 2017 
(64 perinatal deaths; 38 stillbirths and 26 early 
neonatal deaths). In almost over sixty percent of 
these cases (n=40 of 64, 52.6%), the diagnosis 
was made by cytogenetic analysis (n=20 of 38 
stillbirths, 52.6%; n=20 of 26 neonatal deaths, 
76.9%). 
Genetic investigation in chromosomal disorders 
48 Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: Institute of Obstetricians and 
Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, Health Service Executive. 
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2.  Invited Commentary by Dr Anne Twomey:  
The impact on prematurity on our perinatal 
mortality rate 
The NPEC has now published its seventh annual 
report on perinatal mortality in Ireland. The 
fundamental aim of this yearly audit is to improve 
the care of mothers and babies in Ireland. Each 
year in Ireland, approximately 400 babies are 
stillbirth or die within the first week. The loss of a 
baby, whether a stillbirth or a neonatal death, is 
a devastating outcome for all concerned and has 
lasting effects on parents, families and healthcare 
professionals. By providing key epidemiological 
data and monitoring adverse outcomes, this 
annual report aspires to drive improvements 
in perinatal care. Previous commentaries have 
focused on stillbirth, deaths due to congenital 
anomalies and intrapartum deaths. However, one 
area that has not received much attention has 
been the impact of preterm birth (PTB) on our 
national perinatal mortality rate (PMR). 
To place the impact of prematurity in context, it 
is worthwhile considering the following figures 
which are presented in this year’s report. In 2017, 
there were 345 deaths classified as perinatal 
deaths. Of these, 235 were stillbirths (>500g 
and/or ≥24wks gestation) and 110 were deaths of 
liveborn infants within the first 7 days of life. Of 
the 110 early neonatal deaths, 61 cases were due 
to a major congenital anomaly. Of the remaining 
49 cases occurring in normally formed infants, 
a total of 36 cases died from conditions directly 
related to prematurity; 24 died of respiratory 
conditions, four died of necrotising enterocolitis 
(NEC), six died of Intraventricular/periventricular 
haemorrhage (IVH) and two were pre-viable. In 
summary, of a total of 110 early neonatal deaths 
in normally formed infants, 36 (32.7%) cases 
were directly attributable to preterm birth. From 
a neonatologist’s perspective, these numbers do 
not reflect the true impact of preterm birth. If 
late neonatal deaths (ie those deaths occurring 
between 7-28 days of life) are included, another 
10 of 35 deaths occurring in normally formed 
infants in 2017 were as a direct consequence of 
prematurity. Lastly, based on a legal definition 
used by the NPEC that excludes liveborn infants 
<24wks gestation and <500g from our perinatal 
mortality rate figures, a further 38 normally 
formed infants died in the first few days of life as 
a direct consequence of preterm birth. 
For this year’s commentary, we have decided to 
focus on the subset of women who experience 
a perinatal death of a normally formed liveborn 
infant weighing ≤1500g. We wanted to determine 
if these women differed from other women who 
had experienced a perinatal loss. Our aim was 
to identify any epidemiological factors and/
or maternal or foetal risk factors that could 
ultimately lead to improvements in care. For the 
purpose of this study, all liveborn infants ≥401g 
and ≤1500g and/or ≥22wks and ≤29wks gestation 
(please see eligibility criteria for the Very Low 
Birth Weight (VLBW) Infants in the Republic 
of Ireland Annual Report) were included in the 
study population if the infant died within the 
first 28 days of life. Infants with major congenital 
anomaly were excluded. The comparison group 
was all other cases of perinatal deaths in the 
first 28 days not related to a congenital anomaly. 
Data from the previous NPEC audits for the years 
2011-2016 were included. Many neonatologists 
may query why we did not focus exclusively on 
all the VLBW infants who were born in Ireland 
during the same time period (ie the cohort of 
infants in the VLBW Infants in the Republic of 
Ireland Annual Reports). Unfortunately, detailed 
epidemiological and obstetric data is not 
routinely collected on these infants. While we 
accept the limitations of the study group (ie data 
is only available on preterm births that resulted 
in a perinatal loss) and also its comparison group 
(ie detailed data are not collected on stillbirths 
born <24wks and there is often incomplete 
ascertainment of deaths up to 28 days), it was 
still felt to be an important exercise that might 
raise some interesting observations that may 
warrant further investigation. Acknowledging 
these limitations, the following section outlines 
the principle findings of the study. 
Results
The study group included a total of 459 normally 
formed infants, weighing 401-1500g and/or 22-
29wks gestation who died within the first 28 
days of life. This group of infants was compared 
to 1420 normally formed infants who were either 
stillbirth (BW ≥500g and/or ≥24wks gestation) or 
who were liveborn but weighed >1500g and were 
>29 wks gestation. 
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Maternal Characteristics
With respect to the 459 infants in our study 
population, the mean age of the mothers at the 
time of delivery was 32 years (range 17-49 years) 
and the majority (72%) were white Irish. The age 
profile and ethnicity of the study group were 
similar to the comparison group (p-values of 0.10 
and 0.34 respectively). The age profile of both 
the study and comparison group reflected that of 
the general population of mothers. However, Irish 
Travellers, Asian and Black Ethnicities were over-
represented in the study population (11%) and 
in the comparison group (10%) when compared 
to the ethnic breakdown of the 15-49 year old 
national female population. A total of 17% of 
mothers in the study group smoked at the time 
of booking similar to the comparison group (17% 
vs 21%, p-value=0.14). The prevalence of smoking 
during pregnancy for Irish women is not known. 
The body mass index of the study group was 
similar to the comparison group and reflected 
that of women from the general population 
who participated in the 2015 Healthy Ireland 
Survey.1 Neither underweight nor overweight/
obese women were over-represented in the 
study group. Of note, 17% of the women in the 
study group reported that their pregnancy was 
the result of fertility treatment and this was 
significantly different to the comparison group 
(17% vs 5%, p-value<0.001). In addition, 34% 
of the pregnancies in the study group was a 
multiple gestation (twins or greater), almost 4 
fold greater than in the comparison group (8%) 
and again this finding was highly significant 
(p-value <0.001). Of the 158 multiple gestations 
in the study group, over a quarter (28%) were 
as a result of fertility treatment (n=44/126, data 
missing for 32 cases).
In the study group, among women who had 
a previous pregnancy, 12% of mothers had 
experienced a previous preterm birth or mid-
trimester loss compared to only 5% of the 
comparison group (p-value<0.001). In 68% of the 
study group, the pregnancy was complicated 
by spontaneous premature labour compared to 
5% in the comparison group (p-value<0.001). 
Premature rupture of membranes was reported 
in 34% of the study group as opposed to 4% 
in the comparison group (p-value<0.001) and 
in almost a quarter of these cases (22%), the 
membranes were ruptured for >24 hours. The 
corresponding figure was 3% for the comparison 
group (p-value<0.001). Hypertensive disorders 
of pregnancy were reported to be less common 
in the study population (5% vs 8%, p-value 0.04). 
There was no difference between the 2 groups 
with regards to the incidence of pre-existing 
medical problems in the mother or a history of 
alcohol or drug abuse. 
Labour onset differed markedly between the 
groups (p<0.001). In the study group, the vast 
majority of mothers had spontaneous labour 
(81%), only 4% had induced labour and the 
remaining 15% were delivered pre-labour whereas 
only 30% of mothers in the comparison group 
went into spontaneous labour, most were 
induced (56%) and 14% were delivered pre-
labour. This difference in labour onset reflects 
the practice of inducing labour for most women 
with an antepartum stillbirth so they may 
deliver vaginally, as is recommended. A total 
of 71% of the study population and 81% of the 
comparison group were delivered vaginally. Not 
surprisingly, a significantly higher proportion of 
the study group delivered in a tertiary unit (67% 
vs 50%, p-value<0.001) and 16% of mothers 
were transferred antenatally to another centre 
as opposed to only 4% in the comparison group 
(p-value<0.001). 
Foetal Characteristics
There were significantly more male infants born 
in the study group compared to the comparison 
group (58% versus 52%, p-value=0.04). While 
foetal growth restriction (<10th centile) was 
over-represented in the study group, it was still 
significantly less common than in the comparison 
group (26% vs 46%, p-value<0.001). 
Maternal and Foetal Conditions that 
were present during pregnancy and 
reported to be associated with the 
death of the infant 
On reviewing the maternal and/or foetal 
conditions that were present during the 
pregnancy and reported to be associated 
with the death of the infant, infection (either 
maternal infection or ascending infection) was 
over-represented in the study group (30% 
vs 9%, p-value<0.001). Despite hypertensive 
disorders of pregnancy being less commonly 
reported in the study population (5% vs 8%), 
it was found that these conditions were more 
likely to be reported to be associated with the 
death of an infant in the study group (2% vs 
0.8%, p-value<0.001). In contrast, antepartum 
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or intrapartum haemorrhage (11.5% as opposed 
to 3.5%, p-value<0.001), specific placental 
conditions (30% vs 5%, p-value<0.001) and 
mechanical issues such as cord compression, 
malpresentation and uterine rupture (10% vs 
1%, p-value<0.001) were all more commonly 
seen in the comparison group. Examination of 
the placenta, which was performed in 95% of 
cases, documented histological evidence of 
chorioamnionitis in 37.5% of the study group as 
opposed to only 11% of the comparison group 
(p-value<0.001). 
Discussion 
Preterm birth (PTB) (<37wks gestation) is one 
of the leading causes of perinatal morbidity and 
mortality worldwide. Preterm births are said 
to account for 75% of perinatal mortality (with 
about 40% of these deaths occurring in those 
delivered <32wks gestation) and more than 
half the long-term morbidity.2, 3 Each year, in 
Ireland, approximately 6.5% of infants are born 
prematurely (5% for singleton births and 55% 
for multiple births) and, in 2016, they accounted 
for 69% of all perinatal deaths in Ireland (with 
41% of these deaths occurring in those delivered 
<32wks).4, 5 The obstetric precursors leading to 
preterm birth include: (1) delivery for maternal 
or foetal indications, in which labour is either 
induced or the infant is delivered by pre-labour 
Caesarean section; (2) spontaneous preterm 
labour with intact membranes; and (3) preterm 
premature rupture of membranes irrespective 
of whether delivery is vaginal or by caesarean 
section. It is estimated that about 30-35% 
of preterm birth are induced, 40-45% follow 
spontaneous preterm labour and 25-30% 
follow PPROM.3 National data on the reasons 
for PTB in Ireland are not available. In 2017, 
the National Maternity Hospital, in their annual 
neonatal report, noted that amongst their VLBW 
population, preterm labour accounted for 17% of 
PTBs, PPROM for 19% and the remaining 64% of 
cases were due to maternal or foetal reasons.6 
The fact that “indicated” PTB was so high in this 
centre may reflect its role as a tertiary referral 
centre for complex obstetric care. In our study 
group, 81% of women were reported to have 
gone into spontaneous labour and only 15% were 
delivered before the onset of labour. Clearly, 
there is a need for better national data as to the 
reasons why Irish women deliver prematurely. 
This audit has raised some very interesting 
findings on PTB and its contribution to perinatal 
mortality rates in the Irish setting. If we were 
able to impact on the rate of preterm delivery 
(either spontaneous preterm delivery or medially 
indicated preterm delivery), the corrected PMR 
in Ireland could be reduced by almost 20% 
and the impact would likely be even greater if 
late neonatal deaths were included. Whilst an 
exhaustive review of the causes of preterm birth 
and its management is beyond the scope of 
this commentary, I wish to make a number of 
observations, not necessarily in order of their 
importance, which I believe should be highlighted 
at a national level. It is interesting to note that 
many of these observations/recommendations 
have already been raised in previous 
commentaries which have focused specifically on 
stillbirths. It is clear that there is a lot of common 
ground between the two issues. PTB (like 
stillbirth) is a major issue. It affects a significant 
number of babies and their families. Families 
need to be aware of the risks. Equally, healthcare 
professionals and Public Health services have a 
duty to inform and educate the public (and all 
future parents) about these risks and to prioritise 
maternity services, audit and research into this 
critically important area if improvements in 
outcomes are to occur. 
1. Perinatal Audit
All 19 centres delivering infants in this county 
now contribute anonymised data to the NPEC on 
all VLBW infants in Ireland (using the Vermont 
Oxford Network (VON) database collection 
tool) and these infants are the subject of an 
annual report. The NICORE (Neonatal Intensive 
Care Outcomes Research and Evaluation) 
group, a group of consultant neonatologists 
and paediatricians with formal representation 
from all 19 tertiary, regional and peripheral 
neonatal centres in the Republic, oversee this 
audit and are very keen to link the data with 
2 year neurodevelopmental follow up. It can 
only be through the rigorous collection of data 
including detailed follow up that we can identify 
areas from improvement in neonatal care. One 
criticism of the VON database collection tool is 
that it collects minimal obstetric information and 
so it is not possible to elucidate why a particular 
infant delivered preterm. Based on a recently 
published report incorporating three years of 
VON data, some interesting differences were 
noted between the Irish and VON population.7 
A higher proportion of multiple gestation (35% 
vs 27%, p-value<0.001), chorioamnionitis (16% 
vs 13%, p-value<0.001) and major congenital 
52 PERINATAL MORTALITY IN IRELAND 
anomaly (8% vs 5%, p-value<0.001) was found 
among VLBW infants born in Ireland but 
maternal hypertension was less commonly 
seen (27% vs 30%, p-value<0.001). These 
observations warrants further research and 
investigation. These findings are also supported 
by information derived from our study group 
where 34% of pregnancies was a multiple 
gestation and maternal infection (which 
includes chorioamnionitis) was reported as 
an associated factor with the pregnancy and/
or death of the infant in 30%. Why are more 
multiple gestations seen in the Irish population? 
Is it due to assisted reproductive technology 
(ART)? Is chorioamnionitis more prevalent in 
our population and why? By seeking answers 
to these questions, we may be able to offer 
improved management and care. As we are a 
small country that has already a well-established 
national collection system for perinatal deaths 
and VLBW infants, we should now consider 
expanding the VON database to incorporate 
vital pieces of obstetric information. This would 
greatly enhance the quality and usefulness of our 
annual reports. 
2. Primary Prevention of Preterm 
Birth and the role of Public Health 
Education 
The identification of women at risk of preterm 
birth is important. Unfortunately, spontaneous 
PTB (sPTB) is a heterogeneous condition with 
multiple underlying aetiologies. However, it is 
worth drawing attention to some baseline patient 
characteristics, some of which were observed on 
our study population that may be amenable to 
primary intervention and result in a reduced risk 
of delivering a baby preterm. 
Smoking has been significantly associated with 
preterm delivery with a meta-analysis of 20 
prospective studies finding a relative risk (RR) 
of 1.27 with a 95% Confidence interval (CI) of 
1.21-1.33 among women who smoked during 
pregnancy compared with non-smokers.8 In 
our study, 17% of women reported smoking 
at booking but comparative figures for the 
pregnant population are not available. It would 
seem prudent to support all pregnant women 
to quit smoking especially those at high risk of 
delivering a preterm infant.
The relationship between alcohol and illicit drug 
use during pregnancy and preterm birth is less 
clear. While no differences were noted between 
our study group and the comparison group, 
in light of the adverse foetal effects of alcohol 
use, it is not unreasonable to counsel women 
to consider abstaining entirely from alcohol 
during the periconception period. Cocaine and 
opiod abuse has also been associated with 
preterm birth with relative risks ranging from 
2.8-3.5 compared to non-abusers. Women in 
maintenance methadone programmes are also at 
risk of preterm birth with a RR of 2.47 compared 
with patients not on opiates.9
Pre-pregnancy maternal medical co-morbidities 
such as diabetes, hypertension and lupus can 
increase the risk of adverse pregnancy outcomes 
including indicated preterm birth.10, 11 The impact 
of improved control of underlying maternal co-
morbidities prior to pregnancy on the rate of 
preterm delivery is uncertain.12 However, as pre-
pregnancy control of chronic medical disorders 
is related to overall maternal health and may be 
related to other adverse pregnancy outcomes, 
optimising control of diabetes, hypertension and 
other co-morbidities is to be encouraged prior to 
pregnancy.9 Once again, our study group was not 
found to differ from the comparison in terms of 
the presence of pre-existing maternal conditions. 
Both maternal pre-pregnancy overweight and 
underweight can impact on a woman’s risk of 
preterm birth.13 Low pre-pregnancy body mass 
index (<19.5kg/m2) was associated with an 
increased risk of both spontaneous and indicated 
preterm birth compared to women of normal 
weight in a meta-analysis of 78 studies.14 Pre-
pregnancy overweight was associated with 
higher rates of indicated preterm birth but not 
spontaneous preterm birth.15 Neither of these risk 
factors was identified in our study group. 
Birth spacing has an impact on the outcome 
of subsequent pregnancies. The association 
between interpregnancy interval, (typically 
defined as the amount of time between 
delivery of the first pregnancy to conception 
of the second pregnancy) and preterm birth 
forms a J-shaped curve with the highest risk 
of adverse outcomes in pregnancies following 
very short or very long intervals.16 The optimal 
interpregnancy interval associated with the 
lowest risk of preterm birth appears to be 18-23 
months. A meta-analysis of 67 studies found that 
pregnancies conceived after a very short (<6 
months) interpregnancy interval are at highest 
risk of preterm birth compared with pregnancies 
with an interpregnancy interval of 18-23 months.16 
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This information is not routinely collected in our 
annual audit. 
Multiple gestations carry a substantial risk of 
preterm delivery and account for around 15-
20% of all preterm births. In Ireland, in 2016, 
twin or higher order multiple births accounted 
for approximately 4% of all births reported and 
55% of these infants delivered prematurely.4 
Multiple births accounted for 9% of all perinatal 
deaths in Ireland in 2016.5 About 40% of twins 
will have spontaneous labour or PPROM before 
37wks gestation with others having an indicated 
preterm delivery because of pre-eclampsia 
(PET) or other maternal and/or foetal disorders.3 
Nearly all higher multiple gestations will result 
in preterm delivery. Uterine over-distension, 
resulting in contractions and PPROM is believed 
to the causative mechanism for the increased 
rate of sPTB.17 There was a very high rate of 
multiple gestations in our study population and 
the reasons for this need to be examined further. 
Assisted Reproductive Technology (ART) 
can also impact on the rate of preterm 
birth. Research has shown that singletons 
conceived by In Vitro Fertilisation (IVF) have 
an increased risk of PTB compared to those 
conceived spontaneously.18 As the number 
of women achieving pregnancy through IVF 
or intracytoplasmic sperm injection (ICSI) 
is increasing worldwide, it is important to 
understand the causes of PTB in these patients. 
A recent meta-analysis of cohort studies of 
singleton pregnancies conceived after IVF/ICSI 
reported an increased risk, of about 80%, of 
sPTB at both <37wks and <34wks gestation in 
pregnancies conceived by IVF/ICSI compared 
with those conceived spontaneously.19 This is 
separate from the increased risk of indicated 
PTB in this population which is also reported. 
Common indications for indicated PTB in IVF/
ICSI singleton pregnancies include hypertensive 
disorders, foetal growth restriction, antepartum 
haemorrhage, congenital anomalies and/or 
maternal request/anxiety.20 The characteristics of 
the infertile population (infertility or, more likely, 
its causes) or the types of infertility treatment 
received could contribute to the increased 
risk of PTB. The incidence of PTB in a cohort 
of singleton IVF pregnancies appeared to be 
identical to that of matched controls achieving 
pregnancy spontaneously while waiting for IVF 
treatment and higher than that in the general 
population suggesting that infertility in itself is 
a risk factor for PTB.21 However, a more recent 
study found that sub-fertile patients and non-
IVF ART patients had a risk of PTB quite similar 
to that of fertile women, whereas the odds 
ratio of PTB for IVF/ISCI pregnancies was 
1.55, suggesting that the risk of PTB in IVF/
ISCI patients is due to the treatment itself.22 
Another reason for the higher rate of PTB in this 
population is due to the increased risk of multiple 
gestations associated with the treatment. 
Because if this, it is strongly advocated that 
single embryo transfers be performed as these 
give a lower rate of preterm birth compared to 
double or multiple embryo transfers.23 Again, this 
is an area that warrants further investigation in 
the Irish setting.
3. Risk Assessment and Provision 
of Individualised Care Plans for 
Women at increased risk of PTB  
In this section, we will focus of 2 groups of 
women who are at increased risk of PTB to see 
if there are ways to reduce that risk. The first 
group of women are those who have previously 
delivered a preterm baby and the second group 
of women are those who present with symptoms 
of threatened preterm labour. While the 
significant majority of the latter group of women 
do not go on to deliver prematurely, the clinical 
dilemma is to try and identify those who will at 
the time of their initial presentation. 
With regards to the first group, it is widely 
accepted that one of the primary risks for 
preterm birth is the prior delivery of a preterm 
baby and this finding was born out in our study 
group where 12% of the women has suffer a 
previous preterm birth or mid-trimester loss 
as opposed to 5% in the comparison group. 
In a study by Iams at al, the risk of recurrent 
preterm birth <35wks varied between 14-15% 
as opposed to women with a previous history 
of an uncomplicated term delivery who had a 
3% risk of spontaneous preterm delivery.24 A 
recent meta-analysis reported an absolute risk of 
recurrent spontaneous preterm labour at <37wks 
gestation of 30%. Additionally, the absolute risk 
of recurrence appears to be substantially higher 
if the underlying aetiology was PTL as opposed 
to PPROM (a recurrence risk of 7% was reported 
if due to PPROM as opposed to a recurrence risk 
of 23% if due to sPTL).25 Recently, in Ireland, we 
are seeing the emergence of specialist preterm 
labour clinics. These clinics assess women who 
have experienced a previous preterm delivery, 
have a known uterine malformation or have 
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had two or more cervical surgical procedures. 
In many cases, these women are seen in clinic 
at 10-12wks gestation or ideally even prior to 
conception. While frequent provider contact 
alone has not been shown to impact on recurrent 
preterm birth, social support and interventions 
targeted at specific risk factors have been found 
to have the potential to decrease the risk for 
recurrent preterm birth.26, 27 Again, while not 
an exhaustive list of all that can be offered to 
an individual woman attending such a clinic, 
the following outlines some of the possible 
interventions available which can allow clinicians 
create an individualised care plan according to 
the specific circumstances.
Firstly, intrauterine infection is known to play 
a role in spontaneous preterm birth.3 Micro-
organisms can access the intrauterine space by 
ascending through the cervix from the vagina 
spreading intra-abdominally through the fallopian 
tubes or haematogenous spread across the 
placenta. Local and systemic infections such 
as bacteriuria, bacterial vaginosis (BV) and 
periodontal disease have been identified as risk 
factors for preterm birth.3, 28 Lower genital tract 
infections with gonorrhoea and chlamydia have 
also been associated with a two to three fold 
increased risk of preterm birth suggesting that 
women with risk factors for sexually transmitted 
infection should be screened during pregnancy 
to allow early treatment and decrease the risk 
of preterm birth.29 Another potential source of 
ascending intrauterine infection is BV. The shift 
in vaginal flora from predominantly lactoabacilli 
to predominantly anaerobic organisms has 
been associated with a 1.5-3-fold increased risk 
of preterm birth.3 However, a Cochrane review 
of 21 randomised controlled trials found that 
antibiotic treatment of BV did not impact the 
rate of preterm birth in treated versus untreated 
women.30 In a recent study from 2015, 248 
out of 4283 low risk women were screened 
positive for asymptomatic bacteruria of whom 
40 were randomly assigned to treatment with 
nitrofurantoin and 45 to placebo. No difference 
in the rate of PTB was noted.31 Because of the 
conflicting literature, most of these high risk 
clinics do screen women for genital infection and 
often consider a course of treatment if specific 
organisms are found. It is notable that infection 
was reported to be an associated factor in 30% 
of our study group and this is clearly an area that 
warrants further research.
Multiple randomised controlled trials 
have suggested a beneficial effect of 
17αhydroxyprogesterone caproate (17OHPC) for 
prevention of recurrent preterm birth.32 While the 
mechanism of action is uncertain, possibilities 
include modulation of inflammation, maintenance 
of cervical integrity and relation of uterine 
smooth muscle.12 A randomised controlled trial 
of 463 women with prior preterm birth given 
weekly infections of 250 micrograms of 17OHPC 
versus placebo from 15-36wks of gestation 
found a significant reduction in delivery prior to 
37wks (36.3% vs 54.9%).33 A recent study, the 
OPPTIMUM study looked at the role of vaginal 
progesterone prophylaxis for preterm birth. This 
was the largest retrospective, double-blinded 
study of its kind. Although no harmful effects 
were noted, there was no significant value 
attributed to vaginal progesterone, particularly 
in women with a short cervix. The study did 
suggest that there was a “general trend” towards 
benefit and perhaps even significance may have 
been shown if such a large proportion of patients 
had not been lost to follow up.34 A Cochrane 
Review in 2013 including 11 studies encompassing 
1899 singletons with a prior spontaneous 
preterm birth reported a significant reduction 
in spontaneous preterm birth <34wks (RR 0.31: 
95% CI: 0.14-0.69) in those women treated with 
progesterone (by any route).35 Currently, the 
recommendation is that women with a prior 
spontaneous preterm birth should receive vaginal 
progesterone daily or 17OHPC intramuscularly 
weekly starting from around 16wks gestation. 
Of women with a history of a prior sPTB, those 
with a short cervix appear to be at the highest 
risk.36, 37 Furthermore, a prospective blinded 
observation study was conducted in which 
women with a previous sPTB <32wks gestation 
and a current singleton pregnancy underwent 
serial cervical length (CL) assessments.38 The 
investigators found that CL <25mm as a single 
measurement at 16-18 wks gestation was 
associated with a RR of sPTB of 3.3 (95% CI: 
2.1-5.0) and the inclusion of serial observations 
of CL until 23wks 6 days significantly improved 
the predictions compared to an isolated 
measurement. Consequently, serial CL screening 
for women with a singleton pregnancy and a 
history of sPTB is generally recommended. In 
a multicentred trial of 302 women with prior 
preterm birth <34wks gestation and a CL <25mm 
randomised to cerclage or no cerclage, the risk 
of perinatal morbidity was significantly reduced 
with cerclage and preterm delivery <35wks 
gestation was significantly reduced with cerclage 
in the subgroup of women with CL <15 mm.39 The 
benefit of cerclage in women with a shortened 
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cervix and prior preterm birth was subsequently 
supported by a meta-analysis of five trials.40 
While history-indicated cerclage (cerclage placed 
at 12-14wks based on prior history alone) has 
been advocated for women with prior early 
preterm or periviable delivery, serial screening 
cervical lengths with placement of cerclage 
only if a shortened cervix is detected is equally 
efficacious and results in 60% fewer cerclage 
placements based on a meta-analysis of four 
trials.41 Based on the existing literature, it would 
seem prudent to perform serial assessments of 
CL from 16-24wks gestation in women with a 
history of sPTB <34wks gestation with a plan for 
an ultrasound-indicated cerclage if a short cervix 
(<25mm) is identified. 
Women who present with a history of indicated 
preterm birth due to pre-eclampsia or foetal 
growth restriction have an elevated risk of 
recurrent indicated preterm birth.42 Daily dose 
aspirin started prior to 16wks of gestation has 
been studied to decrease the risk of recurrent 
pre-eclampsia or placental insufficiency. It is, 
therefore, not unreasonable to commence daily 
aspirin from 12wks of pregnancy in women with 
one or more high-risk condition such as prior 
pre-eclampsia, hypertension, diabetes, renal 
disease or lupus.43
The second group of women to consider are 
those presenting with symptoms suggestive 
of preterm labour (PTL). If it were possible to 
predict imminent birth among these women 
before advanced cervical dilatation, then it would 
be possible to administer antenatal steroids 
and to arrange an antental transfer to a tertiary 
neonatal centre if required. 
Fetal fibronectin (FFN) is an extracellular matrix 
glycoprotein found in the amniotic membrane, 
decidua and cytotrophoblasts. It can be 
detected in cervical and vaginal secretions in 
all pregnancies, but elevated levels (≥50ng/ml 
at >22wks gestation) has been associated with 
an increased risk of sPTB.44 The efficacy of FFN 
in the prediction of sPTB has been assessed in 
several populations but here we will primarily 
focus on those studies that included women 
with suspected PTL. Initially, it was hoped that 
the use of qualitative FFN testing alone in 
symptomatic women with singleton gestations 
would allow accurate identification of women 
with true preterm labour versus those with false 
labour. In the largest multicentre observational 
study of women with symptoms suggestive of 
PTL, compared to women who had negative 
FFN results, those who had positive FFN results 
were more likely to deliver within 7 days (RR 
25.9, 95% CI: 7.8-86), within 14 days (RR 20.4, 
95% CI: 8.9-53) and before 37wks gestation (RR 
2.9, 95% CI: 2.2-3.7).45 However, the predictive 
value of a positive FFN results was only 13% 
for delivery within 7 days of presentation. The 
most promising finding was that the negative 
predictive value for delivery within 7 days was 
very high at >99%. Despite observational studies 
that suggested FFN testing may help reduce the 
use of unnecessary resources, RCTs have not 
confirmed these findings. In a systematic review 
and cost-analysis of five RCTs, and 15 diagnostic 
test accuracy studies, FFN testing was found 
to have moderate accuracy for predicting PTB 
but no RCT reported a significant improvement 
in maternal or neonatal outcomes.46 In their 
base-case cost analysis, there was a modest 
cost difference in favour of FFN testing but 
this was largely dependent on whether or not 
FFN testing reduced hospital admissions which 
varied significantly. A 2016 systematic review 
and meta-analysis of six RCTS that included 546 
women with singleton gestations who presented 
with PTL symptoms found that those randomly 
assigned to knowledge of FFN results did not 
have reduced rates of PTB at <37wks, <34wks, 
<32wks or <28wks when compared to the control 
group.47 Equally, women who were randomly 
assigned to knowledge of FFN results had 
similar rates of hospitalisations, use of tocolytics 
and receipt of antenatal corticosteroids when 
compared to the control group (no knowledge 
of FFN results). Contrary to prior studies, mean 
hospital costs were actually slightly higher in 
the group randomly assigned to knowledge of 
FFN. It would seem that based on the current 
evidence, there is no reason to justify the routine 
use of FFN alone in women with threatened 
PTL.48 
More recent studies have focused on quantitative 
measurement of FFN hoping that this may 
improve the predictive values when compared 
to the qualitative tests that use 50mg/ml as 
the threshold.49, 50, 51 In a pre-specified secondary 
analysis of a prospective blinded study, the PPV 
for sPTB <34wks gestation increased from 19%, 
32%, 61%, 75% with increasing thresholds (10, 
50, 200 and 500 ng/ml respectively).49 At the 
moment, the use of quantitative FFN remains 
investigational. 
Placental alpha microglobulin-1 (PAMG-1) is 
another biomarker (like FFN) which is assessed 
by a bedside test, PartoSure, making it very 
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user friendly in a clinical situation. This had 
been compared to FFN and cervical length 
measurement and it has been reported that 
PAMG-1 was more accurate in predicting PTB 
within 7 days with 80% sensitivity and 95% 
specificity with the greatest utility in patients 
whose cervical length was 15-35mm.52 A recent 
meta-analysis comparing PAMG-1, FFN and 
phosphorylated Insulin-like Growth Factor 
Binding Protein-1 (phIGFBP-1) in symptomatic 
women reported that PAMG-1 had the highest 
PPV and positive likelihood ratio while the 
negative predictive value and negative likelihood 
ratio remained similarly high between the three 
biomarkers.53
It would seem that the real value of these 
biomarkers in the Irish context is not so much 
in their ability to predict imminent delivery 
but more in their ability to determine which 
women are most likely not to deliver (Ie their 
high negative predictive values). In the context 
of a negative test, it is unlikely that a women 
with deliver within 7 days. This means that 
unnecessary treatments and admission to 
hospital can be avoided. One of the difficulties 
faced by many neonatologists working in 
tertiary centres in Ireland is the inability to 
accept in utero transfers of high risk pregnancies 
from around the country because of a lack of 
antenatal beds. The use of the aforementioned 
biomarkers would assist clinicians in determining 
which mothers are best transferred to tertiary 
centres ensuring better utilisation of a limited 
resource even if it is accepted that many of 
the women transferred will not deliver within 7 
days. Data from the 3 year report on mortality 
of VLBW infants born in Ireland noted a reduced 
mortality for infants <28wks gestation who 
delivered in a tertiary neonatal centre.7 This 
report’s recommendation, which was in line with 
the existing Model of Care for Neonatal Services 
in Ireland, was that infants <28wks gestation 
should ideally be delivered in a tertiary neonatal 
centre.7 It is my opinion that we should advocate 
for the use of one of these tests in the setting 
of threatened PTL to better determine which 
mother should be transferred. 
The role of cervical length (CL) measurement 
in the assessment of women who present with 
PTL symptoms has also been studied. A 2016 
systematic review and meta-analysis of RCTs 
using individual patient-level data concluded 
that knowledge of CL in women with symptoms 
of acute PTL was associated with a significant 
reduction in PTB <37wks (RR 0.64, 95% CI: 0.44-
0.94).54 However, other outcomes, including PTB 
at early gestations, time from randomisation to 
delivery, time from evaluation to discharge and 
other neonatal outcomes were not statistically 
different between those in whom there was 
knowledge of CL as opposed to those who 
were managed without that information. 
Therefore, the role of CL measurement in this 
population remains unclear. As a country that is 
already stretched and unable to provide routine 
ultrasonography to all woman in the second 
trimester of pregnancy, it is doubtful that Irish 
maternity services are currently in a position 
to incorporate the routine assessment of CL in 
this population until there is more compelling 
evidence for its use. 
4. Detection of Foetal Growth 
Restriction (FGR)
As a neonatalogist, I would strongly support 
the NPEC and my obstetric colleagues in their 
many calls to improve detection of foetal growth 
restriction (FGR) and small for gestational age 
(SGA) in pregnant Irish women. The Institute 
of Obstetrics and Gynaecology in collaboration 
with the Royal College of Physicians of Ireland 
and the Directorate of Strategy and Clinical 
Programmes of the Health Service Executive 
published Clinical Practice Guideline No. 29 in 
2014 on Foetal Growth Restriction – Recognition, 
Diagnosis and Management. Without doubt, 
improved antenatal detection of FGR with timely 
delivery is a preventative strategy to reduce 
perinatal mortality. The NPEC has called on many 
occasions for the generation of customised birth 
weight centile charts for every woman during 
pregnancy in addition to staff training in risk 
assessment, plotting of symphysial fundal height 
and scan weight estimates. While this may result 
in more infants being born preterm, these infants 
tend to be born in better condition with less 
significant morbidities and this should hopefully 
improve their chances of survival without 
associated disability. 
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5. Investigations to determine the 
cause of preterm birth
Again, as is currently done with every case 
of a perinatal loss, I would advocate a similar 
systematic approach to every women who 
delivers a preterm infant in Ireland especially 
those who deliver <32-34wks gestation. This 
should include, but not necessarily be limited 
to, a review of maternal risk factors amenable 
to intervention, a review of the obstetric details 
leading to the preterm delivery in addition 
to a thorough examination of the placenta. 
Review of placental pathology from the index 
preterm case may further elucidate a woman’s 
risk of recurrent preterm birth. Placentas from 
spontaneous preterm births are more likely 
than those from indicated preterm births to 
exhibit acute inflammation of the membranes, 
chorionic plate and umbilical cord.55, 56 The 
presence of inflammatory lesions on placental 
pathology is associated with an increased risk of 
recurrent preterm birth (RR 2.4, 95% CI: 1.2-4.7) 
compared with women without inflammatory 
lesions.55 Placental examination may also support 
a diagnosis of placental insufficiency and so 
may lead clinicians to recommend aspirin in a 
subsequent pregnancy. 
In summary
1.  PTB is a significant contributor to perinatal mortality and morbidity in Ireland
2.  The two current audits (Perinatal Mortality and VLBW Infants) should be expanded to 
include a more detailed maternal risk factor assessment and more detailed obstetric 
information. The NPEC should also extend its collection of data to all pregnancies 
delivering ≥22wks gestation irrespective of the outcome of the pregnancy (ie liveborn or 
stillbirth). 
3.  Consideration should be given to the establishment of a national working group to 
include Obstetricians, Neonatalogists, Midwives and Allied Health Professionals whose 
remit is to look at the problem of PTB in Ireland at a national level and how it is best 
addressed. 
4.  The establishment of high risk specialist clinics for women at risk of recurrent PTB is to 
be strongly encouraged. 
5.  Maternity Units should strongly consider the use of a biomarker to better determine 
which mother, who presents with threatened preterm labour, should be transferred to a 
tertiary centre.
6.  More resources, including in the area of antenatal ultrasound, are urgently required. 
7.  Placental Examination should form part of the work up in the case of any woman who 
delivers a baby <34wks gestation. 
8.  As with every perinatal death, consideration should also be given to establishing a 
confidential enquiry into any infant <28wks who delivers outside a tertiary neonatal 
centre. This would lead to a better understanding of the myriad of factors at play but 
could better inform the organisation of maternity services into the future. 
58 PERINATAL MORTALITY IN IRELAND 
1. Ipsos MRBI (2015). Healthy Ireland Survey 2015. Dublin. 
The Stationary Office
2. Slattery MM, Morrison JJ. Preterm delivery. Lancet 
2002;360:1489-1497.
3. Goldenberg RL, Culhane JF, Romero R. Epidemiology 
and causes of preterm birth. Lancet 2008;371:75-84
4. HPO (Healthcare Pricing Office). Perinatal Statistics 
Report 2016. 
5. Manning E, Leitao S, Corcoran P et al. Perinatal Mortality 
in Ireland Annual Report 2016. Cork: National Perinatal 
Epidemiology Centre. 2018. 
6. NMH Annual Neonatal Report 2017
7. Corcoran P, Drummond L, Twomey A et al. Mortality risk 
amongst very low birth weight infants in the Republic of 
Ireland, 2014-2016. Cork: National Perinatal Epidemiology 
Centre. 2018. 
8.  Shah NR, Bracken MB. A systematic review and meta-
analysis of prospective studies on the association 
between maternal cigarette smoking and preterm 
delivery. Am J Obstet Gynecol 2000;182(2):465-472
9. Colicchia LC, Simhan HN. Optomizing subsequent 
pregnancy outcomes for women with a prior preterm 
birth. Am J Perinatol 2016;33:267-275
10. Haas JS, Fuentes-Afflick E, Stewart AL et al. 
Prepregnancy health status and the risk of preterm 
delivery. Arch Pediatr Adolesc Med 2005;159(1):58-63. 
11. Bramham K, Parnell B, Nelson-Piercy C et al. Chronic 
hypertension and pregnancy outcomes; systematic 
review and meta-analysis. BMJ 2014;348:g2301
12. Iams JD, Romero R, Culhane JF et al. Primary, secondary 
and tertiary interventions to reduced the morbidity and 
mortality of preterm birth. Lancet 2008;371:164-175.
13. Parker MG, Ouyang F, Pearson C et al. Pre-pregnancy 
body mass index and risk of preterm birth: association 
heterogeneity by preterm subgroups. BMC Pregnancy 
Childbirth. 2014;14(1):153.
14. Han Z, Mulla S, Beyene J et al. Maternal underweight 
and the risk of preterm birth and low birth weight: a 
systematic review and meta-analyses. Int J Epidemiol 
2011:401(1): 65-101 
15. McDonald SD, Han Z, Mulla S et al. Maternal overweight 
and obesity in mothers and risk of preterm birth and low 
birth weight: systematic review and meta-analysis. BMJ 
2010;341:c3428. 
16. Conge-Agudelo A, Rosas-Bermudez A, Kafury-Goeta AC. 
Birth spacing and the risk of adverse perinatal outcomes: 
a meta-analysis. JAMA 2006;295(15):1809-1823.
17. Romero R, Espinoza J, Kusanovic J et al. The preterm 
parturition syndrome, BJOG 2006;113:17-42
18. McDonald SD, Han Z, Mulla S et al. Preterm birth and 
low birth weight among in vitro fertilization singletons: 
a systematic review and meta-analyses. Eur J Obstet 
Gynecol Reprod Biol 2009;146:138-148 
19.  Cavoretto P, Canidiani M, Giorgione V et al. Risk of 
spontaneous preterm birth in singleton pregnancies 
conceived after IVF/ICSI treatment: meta-analysis of 
cohort studies. Ultrasound Obstet Gynecol 2018:51:43-53
20. Pandey S, Sherry A, Hamilton M et al. Obstetric and 
perinatal outcomes in singleton pregnancies resulting 
from IVF/ISCI: a systematic review and meta-analysis. 
Hum Report Update 2012:18:485-503
21. Saunders DM, Matthews M, Lancaster FAL. The Australian 
register: current research and future role. Ann N Y Acad 
Soc 1988;541:7-21
22. Wisborg K, Ingerslev HJ, Henricksen TB. In vitro 
fertilization and preterm delivery, low birth weight, 
and admission to the neonatal intensive care unit: a 
prospective follow-up study. Fertil Steril 2010;94:2102-
2106
23. Grady R, Alavi N, Vale R et al. Elective single embryo 
transfer and perinatal outcomes: a systematic review and 
meta-analysis. Fertil Steril. 2012;97:324-331
24. Iams JD, Goldenberg RL, Mercer BM et al. The Preterm 
Prediction Study: Recurrence risk of spontaneous 
preterm birth. Am. J. Obstet Gynecol 1998;178:1035-1040. 
25. Phillips C, Velji Z, Hanly C et al. Risk of recurrent 
spontaneous preterm birth: a systematic review and 
meta-analysis, BMJ Open 2017;7(6):e015402
26. Ricketts SA, Murray EK, Schwalberg R. Reducing 
low birthweight by resolving risks: results from 
Colorado’s prenatal plus program. Am J Public Health 
2005;95(11):1952-1957
27. Hughes K, Sim A, Roman A et al. Outcomes and 
predictive tests from a dedicated specialist clinic for 
women at high risk of preterm labour: A ten year audit. 
Aus N Z J Obstet Gynaecol 2017;57:405-411
28. Koullali B, Oudijk MA, Nijman TAJ et al. Risk assessment 
and management to prevent preterm birth. Seminars in 
Fetal Neo Med 2016;21:80-88 
29. Andrew WW, Goldenberg RL, Mercer B et al. The Preterm 
prediction study: association of second-trimester 
genitourinary chlamydia infection with subsequent 
spontaneous preterm birth. Am. J. Obstet Gynecol 2000; 
183(3): 662-668
30. Brocklehurst P, Gordon A, Heatley E et al. Antibiotics 
for treating bacterial vaginosis in pregnancy. Cochrane 
Database Syst Rev 2013;1(1):CD000262
31.  Kazemier BM, Koningstein FN, Schneeberger C et al. 
Maternal and neonatal consequences of treated and 
untreated asymptomatic bacteruria in pregnancy: a 
prospective cohort study with an embedded randomised 
controlled trial. Lancet Infect. Dis. 2015;15(11):1324-1333
32. Likis FE, Edwards DRV, Andrew JC et al. Progesterone for 
preterm birth prevention: a systematic review and meta-
analysis. Obstet. Gynecol. 2012;120(4):897-907.
33. Meis PJ, Klebanoff M, Thom E et al. National Institute of 
Child Health and Human Development Maternal-Fetal 
Medicine Unit Network. Prevention of recurrent preterm 




34. Norman JE et al. Vaginal progesterone prophylaxis 
for preterm birth (the OPPTIMUM study): a 
multicentre, randomised, double-blind trial. Lancet 
2016;387(10033):2106-2116
35. Dodd JM, Jones L, Flenady V et al. Prenatal 
administration of progesterone for preventing preterm 
birth n women considered at risk of preterm birth. 
Cochrane Database Syst Rev 2013;7:CD004947
36. Iams JD, Goldenberg RL, Meis PG et al. National Institute 
of Child Health and Human Development Maternal Fetal 
Medicine Units Network. The length of the cervix and the 
risk of spontaneous premature delivery. NEJM. 1996;334 
(9):567-572
37. Guzman ER, Walters C, Ananth CV et al. A comparison 
of sonographic cervical parameters in predicting 
spontaneous preterm birth in high-risk singleton 
gestations. Ultrasound Obstet Gynecol 2001;18(3):204-
210. 
38. Owen J, Yost N, Berghella Vet al. Midtrimester 
enodvaginal sonography in women at high risk from 
spontaneous preterm birth. JAMA 2001;286(11): 1340-
1348
39. Owen J. Hankins G, Iams JD et al. Multicenter randomised 
trial of cerclage for pretem birth prevention in high risk 
women with shortened midtrimester cervical length. Am 
J Obstet Gynecol 2009;201(4):375.e1-375.e8
40. Berghella V, Rafael T, Szychowski JM et al. Cerclage for 
short cervix on ultrasongraphy in women with singleton 
gestations and previous preterm birth: a meta-analysis. 
Obstet Gynecol 2011:117(3):663-671
41. Berghella V, Mackeen AD. Cervical length screening with 
ultrasound-indicated cerclage compared with history-
indicated cerclage for prevention of preterm birth: a 
meta-analysis. Obstet Gynecol 2011; 118(1):148-155. 
42. Barton JR, Sibai BM. Prediction and prevention of 
recurrent preeclampsia. Obstet Gynecol 2008;112(2, Part 
1): 359-372. 
43. LeFevre ML. US Preventive Services Task Force. Low 
dose aspirin use for the prevention of morbidity and 
mortality from pre-eclampsia: US Preventive Services 
Task Force recommendation statement. Ann Intern Med 
2014;161(11): 819-826 
44. Lockwood CJ, Senyei AE, Dische MR et al. Fetal 
fibronectin in cervical and vaginal secretions as a 
predictor of preterm delivery. NEJM 1991;325(10):669-674 
45. Peaceman AM, Andrews WW, Thorp JM et al. Fetal 
fibronectin as a predictor of preterm birth in patients 
with symptoms: a multicentrer trial. Am J Obstet Gynecol 
1997;177(1):13-18 
46. Deshpande SN, Van Asselt AD, Tomini F et al. Rapid fetal 
fibronectin testing to predict preterm birth in women 
with symptoms of preterm labour: a systematic review 
and cost analysis. Health Technol Assess 2013;17(40): 
1-138
47. Bergella V, Saccone G. Fetal fibronectin testing for 
prevention of preterm birth in singleton pregnancies with 
threatened preterm labor: a systematic review and meta-
analysis of randomized controlled trials. Am J Obstet 
Gynecol 2016;215(4):431-438
48. Committee on Practice Bulletins – Obstetricss TACoO, 
Gynecologists. Practice bulletin no. 130: Prediction 
and prevention of preterm birth. Obstet Gynecol 
2012;120(4):964-973
49. Abbott DS, Radford SK, Seed PT et al. Evaluation of 
a quantitative fetal fibronectin test for spontaneous 
preterm birth in symptomatic women. Am J Obstet 
Gynecol 2013;208 (2):122.e1-122.e6
50. Kuhrt K, Unwin C, Hezelgrave N et al. Endocervical 
and high vaginal quantitative fetal fibronectin in 
predicting preterm birth. J Matern Fetal Neonatal Med 
2014;27(15):1576-1579
51. Kuhrt K, Hezelgrave N, Foster C et al. Development 
and validation of a tool incorporating quantitative 
fetal fibronectin to predict spontaneous preterm birth 
in symptomatic women. Ultrasound Obstet Gynecol 
2016;47(2):210-216
52. NIkolova T, Bayev O, Nikolova N et al. Comparison of a 
novel test for placental alpha microglobulin-1 with fetal 
fibronectin and cervical length measurement for the 
prediction of imminent spontaneous preterm delivery in 
patients with threatened preterm labor. J. Perinat. Med. 
2015:43(4):395-402
53. Melchor JC, Khalil A, Wing D et al. Prediction of 
preterm delivery in symptomatic women using 
PAGM-1, fetal fibronectin and phIGFBP-1: a systematic 
review and meta-analysis. Ultrasound Obstet Gynecol 
2018;52(4):442-451
54. Berghella V, Palacio N, Ness A. et al. Cervical length 
screening for prevention of pretern birth in singleton 
pregnancies with threatened preterm labor: systematic 
review and meta-analysis of randomised controlled trials 
using individual patient-level data. Ultrasound Obstet 
Gynecol 2017;49:322-329
55. Himes KP, Simhan HN, Risk of recurrent preterm birth 
and placental pathology. Obstet Gynecol 2008;112(1):121-
126
56. Goldenberg. RL, Andrew WW, Faye-Petersen O et al. The 
Alabama Preterm Birth Project: placental histology in 
recurrent spontaneous and indicated preterm birth. Am J 
Obstet Gynecol 2006;195(3):792-796 
60 PERINATAL MORTALITY IN IRELAND 
3. Stillbirths: specific findings
Cause of death in stillbirths
Specific placental conditions was the primary 
cause of death in over thirty percent (n=76, 
32.3%) of the 235 stillbirths that occurred in 
2017 (Figure 3.1). The most commonly occurring 
placental condition was maternal vascular 
malperfusion (n=28 of 76, 36.8%).
Table 3.1 shows further detail into the causes of 
death for stillbirths. Major congenital anomaly 
was the second most common cause of 
death in stillbirths (n=64, 27.2%). There was a 
chromosomal disorder in almost sixty percent 
of the 64 stillbirths due to congenital anomaly 
(n=38, 59.3%), as shown in Figure 3.2. In these 
cases, over half were diagnosed by cytogenetic 
analysis (n=20 of 38, 52.6%). Anomalies of 
the cardiovascular system (n=5), urinary tract 
(n=5), central nervous system (n=3), gastro-
intestinal (n=2) and musculo-skeletal (n=1) 
systems collectively caused 16 additional (25.0%) 
stillbirths. The remaining ten cases were due to 
multiple anomalies (n=6), other major congenital 
anomalies (n=3) and metabolic disorders (n=1). 
For the first year of this audit, the NPEC has 
collected data on whether the diagnosis of 
a major congenital anomaly was confirmed/
suspected by a consultant fetal medicine 
specialist. Data on whether the diagnosis was 
confirmed/suspected by a consultant fetal 
medicine specialist was recorded for all but 
three of 64 stillbirths. In almost all of these cases 
a diagnosis was confirmed/suspected by a 


































Figure 3.1: Primary cause of death in stillbirths in 2017 (left chart) and detailed cause of death in cases of major 
congenital anomaly in stillbirths in 2017 (right chart) 
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Antepartum or intrapartum haemorrhage (n=21, 
8.9%) and specific fetal conditions (n=18, 7.7%) 
were the next most common cause of death. In 
five percent of stillbirths, specific mechanical 
causes were the main factors leading to death 
(n=12, 5.1%). All of the mechanical causes were 
due to the umbilical cord around the baby’s neck 
or another entanglement or knot in the umbilical 
cord. In over two percent of stillbirths, infection 
was the main cause of death (n=6, 2.6%); this 
is lower than rates found in 2015 (n=25 of 294, 
8.7%) and 2016 (n=9 of 250, 3.6%). Intra-uterine 
growth restriction was the main cause of death in 
one case of stillbirth (n=1, 0.4%). 
For eleven percent of stillbirths (n=26, 11.1%), the 
cause of death was unexplained. This is slightly 
lower to the proportion in 2016 (n=38, 15.2%) and 
2015 (n=44, 15.3%). For almost forty percent of 
the stillbirths with unexplained cause of death, 
it was reported that there were no antecedents 
or associated obstetric factors (n=10, 38.5%). In 
under half of these cases with unexplained death, 
an autopsy was performed (n=12 of 26, 46.2%). 
Autopsy was offered but not performed in 12 
cases where death was unexplained (46.2%). 
There were only two additional unexplained 
stillbirths where an autopsy was neither 
performed nor offered. For these two cases 
antecedents or associated obstetric factors 
impacting on the death were present (n=2, 7.6%). 











Major congenital anomaly 68(23.1%) 83(25.6%) 76(26.5%) 78(31.2%) 64(27.2%)
Central nervous system 10 9 3 5 3
Cardiovascular system 8 5 3 3 5
Respiratory system 1 0 0 1 0
Gastro-intestinal system 2 2 0 3 2
Urinary tract 6 4 2 3 5
Musculo-skeletal system 1 1 3 3 1
Multiple anomalies 5 3 3 6 6
Chromosomal disorders 33 57 51 50 38
Metabolic disorders 0 0 0 0 1
Other major congenital anomaly 2 2 11 4 3
Specific placental conditions 1 66(22.4%) 81(25.0%) 71(24.7%) 70(28.0%) 76(32.3%)
Maternal vascular malperfusion 22 32 26 24 28
Fetal vascular malperfusion 16 16 18 15 17
Cord pathology 11 17 15 15 15
Cord pathology with distal disease 0 0 0 9 0
Delayed villous maturation2 8 7 8 2 5
Chorioamnionitis 1 1 0 0 0
Villitis 2 5 3 0 1
Other placental condition 6 3 1 5 10
Mechanical 30(10.2%) 28(8.6%) 19(6.6%) 20(8.0%) 12(5.1%)
Prolapse cord 2 3 3 2 0
Cord around neck 18 17 11 10 8
Uterine rupture before labour 1 1 0 1 0
Mal-presentation 0 0 0 0 0
Shoulder dystocia 0 0 0 0 0
Other cord entanglement or knot 9 7 5 7 4
Antepartum or intrapartum haemorrhage 26(8.8%) 32(9.9%) 21(7.3%) 18(7.2%) 21(8.9%)
Praevia 0 0 1 0 0
Abruption 26 31 20 18 21
Uncertain haemorrhage 0 1 0 0 0
1 The main placental pathology associated with perinatal death is reported.
2  The term ‘Delayed villous maturation’ (DVM) has replaced conditions previously reported as ‘Placental maturation defect’.  
DVM includes distal villous immaturity and delayed villous maturation.
62 PERINATAL MORTALITY IN IRELAND 











Infection 16(5.4%) 22(6.8%) 25(8.7%) 9(3.6%) 6(2.6%)
Bacterial 0 2 0 1 0
Syphilis 0 0 0 0 0
Viral diseases 1 0 0 1 0
Group B Streptococcus 3 2 0 1 0
Other maternal infection 1 0 2 0 0
Chorioamnionitis 8 15 23 4 5
Other ascending infection 3 3 0 2 1
Specific fetal conditions 12(4.1%) 18(5.6%) 23(8.0%) 9(3.6%) 18(7.7%)
Twin-twin transfusion 4 6 10 1 5
Feto-maternal haemorrhage 4 6 7 3 8
Non immune hydrops 1 2 4 3 4
Other fetal condition 3 3 2 2 1
Iso-immunisation 0 1 0 0 0
Intra-uterine growth restriction 5(1.7%) 7(2.2%) 6(2.1%) 4(1.6%) 1(0.4%)
IUGR-Suspected antenatally 2 5 5 4 1
IUGR-Observed at delivery 1 2 0 0 0
IUGR-Observed at post mortem 2 0 1 0 0
Associated obstetric factors 2(0.7%) 1(0.3%) 0(0%) 2(0.8%) 6(2.6%)
Intracranial haemorrhage 0 0 0 0 0
Birth injury to scalp 0 0 0 0 0
Fracture 0 0 0 0 0
Other birth trauma 0 0 0 0 0
Polyhydramnios 0 0 0 0 0
Oligohydramnios 0 0 0 0 0
Prolonged rupture of membranes >24 hrs 0 1 0 0 1
Intrapartum asphyxia 0 0 0 2 3
Premature rupture of membranes 2 0 0 0 1
Other obstetric factors 0 0 0 0 0
Spontaneous premature labour 0 0 0 0 1
Maternal disorder 1(0.3%) 3(0.9%) 2(0.7%) 0(0%) 3(1.3%)
Pre-existing hypertensive disease 0 0 0 0 0
Diabetes 0 0 1 0 2
Thrombophilias 0 1 0 0 0
Uterine anomalies 0 1 0 0 0
Other maternal disorder 1 1 1 0 1
Other endocrine conditions 0 0 0 0 0
Obstetric cholestasis 0 0 0 0 0
Drug misuse 0 0 0 0 0
Hypertensive disorders of pregnancy 0(0%) 2(0.6%) 0(0%) 2(0.8%) 2(0.9%)
Pregnancy induced hypertension 0 2 0 1 0
Pre-eclampsia toxaemia 0 0 0 1 2
HELLP syndrome 0 0 0 0 0
Eclampsia 0 0 0 0 0
Unexplained 68(23.1%) 47(14.5%) 44(15.3%) 38(15.2%) 26(11.1%)
No antecedents or associated obstetric factors 25 26 19 17 10
Antecedents or associated obstetric factors present 34 18 24 15 15
Very limited information available 4 0 0 1 0
Pending post mortem or other investigation 5 3 1 5 1
Note: 2013-2015 figures revised to exclude cases of intrauterine death diagnosed before 24 gestational weeks with a birthweight 
<500g as they are not considered to have reached a gestational age of 24 weeks or more and thus are not included as stillbirths 
in this audit. 
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Management of women experiencing 
antepartum stillbirths 
Factors influencing the delivery management 
of women experiencing antepartum stillbirths 
include maternal choice, maternal wellbeing, risk 
of developing severe medical complications and 
previous obstetric history. Management of clinical 
care may involve planned induction of labour, 
awaiting spontaneous labour or in some cases 
elective delivery by caesarean section.49
In 2017, 213 women experienced antepartum 
stillbirth (90.6% of all the stillbirths) (Table 3.3). 
The management of clinical care (i.e. whether 
the care involved planned induction of labour or 
awaiting spontaneous labour, elective delivery by 
caesarean section) was recorded for all the 213 
women who experienced antepartum stillbirth. 
Labour was induced for over two-thirds of 
the 213 women who experienced antepartum 
stillbirth (n=144, 67.6%) whereas labour was 
spontaneous for 18.8% (n=40). 
As shown in Figure 3.3, the time from diagnosis of 
fetal demise to delivery was different for women 
whose labour was induced from the delivery time 
for women whose labour was spontaneous. The 
confirmation of death and delivery took place 
on the same day for 61.5% (n=24 of 39, date of 
confirmation of date unknown for one case) 
of the women whose labour was spontaneous. 
For women whose labour was induced, it was 
common for up to three days to pass between 
diagnosis and delivery. As can be observed 
from Figure 3.3, a small number of antepartum 
stillbirths (n=6), were delivered more than two 
weeks after confirmation of fetal demise. Of these 
six cases, all but one case were associated with a 
multiple birth. 
Note: Date of confirmation of date unknown for two antepartum stillbirth cases.
Figure 3.2: Time from confirmation of fetal demise to delivery for women who experienced antepartum 
stillbirth in 2017
49 Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: Institute of Obstetricians and 
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Vaginal birth is the recommended mode 
of delivery for most women experiencing 
antepartum stillbirth, but caesarean section may 
be clinically indicated in some cases.50 Vaginal 
cephalic delivery was the most common mode of 
delivery in cases of antepartum stillbirth (n=139, 
61.0%).
In 23 cases of antepartum stillbirth (10.8% of all 
antepartum stillbirths, unknown for one case), 
the intended mode of delivery was a planned 
caesarean section and ultimately, caesarean 
section was the mode of delivery for 35 women 
(16.4%; 29 pre-labour caesarean sections and 
six caesarean sections performed after onset 
of labour). The indication for caesarean section 
was known for 34 of these 35 women. Of 
these 34 women, the indication was classified 
as ‘elective’ in 32.4% of the cases, 38.2% were 
‘urgent’ and 29.4% were ‘emergency’ (Table 3.2). 
One third (n=12, 34.3%) of the 35 women who 
delivered by caesarean section had previously 
had a caesarean section and nearly half (n=17, 
48.6%) had a multiple delivery, both of these 
were factors that may have influenced the 
mode of delivery. The location of delivery for all 
the antepartum stillbirths was in obstetric-led 
maternity units (n=223, 100.0%).
Table 3.2: Indication for caesarean section in women experiencing antenatal stillbirth in 2017
Indication for caesarean section N(%)
Elective: At a time to suit the woman or the maternity team 11(32.4)
Urgent: Maternal or fetal compromise which is not 
immediately life threatening
13(38.2)
Emergency: Immediate threat to life of woman or baby 10(29.4)
Note: Values are N(%) unless otherwise stated. The indication for caesarean section was not known for one case. 
Intrapartum stillbirths 
It has been suggested that the comparatively 
low proportion of intrapartum stillbirths in high-
income countries indicates that fetal deaths 
occurring in labour, in non-anomalous babies, are 
most likely preventable with quality intrapartum 
care.51 Intrapartum deaths in this audit were 
identified by a specific question on the NPEC 
Perinatal Death Notification Form (Appendix E) 
as to whether the baby was alive at the onset of 
care in labour. This was not known in six cases 
(Table 3.3), all six cases were not booked to a 
maternity unit and one of the six cases was born 
before arrival at maternity. There were 16 cases of 
stillbirths where the baby was known to be alive 
at the onset of care in labour. Thus, intrapartum 
deaths accounted for 6.8% of stillbirths in the 
Republic of Ireland Ireland in 2017 (Table 3.3). 
This was slightly lower than the proportion of 
intrapartum deaths reported in 2016 in Ireland 
(n=18, 7.2% of stillbirths) but generally lower 
than the most recently published 2016 figures 
in the United Kingdom, ranging from 8.8% in 
both England and Wales, to 8.5% in Scotland. In 
Northern Ireland, the rate of intrapartum deaths 
was similar (6.3%).52
51  Darmstadt G, Yakoob M, Haws R, Menezes E, Soomro T and Bhutta Z. Reducing stillbirths: interventions during labour. BMC Pregnancy and 
Childbirth 2009;9 (Suppl 1):s6
52 Draper ES, Gallimore ID, Kurinczuk JJ, Smith PW, Boby T, Smith LK, Manktelow BN, on behalf of the MBRRACE-UK Collaboration. MBRRACE-UK 
Perinatal Mortality Surveillance Report, UK Perinatal Deaths for Births from January to December 2016. Leicester: The Infant Mortality and Morbidity 
Studies, Department of Health Sciences, University of Leicester. 2018.
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Table 3.3: Life status of baby at the onset of care in labour for stillbirths in 2017
Type of Stillbirth case Description N(%)
Antepartum
Baby not alive at onset of care in 
labour (Antepartum Stillbirth)
201(85.5)
Never in labour 12(5.1)
Intrapartum Baby alive at onset of care in labour 16(6.8)
Not known/Unattended 6(2.6)
*Six cases were not booked to a maternity unit and one of the six cases was born before arrival (BBA) at maternity unit.
Major congenital anomaly was the primary 
cause of death for under forty percent of the 
16 intrapartum deaths (n=6, 37.5%). The second 
most common cause of death was associated 
obstetric factors, accounting for five (31.3%) of 
the 18 intrapartum deaths, conditions included 
intrapartum asphyxia (n=3), premature rupture 
of membranes (n=1) and spontaneous premature 
labour (n=1). Other cases involved infection (n=1), 
specific placental conditions (n=1)) or intrapartum 
haemorrhage (n=1) and in two cases the primary 
cause of death remains unexplained. There was no 
clustering by hospital in the intrapartum deaths 
due to causes other than congenital anomaly. 
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4. Early neonatal deaths: specific findings
Cause of early neonatal death
The cause of early neonatal deaths was classified 
using both the NPEC Neonatal Classification 
System and the NPEC Maternal and Fetal 
Classification System in order to identify both 
the primary neonatal condition causing the death 
and the underlying main antecedent or obstetric 
factor associated with the death.
Major congenital anomaly was the primary cause 
of death for fifty-six percent (n=62, 55.9%) of 
the 111 early neonatal deaths (Figure 4.1) followed 
by respiratory disorder, accounting for more 
than one in five (n=24, 21.6%) of early neonatal 
deaths. Neurological disorder was the next most 
common cause of death, causing eight percent 
of early neonatal deaths (n=9, 8.1%). Three deaths 
(2.7%) were unexplained pending post mortem or 
other investigation. A detailed listing of the main 
cause of death for the 111 early neonatal deaths 
is given at the end of this section of the report 
(Table 4.3).
Major congenital anomalies 
The types of major congenital anomalies 
which caused 62 of the 111 neonatal deaths are 
illustrated in Figure 4.2. Chromosomal disorders 
were the most common type of major congenital 
anomaly, occurring in over forty percent of 
cases (n=26, 41.9%). The second most frequent 
anomalies were those of the cardiovascular 
system occurring in sixteen percent of the cases 
within the major congenital anomaly group 
(n=10, 16.1%). Other occurring anomalies included 
disorders of the central nervous system (n=7, 
11.3%), urinary tract (n=4, 6.5%), musculo-skeletal 
system (n=3, 4.8%) and respiratory system (n=2, 
3.2%). Five cases were categorised as having 
other major congenital anomalies (8.1%) and four 
cases had multiple anomalies (6.5%). 
Data on whether the diagnosis of a major 
congenital anomaly was confirmed/suspected 
by a consultant fetal medicine specialist was 
recorded for all but five of the 62 neonatal 
deaths. In almost all of these 57 cases a diagnosis 
was confirmed/suspected by a consultant 
fetal medicine specialist (n=49 of 57, 86.0%). 
Furthermore, the vast majority of the 26 neonatal 
deaths attributed to a chromosomal disorder 
were diagnosed by cytogenetic analysis (n=18, 
69.2%).
Respiratory disorders 
Of the 24 early neonatal deaths caused by 
respiratory disorder, over half (n=13, 54.2%) were 
due to severe pulmonary immaturity (Figure 
4.3). Surfactant deficiency lung disease occurred 
in one in four cases (n=6, 25.0%). Pulmonary 
hypoplasia occurred in three cases (n=3, 12.5%). 
All but three of the 24 early neonatal deaths 
attributed to respiratory disorder occurred in 
babies delivered before 28 weeks gestation 
(Table 4.1). This pattern of gestational age was in 
marked contrast to the early neonatal deaths due 
to major congenital anomaly and to those due to 









































Surfactant deficiency lung disease(25%)
Pulmonary hypoplasia(12.5%)
Other respiratory disorder(8.3%)
Figure 4.1: Primary cause of early neonatal death in 2017 (upper chart), detailed cause of death in cases of 
major congenital anomaly in neonatal deaths in 2017 (lower left chart) and detailed cause of death in cases of 
respiratory disorder in neonatal deaths in 2017 (lower right chart).
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Table 4.1: Gestational age distribution in neonatal deaths by broad main cause of death in 2017















≥ 42  
weeks 
N(%)
Respiratory disorder 0(0) 21(87.5) 3(12.5) 0(0) 0(0) 0(0)
Major congenital anomaly 0(0) 3(4.8) 7(11.3) 26(41.9) 25(40.3) 1(1.6)
All Other 2(8.0) 7(28.0) 6(24.0) 3(12.0) 7(28.0) 0(0)
Note: Values are n (%) unless otherwise stated. 
Neurological disorders 
A neurological disorder was attributed as the 
main cause of death in nine early neonatal 
deaths. For six of these cases, the condition 
involved was hypoxic ischaemic encephalopathy 
(HIE) and for three cases death was due to 
intraventricular/periventricular haemorrhage. 
Table 4.2 details the gestational age, customised 
birthweight centile and main antecedent or 
obstetric factor associated with the nine early 
neonatal deaths attributed to neurological 
disorders. Six of these nine cases occurred in 
babies with a gestational age of 37-41 weeks. 
Seven of these nine early neonatal deaths had an 
autopsy performed and six became coroner cases. 







Main antecedent or obstetric factor 
associated with the death
Autopsy Performed 
(Yes/No)
HIE 33  <3rd centile Maternal vascular malperfusion
Autopsy Performed 
(Coroner case)
HIE 26 71st Placental Abruption
Autopsy Performed  
(Coroner case)
HIE 41 19th Fetal vascular malperfusion
Autopsy Performed  
(Coroner case)
HIE 36 95th Placental Abruption
Autopsy Performed  
(Coroner case)
HIE 38 83rd
Other birth trauma (Subgaleal 
haematoma)
Autopsy Performed  
(Coroner case)
HIE 38 58th Placental Abruption
Autopsy not performed 
and not offered
IVH/PVH 25 7th Infection (chorioamnionitis) Autopsy Performed
IVH/PVH 23 71st Infection (chorioamnionitis)
Autopsy not performed 
but offered
IVH/PVH 30 2nd Twin-twin transfusion
Autopsy Performed  
(Coroner case)
Note: IVH/PVH = Intraventricular/periventricular haemorrhage; HIE = hypoxic ischaemic encephalopathy. 
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Major congenital anomaly 92(56.8%) 68(47.9%) 98(59.0%) 68(54.8%) 62(55.9%)
Chromosomal disorders 25 25 17 18 26
Cardiovascular system 9 7 16 9 10
Central nervous system 19 7 11 7 7
Urinary tract 9 10 19 11 4
Multiple anomalies 17 8 11 8 4
Musculo-skeletal system 1 4 5 6 3
Respiratory system 1 2 1 3 2
Gastro-intestinal system 2 1 4 0 1
Metabolic disorders 0 0 1 3 0
Other major congenital anomaly 9 4 13 3 5
Pre-viable (<22 weeks) 1(0.6%) 1(0.7%) 1(0.6%) 0(0%) 2(1.8%)
Respiratory disorders 53(32.7%) 47(33.1%) 41(24.7%) 36(29.0%) 24(21.6%)
Severe pulmonary immaturity 32 36 31 25 13
Surfactant deficiency lung disease 14 5 1 4 6
Pulmonary hypoplasia 2 4 4 5 3
Primary persistent pulmonary hypertension 0 0 1 0 0
Meconium aspiration syndrome 0 0 0 0 0
Chronic lung disease/bronchopulmonary 0 0 0 0 0
Other respiratory disorder 5 2 4 2 2
Gastro-intestinal disease 1(0.6%) 2(1.4%) 0(0%) 1(0.8%) 4(3.6%)
Necrotising enterocolitis 1 2 0 1 4
Other gastro-intestinal disease 0 0 0 0 0
Neurological disorder 10(6.2%) 9(6.3%) 17(10.2%) 8(6.5%) 9(8.1%)
Hypoxic ischaemic encephalopathy 9 7 13 5 6
Intraventricular/periventricular haemorrhage 1 2 4 3 3
Other neurological disorder 0 0 0 0 0
Infection 3(1.9%) 12(8.5%) 3(1.8%) 4(3.2%) 1(0.9%)
Sepsis 1 7 0 4 1
Pneumonia 1 2 1 0 0
Meningitis 0 1 0 0 0
Other infection 1 2 2 0 0
Injury/trauma 0 0 0 0 0
Other specific causes 1(0.6%) 0(0%) 2(1.2%) 2(1.6%) 5(4.5%)
Malignancies/tumours 0 0 0 0 0
Other specific causes 1 0 2 2 5
Sudden unexpected deaths 0(0%) 1(0.7%) 1(0.6%) 0(0%) 1(0.9%)
Sudden infant death syndrome (SIDS) 0 1 1 0 1
Infant deaths - cause unascertained 0 0 0 0 0
Unexplained 1(0.6%) 2(1.4%) 3(1.8%) 5(4.0%) 3(2.7%)
Pending post mortem or other investigations 1 2 3 5 2
Antecedents or associated obstetric factors present 0 0 0 0 1
No antecedents or associated obstetric factors present 0 0 0 0 0
Very limited information available 0 0 0 0 0
Note: 2013-2014 figures published in previous reports included early neonatal deaths only if the death occurred during the 
calendar year. The figures presented here have now been revised and are based on perinatal mortality for a birth cohort.  
For example, deaths are presented for births from 1 January 2013 to 31 December 2013; thus allowing, early neonatal deaths of 
December 2013 births which occurred in January 2014 to be included in 2013 figures. 
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Condition and management at birth 
The NPEC Perinatal Death Notification Form 
(Appendix E) records the condition, in terms of 
respiratory activity and heart rate shortly after 
delivery, of babies who die in the early neonatal 
period. For most of these babies (n=63 of 110, 
57.3%, unknown for one case) spontaneous 
respiratory activity was absent or ineffective at 
five minutes following delivery and for over one 
third (n=41, 37.9%) the heart rate was persistently 
less than 100 beats per minute.
Active resuscitation was offered in the delivery 
room in sixty percent of early neonatal deaths 
(n=66 of 110, 60.0%, unknown for one case). 
Of the early neonatal deaths not receiving 
resuscitation (n=44), the majority (n=35) were 
associated with a major congenital anomaly 
(Table 4.4). More early neonatal cases born 
without major congenital anomaly and not 
offered resuscitation were delivered prematurely 
less than 27 weeks gestation compared to those 
born without a major congenital anomaly and 
not offered resuscitation.























Total ENDs not offered 
resuscitation 2(4.5) 7(15.9) 4(9.1) 17(38.6) 13(29.5) 1(2.3) 44
Death due to Major 
congenital anomaly 0(0) 1(2.9) 4(11.4) 17(48.6) 12(34.3) 1(2.9) 35
Note: Values are n(%) unless otherwise stated.
Nearly sixty percent of early neonatal babies 
were admitted to a neonatal unit in the hospital 
of delivery (n=64, 57.7% of 111) and fourteen 
percent (n=16, 14.4%) were transferred to another 
unit. Such admission and transfer depended on 
whether active resuscitation had been offered 
in the delivery room. Admission to a neonatal 
unit followed nearly ninety percent of the cases 
offered active resuscitation (n=58 of 66, 87.9%) 
compared to fourteen percent not offered active 
resuscitation (n=6 of 44, 13.6%) - Table 4.5. Over 
one in five cases offered active resuscitation were 
transferred to another unit (n=14 of 66, 21.2%) 
compared to just five percent of babies not 
offered receiving resuscitation (n=2 of 44, 4.5%).
Table 4.5: Management at birth of babies who died within the first week of birth, 2017
Baby admitted to neonatal unit N(%) Baby transferred to another unit N(%)
Resuscitation
Yes (n =66) 58(87.9) 14(21.2)
No (n = 44) 6(13.6) 2(4.5)
Note: Values are N (%) unless otherwise stated. Active resuscitation in the delivery room includes BMV, PPV, intubation, cardiac 
massage. Data on active resuscitation was unknown for one case.
Age of neonate at death 
Two thirds of the early neonatal deaths occurred within 24 hours of delivery (Table 4.6). Major 
congenital anomaly and respiratory disorders (mainly severe pulmonary immaturity) were the main 
cause of death in 64.4% (n=47) and 21.9% (n=16) of these cases, respectively.
Table 4.6: Age of neonate at death, 2017
Completed days 0 1 2 3 4 5 6
Number 73 8 10 5 5 5 4
% 65.8 7.2 9 4.5 4.5 4.5 3.6
Cumulative % 66.4 73.6 82.7 87.3 91.8 96.4 100
Note: Age of neonate at death unknown for one early neonatal death.
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Location of neonatal death 
The vast majority of early neonatal deaths occurred either in the neonatal unit, the labour ward, or in 
another maternity unit ward (Table 4.7). A very small proportion of deaths occurred in a paediatric centre.
Table 4.7: Location of neonatal death, 2017
Place of death  n(%)
Neonatal Unit 46(41.4)
Labour Ward 33(29.7)




Note: Values are n(%) unless otherwise stated. 
All 33 neonatal deaths that occurred in the labour ward occurred within 24 hours of delivery. These 33 
deaths in the labour ward accounted for under half of the neonatal deaths that occurred within the first 
day of the birth (total n=73, 45.2%). A further 26.0% (n=19) of first day neonatal deaths occurred in a 
neonatal unit. As detailed in Table 4.6, the daily number of neonatal deaths was significantly lower once 
24 hours had elapsed after delivery. Seventy percent of the neonatal deaths that occurred between 1-6 
completed days (n=37) happened in a neonatal unit (n=26, 70.3%) and a further 8.1% of these deaths 
(n=3) occurred in a ward of the maternity unit (Figure 4.2).
Figure 4.2: Place of neonatal death 0-6 complete days after birth, 2017























Ward of the maternity Unit
Neonatal Unit
Labour Ward
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5.  Perinatal deaths associated with 
intrapartum events 
The investigation of perinatal deaths due to 
intrapartum events is valuable in assessing 
quality of care. These deaths are unexpected 
and include stillbirths alive at the onset of 
professional care in labour and neonatal deaths. 
Traditionally intrapartum deaths referred to 
babies who were alive at onset of labour but 
stillborn. The inclusion of neonatal deaths 
facilitates the assessment of all perinatal deaths 
that may have an intrapartum origin.
We reviewed perinatal deaths reported in 2017, 
focusing on cases with a gestational age of at 
least 34 weeks and a birthweight of at least 
2,500g who were alive at the onset of care in 
labour and whose death was not due to major 
congenital anomaly or infection. Babies who 
were delivered by pre-labour caesarean section 
were not included. 
In 2017, there were 18 cases of perinatal death 
with a gestational age of at least 34 weeks and 
a birthweight of at least 2,500g who were alive 
at the onset of care in labour and were not 
delivered by pre-labour caesarean section. There 
were no cases with death due to infection and 14 
of the 18 perinatal deaths mentioned above were 
due to major congenital anomaly (n=14, 77.8%). 
Therefore, in total in 2017, there were four 
perinatal deaths (one stillbirth and three early 
neonatal deaths) associated with intrapartum 
events with a gestational age of at least 34 
weeks and a birthweight of at least 2,500g 
who were alive at the onset of labour and not 
delivered by pre-labour caesarean section and 
whose death was not due to major congenital 
anomaly or infection. All of the four deaths were 
coroner cases. Details of the cases are provided 
in Table 5.1 below. 









Main antecedent or obstetric factor 
associated with the death
Neonatal cause of death Autopsy Uptake  
Yes/No
SB 37-41 25th Intrapartum asphyxia Not Applicable Yes (coroner case)
END 37-42 <3rd
Pending results of post mortem 
or other investigations
Pending results of 
post mortem or other 
investigations
Yes (coroner case)
END 37-43 19th Fetal vascular malperfusion HIE Yes (coroner case)
END 37-44 83th
Other birth trauma  
(Subgaleal Hematoma)
HIE Yes (coroner case)
Note: SB=Stillbirth; END=Early neonatal death; HIE=hypoxic ischaemic encephalopathy. 
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6. Late neonatal deaths: specific findings
Data relating to 35 late neonatal deaths 
occurring in 2017 were reported to the NPEC for 
the purposes of this clinical audit. At the time 
of reporting, finalised figures for late neonatal 
deaths in 2017 were not yet published by the 
Central Statistics Office (CSO). However, in their 
provisional data, it was reported that 36 late 
neonatal deaths had occurred in 2017. 
In each of the preceding three years there has 
been some variation between the number of late 
neonatal deaths reported by the CSO and the 
number reported to the NPEC. For 2014, 2015 
and 2016 respectively, the CSO reported 38, 32 
and 33 late neonatal deaths while 34, 28 and 33 
were reported to the NPEC. Maternity hospitals 
may not be notified of the late neonatal death 
of a baby delivered in their unit if the baby was 
transferred to a paediatric unit or discharged 
home. The NPEC is working with colleagues in 
the relevant hospitals (maternity and paediatric) 
to address this issue.
Given the notification issue and the limited 
number of late neonatal deaths reported, this 
section of the report provides a brief summary of 
the submitted data as well as the detailed listing 
of the main cause of the 35 deaths according to 
the NPEC Classification System.
Table 6.1 describes a range of characteristics 
of the babies who died in the late neonatal 
period. Slightly more babies who died in the 
late neonatal period were male. This is in line 
with previous years trends, although the values 
fluctuate from year to year. 
Over one third of the babies who died in the late 
neonatal period in 2017 were born by vaginal 
cephalic delivery (n=13, 37.1%) and thirty-one 
percent were delivered by pre-labour caesarean 
section (n=11, 31.4%). Most had a gestational 
age between 22-27 weeks or 37-41 weeks at 
birth (n=28, 80.0%) and over sixty percent 
(n=22, 62.9%) had a birthweight less than 2,500 
grams. Almost one third of babies were small for 
gestational age (SGA: <10th centile, n=11, 31.4%).
In 2017, the proportion of late neonatal deaths 
was found to decrease across the second, 
third and fourth weeks of life. For example, the 
proportion of late neonatal deaths decreased 
from 48.6% in week two to 31.4% in week three to 
20.0% in week four.
Over sixty percent of late neonatal deaths in 2017 
occurred in the neonatal unit and almost thirty 
percent died in a paediatric centre (n=21, 61.8% 
and n=10, 29.4%, respectively).
As shown in Table 6.2, under forty percent of late 
neonatal deaths were due to major congenital 
anomaly (n=13, 37.1%). The next most common 
causes were gastro-intestinal disorders (n=8, 
22.9%), respiratory disorders (n=5, 14.3%) and 
neurological disorders (n=5, 14.3%). Other causes 
of death for these babies included sudden infant 
death syndrome (n=1, 2.9%) and infection (n=1, 
2.9%). Two deaths were unexplained pending 
post mortem or other investigation (n=2, 5.7%).
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Male 22(61.1) 22(64.7) 19(73.1) 19(57.6) 18(51.4)
Female 14(38.9) 12(35.3) 7(26.9) 14(42.4) 17(48.6)
Mode of delivery
Vaginal cephalic delivery 18(50) 10(32.3) 11(42.3) 11(33.3) 13(37.1)
Vaginal breech delivery 0(0) 1(3.2) 1(3.8) 3(9.1) 3(8.6)
Pre-labour caesarean section 8(22.2) 10(32.3) 9(34.6) 9(27.3) 11(31.4)
Caesarean section after onset of labour 7(19.4) 9(29) 3(11.5) 6(18.2) 6(17.1)
Forceps 0(0) 0(0) 0(0) 1(3) 1(2.9)
Assisted breech 2(5.6) 1(3.2) 1(3.8) 2(6.1) 0(0)
Ventouse 1(2.8) 0(0) 1(3.8) 1(3) 1(2.9)
Gestational age at delivery
22-27 weeks 12(33.3) 12(35.3) 8(28.6) 12(36.4) 15(42.9)
28-31 weeks 3(8.3) 9(26.5) 2(7.1) 3(9.1) 3(8.6)
32-36 weeks 2(5.6) 4(11.8) 7(25) 6(18.2) 4(11.4)
37-41 weeks 19(52.8) 9(26.5) 10(35.7) 12(36.4) 13(37.1)
42+ weeks 0(0) 0(0) 1(3.6) 0(0) 0(0)
Birthweight
<500g 0(0) 2(5.9) 1(3.6) 1(3) 0(0)
500<1000g 12(33.3) 10(29.4) 8(28.6) 14(42.4) 15(42.9)
1000<1500g 1(2.8) 6(17.6) 2(7.1) 2(6.1) 2(5.7)
1500<2000g 3(8.3) 2(5.9) 2(7.1) 2(6.1) 2(5.7)
2000<2500g 2(5.6) 2(5.9) 4(14.3) 5(15.2) 3(8.6)
2500<3000g 7(19.4) 3(8.8) 3(10.7) 1(3) 4(11.4)
3000<3500g 6(16.7) 4(11.8) 5(17.9) 6(18.2) 4(11.4)
3500<4000g 4(11.1) 4(11.8) 3(10.7) 2(6.1) 4(11.4)
4000g+ 1(2.8) 1(2.9) 0(0) 0(0) 1(2.9)
Customised birthweight centile category
<3rd 4(11.1) 6(17.6) 10(35.7) 10(30.3) 7(20.0)
<10th* 10(27.8) 8(23.5) 11(39.3) 11(33.3) 11(31.4)
10-49th 13(36.1) 12(35.3) 8(28.6) 15(45.5) 13(37.1)
50-89th 8(22.2) 9(26.5) 9(32.1) 6(18.2) 8(22.9)
90th+ 5(13.9) 5(14.7) 0(0) 1(3) 3(8.6)
Timing of death
2nd week of life 15(41.7) 19(59.4) 17(60.7) 15(45.5) 17(48.6)
3rd week of life 9(25) 6(18.8) 7(25) 9(27.3) 11(31.4)
4th week of life 12(33.3) 7(21.9) 4(14.3) 9(27.3) 7(20.0)
Location of death
Neonatal unit 20(55.6) 25(73.5) 14(50) 22(66.7) 21(61.8)
Ward of the maternity unit 1(2.8) 0(0) 0(0) 1(3) 0(0)
Paediatric centre 10(27.8) 9(26.5) 9(32.1) 7(21.2) 10(29.4)
Home 5(13.9) 0(0) 4(14.3) 3(9.1) 3(8.8)
In transit home 0(0) 0(0) 1(3.6) 0(0) 0(0)
Note: 2013-2014 figures published in previous reports included late neonatal deaths only if the death occurred during the calendar 
year. The figures presented here have now been revised and are based on perinatal mortality for a birth cohort. For example, 
deaths are presented for births from 1 January 2013 to 31 December 2013; thus allowing, early neonatal deaths of December 2013 
births which occurred in January 2014 to be included in 2013 figures. Furthermore, data was missing for the following variables: 
In 2017, place of death not known for one case, in 2015 gender not known for two cases and mode of delivery was not known for 
two cases, in 2014 mode of delivery was not known for three cases and age of neonate not known for two cases. 
*Includes cases from the category <3rd Centile. 
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Major congenital anomaly 16(44.4%) 19(55.9%) 15(53.6%) 15(45.5%) 13(37.1%)
Central nervous system 1 3 1 1 0
Cardiovascular system 4 5 5 2 5
Respiratory system 0 0 1 0 0
Gastro-intestinal system 1 0 1 1 0
Musculo-skeletal system 0 1 0 0 0
Multiple anomalies 1 0 0 2 2
Chromosomal disorders 3 1 0 1 0
Metabolic disorders 4 7 7 6 6
Urinary tract 1 2 0 1 0
Other major congenital anomaly 1 0 0 1 0
Respiratory disorders 5(13.9%) 8(23.5%) 3(10.7%) 10(30.3%) 5(14.3%)
Severe pulmonary immaturity 4 2 3 3 3
Surfactant deficiency lung disease 0 6 0 6 1
Pulmonary hypoplasia 0 0 0 0 0
Meconium aspiration syndrome 0 0 0 0 0
Primary persistent pulmonary hypertension 0 0 0 0 0
Chronic lung disease/bronchopulmonary 
dysplasia
1 0 0 0 0
Other respiratory disorder 3 - - - 1
Gastro-intestinal disease 2(5.6%) 3(8.8%) 3(10.7%) 3(9.1%) 8(22.9%)
Necrotising enterocolitis 2 3 3 3 7
Other gastro-intestinal disease 0 0 0 0 1
Neurological disorder 7(19.4%) 1(2.9%) 2(7.1%) 4(12.1%) 5(14.3%)
Hypoxic-ischaemic encephalopathy 3 0 1 3 5
Intraventricular/periventricular haemorrhage 4 1 1 1 0
Other neurological disorder 0 0 0 0 0
Infection 1(2.8%) 2(5.9%) 4(14.3%) 0(0%) 1(2.9%)
Sepsis 1 2 1 0 1
Pneumonia 0 0 0 0 0
Meningitis 0 0 2 0 0
Other infection 0 0 1 0 0
Injury/Trauma 0(0%) 1(2.9%) 0(0%) 0(0%) 0(0%)
Other specific causes 0(0%) 0(0%) 0(0%) 0(0%) 0(0%)
Malignancies/tumours 0 0 0 0 0
Other specific cause 0 0 0 0 0
Sudden unexpected deaths 4(11.1%) 0(0%) 1(3.6%) 1(3.0%) 1(2.9%)
Sudden infant death syndrome (SIDS) 4 0 1 1 1
Infant Deaths - Cause Unascertained 0 0 0 0 0
Unexplained 1(2.8%) 0(0%) 0(0%) 0(0%) 2(5.7%)
No antecedents or associated obstetric factors 0 0 0 0 0
Antecedents or associated obstetric factors 
present
0 0 0 0 0
Very limited information available 0 0 0 0 0
Pending results of post mortem or other 
investigations
1 0 0 0 2
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7.  Early neonatal deaths with a birthweight <500g 
and a gestational age at delivery <24 weeks
While not included in the calculation of perinatal 
mortality rates, we ask for notification of 
deaths in the early neonatal period of babies 
born before 24 weeks gestation and weighing 
less than 500g. For 2017, 38 such deaths were 
reported by eight maternity units. Twenty-one of 
the 38 deaths occurred in babies born between 
21 and 22 weeks gestation and seventeen deaths 
occurred in babies born between 12-20 weeks 
gestation. Details of the 38 early neonatal deaths 
born before 24 weeks gestation and weighing 
less than 500g are provided in Table 7.1.
Using the NPEC Neonatal Classification System, 
the assigned cause of death was pre-viable (<22 
weeks) for 28 cases (73.7%), severe pulmonary 
immaturity for nine cases (23.7%) and sepsis for 
one case (2.6%). Based on the NPEC Maternal 
and Fetal Classification System, the most 
commonly occurring antecedents or associated 
obstetric factors in these 38 early neonatal 
deaths were chorioamnionitis (n=21, 55.3 %) and 
spontaneous premature labour (n=7, 18.4%). 
The birthweights of the babies were in the range 
58g to 490g and their gestation at delivery was 
12-22 weeks. Customised birthweight centiles 
calculated for the 36 babies showed evidence 
of fetal growth restriction. One third (n=9 of 
27, 33.1%) were small-for-gestational-age (SGA; 
<10th centile) and fifteen percent (n=4 of 27, 
14.8%) were severely SGA (<3rd centile), growth 
centiles could not be calculated for 11 of 38 early 
neonatal deaths.
All 38 babies died within 24 hours of being 
delivered, most commonly in the labour ward 
(n=24, 63.2%) but in some cases in another ward 
of the maternity unit (n=12, 31.6%) or a theatre 
(n=2, 5.3%).
An autopsy was performed in only one case 
(2.7%, data on autopsy unknown for one case) 
but an autopsy was offered in a further ten cases 
(27.0%). Placental histology examination was 
conducted following all but one of the 38 deaths 
(97.4%).
A recurrent issue raised by maternity units relates 
to the registration of live babies born before the 
age of viability. Correspondence from the General 
Registers Office (GRO) has confirmed the 
current legislation on registration of such births: 
if an infant is born with signs of life, regardless 
of birthweight or gestational age at delivery, 
the birth is registered as a live birth and if the 
subsequent death of the infant occurs during the 
perinatal period, the death should then also be 
registered as a neonatal death.53
53  Smith B, Assistant Registrar General 2016, personal communication, 12th October. 
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Table 7.1: Early neonatal deaths in 2017 with a birthweight <500g and a gestational age at delivery <24 weeks
Gestational age 
(weeks)
Birthweight Location of death Cause of Neonatal Death Autopsy Uptake  
(Yes/No)
12 182 Ward Pre-viable (<22 weeks) No (and not offered)
14 58
17 100 Ward Pre-viable (<22 weeks) No (and not offered)
17 150 Ward Pre-viable (<22 weeks) No (and not offered)
17 160 LabourWard Pre-viable (<22 weeks) No (and not offered)
17 180 LabourWard Pre-viable (<22 weeks) No (and not offered)
17 200 LabourWard Pre-viable (<22 weeks) No (and not offered)
18 210 Ward Pre-viable (<22 weeks) No (and not offered)
19 250 LabourWard Pre-viable (<22 weeks) No (and not offered)
19 270 Theatre Pre-viable (<22 weeks) Not known
19 360 LabourWard Pre-viable (<22 weeks) No (and not offered)
20 225 LabourWard Pre-viable (<22 weeks) No (and not offered)
20 301 LabourWard Pre-viable (<22 weeks) No (but offered)
20 320 LabourWard Pre-viable (<22 weeks) No (but offered)
20 325 Ward Pre-viable (<22 weeks) No (and not offered)
20 375 LabourWard Pre-viable (<22 weeks) No (and not offered)
20 380 LabourWard Pre-viable (<22 weeks) No (but offered)
21 308 Ward Pre-viable (<22 weeks) No (and not offered)
21 345 LabourWard Pre-viable (<22 weeks) No (but offered)
21 350 LabourWard Pre-viable (<22 weeks) No (but offered)
21 370 LabourWard Pre-viable (<22 weeks) Yes
21 375 LabourWard Pre-viable (<22 weeks) No (but offered)
21 380 LabourWard Sepsis No (and not offered)
21 385 LabourWard Pre-viable (<22 weeks) No (but offered)
21 430 Ward Pre-viable (<22 weeks) No (but offered)
21 430 LabourWard Pre-viable (<22 weeks) No (and not offered)
21 440 Ward Pre-viable (<22 weeks) No (and not offered)
21 452 LabourWard Severe pulmonary immaturity No (and not offered)
21 480 LabourWard Pre-viable (<22 weeks) No (and not offered)
22 400 Ward Severe pulmonary immaturity No (and not offered)
22 400 LabourWard Severe pulmonary immaturity No (and not offered)
22 400 LabourWard Severe pulmonary immaturity No (and not offered)
22 407 LabourWard Severe pulmonary immaturity No (and not offered)
22 440 LabourWard Severe pulmonary immaturity No (and not offered)
22 445 Ward Severe pulmonary immaturity No (and not offered)
22 453 Theatre Pre-viable (<22 weeks) No (but offered)
22 482 Ward Severe pulmonary immaturity No (but offered)
22 490 LabourWard Severe pulmonary immaturity No (and not offered)
Note: None of the above early neonatal deaths were coroner cases, Data on autopsy unknown for one case. 
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Appendix A: Hospital Co-ordinators and Contributors 2017
Hospital Co-ordinators Additional contributors
Cavan General Hospital Dr Rukhsana Majeed
Ms Karen Malocca
Ms Louise Dempsey
Coombe Women and Infants  
University Hospital, Dublin
Ms Julie Sloan 
Dr Naomi Burke and  
Dr Anna Durand O’Connor
Dr Sharon Sheehan
Cork University Maternity Hospital 




Dr Brendan Murphy 
Ms Linda Dawson
University Hospital Kerry Ms Mary Stack Courtney
Letterkenny University Hospital Ms Mary Lynch Ms Evelyn Smith
Mayo University Hospital
Ms Pauline Corcoran Dr Hilary Ikele
Ms Diane Brady Dr Meabh Ní Bhuinneain
Regional Hospital Mullingar Ms Marie Corbett
Midland Regional Hospital Portlaoise
Ms Emma Mullins
Ms Ita Kinsella
University Maternity Hospital Limerick
Ms Sandra O’Connor Dr Gerry Burke
Ms Margo Dunworth Dr Roy Philip
National Maternity Hospital, Dublin Ms Fionnuala Byrne
Dr Eoghan Mooney
Dr Anne Twomey
Dr Rhona Mahony 
Our Lady of Lourdes Hospital, Drogheda Ms Fiona Mulligan 
Ms Siobhan Weldon 
Dr Seosamh Ó Cóigligh
Portiuncula University Hospital, Ballinasloe
Ms Priscilla Neilan
Ms Aisling Dixon





South Tipperary General Hospital, Clonmel Ms Siobhan Kavanagh




University Hospital Galway Ms Marie Hession
University Hospital Waterford
Ms Paula Curtin
Ms Margaret Coe 
Ms Emer Denn
Wexford General Hospital Ms Helen McLoughlin
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Appendix B: Perinatal Mortality Group Membership
Ms Bridget Boyd, Assistant Director of Midwifery, Coombe Women & Infants University Hospital 
Nominated by the Deputy Nursing Services Director, HSE
Dr Gerry Burke, Consultant Obstetrician & Gynaecologist, University Maternity Hospital Limerick 
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI
Dr David Corcoran, Consultant Neonatologist, Rotunda Hospital 
Nominated by the Faculty of Paediatrics, RCPI
Dr Siobhan Gormally, Consultant Paediatrician, Our Lady of Lourdes Hospital 
Nominated by the Faculty of Paediatrics, RCPI
Ms Oonagh McDermott, Assistant Director of Midwifery, Sligo General Hospital 
Nominated by the Deputy Nursing Services Director, HSE
Professor John Morrison, Consultant Obstetrician & Gynaecologist, University Hospital Galway 
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI
Dr Eoghan Mooney, Consultant Pathologist, National Maternity Hospital 
Nominated by the Faculty of Pathology, RCPI
Dr Keelin O’Donoghue, Consultant Obstetrician & Gynaecologist, Cork University Maternity Hospital 
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI
Ms Breda O’Donovan, Clinical Midwife Manager III from 2017, University Hospital Waterford 
Nominated by the National Lead Midwife Office of the Nursing & Midwifery Services Director 
Ms Ann Rath, Clinical Midwife Manager III, National Maternity Hospital  
Nominated by the Deputy Nursing Services Director, HSE 
Dr Anne Twomey, Consultant Neonatologist, National Maternity Hospital  
Nominated by the Faculty of Paediatrics, RCPI 
Ms Patricia Williamson, Assistant Director of Midwifery, Rotunda Hospital  
Nominated by the Deputy Nursing Services Director, HSE
Ms Siobhan Whelan, Patient Representative
Prof Richard Greene, Consultant Obstetrician & Gynaecologist, Cork University Maternity Hospital  
Chair, Director of the National Perinatal Epidemiology Centre 
Ms Edel Manning, Research Midwife, National Perinatal Epidemiology Centre  
Perinatal Mortality Project Manager 
Mr Paul Corcoran, PhD, Senior Lecturer in Perinatal Epidemiology, National Perinatal Epidemiology Centre  
National Perinatal Epidemiology Centre contributor 
Ms Sarah Meaney, Research Officer, National Perinatal Epidemiology Centre  
National Perinatal Epidemiology Centre contributor
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Appendix C: NPEC Governance Committee Members 
Chair: Dr Michael Robson, Consultant Obstetrician and Gynaecologist, National Maternity Hospital
Professor Tom Clarke, Consultant Neonatologist, Rotunda Hospital (Retired)
Dr Sharon Cooley, Institute of Obstetrics and Gynaecology Representative
Ms Marie Cregan, Patient Representative, University College Cork
Professor Declan Devane, Chair of Midwifery, National University of Ireland, Galway
Dr Geraldine Gaffney, Senior Lecturer, National University of Ireland, Galway
Professor Richard Greene, Consultant Obstetrician & Gynaecologist, Cork University Maternity Hospital, 
Director of the National Perinatal Epidemiology Centre
Professor Shane Higgins, Master, The National Maternity Hospital
Dr Heather Langan, Consultant Obstetrician and Gynaecologist, Sligo General Hospital
Professor Fergal Malone, Master, The Rotunda Hospital
Professor Eleanor Molloy, Faculty of Paediatrics Representative
Ms Connie McDonagh, Clinical Midwife Manager 3, St. Luke’s General Hospital
Dr Mary O’Mahony, Specialist in Public Health Medicine, HSE
Dr Sharon Sheehan, Master, Coombe Woman and Infants University Hospital
Ms Collette Tully, NOCA Executive Director, National Office of Clinical Audit
Ms Ann O’Byrne, Chair of the national Designated Midwifery Officer Group - Home Births
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Appendix D: National Office of Clinical Audit (NOCA) endorsement 
of the Perinatal Mortality in Ireland Annual Report 2017 
National Office of Clinical Audit 
2nd Floor 
Ardilaun House, Block B 
111 St Stephen’s Green 
Dublin 2, D02 VN51 
Tel: + (353) 1 402 8577 
Email: auditinfo@noca.ie 
Professor Richard A. Greene 
Director 
National Perinatal Epidemiology Centre 
5th Floor, Cork University Maternity Hospital 
Wilton 
Cork 
21st June 2019 
Perinatal Mortality in Ireland, Annual Report 2017 
Dear Professor Greene, 
I write to thank you and your colleague Dr Paul Corcoran for your detailed presentation to the NOCA 
Governance Board, 6th June 2019 of NPEC’s Perinatal Mortality in Ireland – Annual Report 2017. 
You and your NPEC colleagues are to be congratulated for the quality of the report and manner in 
which you continue to engage with maternity services to maintain this work.   
The NOCA Board and Executive Team will continue to support NPEC governance efforts and in 
particular highlight the national requirement for resource commitment to ensure sustainable clinical 
audit of perinatal and maternal outcomes. 
Please accept this as formal endorsement from the NOCA Governance Board of the Perinatal Mortality 
in Ireland Annual Report 2017. 
Yours sincerely, 
Professor Conor O’ Keane FFPath FRCPI 
Chair 
National Office of Clinical Audit Governance Board 
The National Office of Clinical Audit (NOCA) was established in 
2012 to create sustainable clinical audit programmes at national 
level. NOCA enables those who manage and deliver healthcare to 
improve the quality of care through national clinical audit.
The NPEC aligns its audit governance structures to the NOCA 
audit governance standards for audit governance committees, 
monitoring & escalation of outliers and national reporting.
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Appendix E: 2017 Perinatal Mortality Notification Form 
1 
PERINATAL DEATH NOTIFICATION FORM 
2017
CHOOSE Type of Case (TICK)
 STILLBIRTH: A baby delivered without signs of life from 24 weeks’ gestation and/or with a birth weight of ≥
500g.
*If the birth occurred unattended and there was no lung aeration seen at Post Mortem (PM) and no other
circumstantial evidence of life at birth, it should be assumed that the baby was stillborn.
OR
 EARLY NEONATAL DEATH: Death of a live born baby occurring before 7 completed days after birth.
OR
 LATE NEONATAL DEATH:  Death of a live born baby occurring from the 7th day and before 28 completed 
days after birth.
* For the purpose of reporting, a ‘live born’ baby is defined as any baby born with evidence of life such as
breathing movements, presence of a heart beat, pulsation of the cord or definite movement of voluntary
muscles.
*If a baby born at <22 completed weeks is being registered as a neonatal death, please report same to
NPEC.
The National Perinatal Epidemiology Centre is sincerely grateful for your contribution to this 
audit.
Guidance for completing this form, with specific reference to Sections 11, 12 and 13 on Cause 
of Death, is outlined in the accompanying reference manual.
The National Perinatal Epidemiology Centre also acknowledges with thanks the Centre for Maternal and Child 
Enquiry (CMACE) UK for permission to modify and use its Perinatal Mortality Notification Proforma for use in the 
Irish context. 















































Appendix E: 2017 Perinatal Mortality Notification Form
83ANNUAL REPORT 2017
2 
SECTION 1.  WOMANS’ DETAILS  
       1.1. Mother’s age   
1.2. Ethnic group: 
     White - Irish                               Irish Traveller  
            Any other White background         Please specify country of origin ______________________________________  
      Asian or Asian Irish                    Black or Black Irish    
     Other including mixed ethnic backgrounds: Please specify  ______________________________________________      
            Not recorded 
         
 
        1.3. Marital status:      Married             Never married       Separated/Divorced     Widowed     Unknown    
 
         1.4. Living with partner / spouse?              Yes                        No                                   Unknown 
 
         1.5. Woman’s employment status at booking? 
 
             Employed or self-employed (full or part time)                      Unemployed (looking for work)            
 Student             Home maker                              Permanently sick/disabled     
Other________________       Unknown 
 
  
 1.7. Height at booking (round up to the nearest cm):  
 1.8. Weight at booking (round up to the nearest kg):    
 If weight is unavailable, was there evidence that the woman was too heavy for hospital scales?  Yes  No 
 1.9. Body Mass Index at booking (BMI):  . 
 
 1.10.a. Did the woman smoke at booking?      Yes, specify quantity smoked per day__________________ 
                                 No                     Unknown 
 1.10.b. Did she give up smoking during pregnancy?             Yes             No          Unknown     N/A 
 
 1.11. Is there documented history of alcohol abuse?  
        None recorded                  Prior to this pregnancy                  During this pregnancy  
 
           
       1.12. Is there documented history of drug abuse or attendance at a drug rehabilitation unit?  
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SECTION 2.  PREVIOUS PREGNANCIES  
2.1. Did the woman have any previous pregnancies?    If yes, please complete questions 2.2-2.4                 Yes        No 
2.2. No. of completed pregnancies ≥24 weeks and or with a birth weight ≥ 500g (all live and stillbirths):   
2.3. No. of pregnancies <24 weeks and with a birth weight < 500g:         
2.4. Were there any previous pregnancy problems? If yes, please tick all that apply below  Yes  No 
       Three or more miscarriages  Pre-term birth or mid trimester loss         Stillbirth, please specify number   
       Infant requiring intensive care    Baby with congenital anomaly              Neonatal death, please specify number   
Previous caesarean section Placenta praevia               Placental abruption      
Pre-eclampsia (hypertension &  proteinuria)          Post-partum haemorrhage requiring transfusion 
Other, please specify_______________________________________   Unknown 
 
SECTION 3.  PREVIOUS MEDICAL HISTORY 
3.1. Were there any pre-existing medical problems? If yes, please  tick all that apply below    Yes  No Unknown 
Cardiac disease (congenital or acquired)  Epilepsy  
Endocrine disorders e.g. hypo or hyperthyroidism  Renal disease 
Haematological disorders e.g. sickle cell disease       Psychiatric disorders 
Inflammatory disorders e.g. inflammatory bowel disease  Hypertension  
Diabetes  Other, please specify  ________________________  
 
SECTION 4.  THIS PREGNANCY 
4.1. Final Estimated Date of Delivery (EDD):      //      Unknown 
  Use best estimate (ultrasound scan or date of last menstrual period) based on a 40 week gestation, or the final date agreed 
in the notes. 
4.2. Was this a multiple pregnancy at the onset of pregnancy?             Yes       No 
 
4.3. Was this pregnancy a result of infertility treatment?                          Yes     No             Unknown 
 
               If yes, please specify method of fertility treatment _______________________________________________________________ 
  
       4.4 Gestation at first booking appointment:        weeks + days               Not booked         Unknown  
 
 4.5 Intended place of delivery at booking:  Name of unit _________________________________ 
 
Please specify the type of unit  
  Obstetric Unit      Alongside Midwifery Unit               Home                   Unbooked 
 
 4.6 What was the intended type of delivery care at booking?  
         Obstetric-Led Care         Midwifery-Led Care            Self-Employed Community Midwife      
         Home c/o Hospital DOMINO Scheme 





        4.7a Was the care of the mother transferred from another unit with the fetus in utero?          Yes       No 
                 If yes please answer question 4.7 b  
       4.7b Gestation at time of in-utero transfer:                                      weeks + days            Unknown 
 
       4.8 a Did the woman undergo an anatomy scan?                                  Yes       No 
                 If yes please answer question 4.8 b  
        4.8 b Gestation at time of anatomy scan:                                          weeks + days            
 
    
         
SECTION 5.  DELIVERY 
      
       5.1. Onset of labour: 
 Spontaneous          Induced  Never in labour  
 
5.2. Intended place of delivery at onset of labour:  Name of unit ____________________________ 
  
Please specify the type of unit 
 Obstetric Unit    Alongside Midwifery Unit     Home 
       
       5.3. What was the intended type of care at onset of labour?  
 Obstetric-Led Care         Midwifery-Led Care            Self-Employed Community Midwife      
 Home c/o Hospital DOMINO Scheme 
 
5.4. Was the intended mode of delivery a planned caesarean section?    Yes    No  
 
5.5. Place of delivery: Name of unit ____________________________________  
 
Please specify the type of unit 
  Obstetric Unit             Alongside Midwifery Unit        Other, please specify___________________ 
 
5.6. What was the type of care at delivery?  
 Obstetric-Led Care        Midwifery -Led Care              Born Before Arrival (BBA) - Unattended      
 Self-Employed Community Midwife       Home c/o Hospital DOMINO Scheme                             
       5.7. Date and time of delivery/birth:  Date: //       Time:: 
 
5.8. What was the lie of the fetus at delivery?  
 Longitudinal                           Oblique                    Transverse   
5.9. What was the presentation at delivery?  
Vertex  Breech  Compound (includes transverse and shoulder presentations) Brow  Face    
 
5.10. What was the mode of delivery? (Please tick all that apply) 
 Vaginal cephalic delivery     Ventouse           Forceps            Assisted Breech delivery          
Vaginal Breech delivery           Pre-Labour Caesarean Section          Caesarean Section After Onset of Labour 
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5 
CAESAREAN SECTIONS ONLY 
 
5.11. What was the type of or indication for Caesarean Section? 
Elective - At a time to suit woman or maternity team Urgent - Maternal or fetal compromise which is not immediately life threatening    
Emergency - Immediate threat to life of woman or fetus          Failed instrumental delivery  
SECTION 6.  ALL BABY OUTCOME 
      6.1. Sex of fetus/baby:     Male    Female     Indeterminate  
      6.2. Number of fetuses/babies in this delivery: (all identifiable including papyraceous)                   
             Birth order of this fetus/baby:   
Singleton  
 Twin 1  Twin 2   
 Triplet 1  Triplet 2                 Triplet 3  
Other multiple birth pregnancy, please specify__________         Birth Order   
       
        6.3. If from a multiple delivery, what was the chorionicity? Please tick all that apply 
Dichorionic diamniotic  Monochorionic diamniotic   Monochorionic monoamniotic Trichorionic   
 Singleton Not known 
       
        6.4. Birth weight (kg):  .  
 6.5. Gestation at delivery:  weeks + days                        Unknown 
       6.6. Was this a termination of pregnancy?   Yes  No 
              Please refer to the reference manual  
 
       6.7. Was a local hospital review of this case undertaken?      Yes  No 
               Please refer to the reference manual 
 
 
SECTION 7. MATERNAL OUTCOME 
       7.1. Admission to HDU:                                                                                                                           Yes    No  
       7.2. Admission to ICU:                                                                                                                             Yes    No  
       7.3. Maternal Death:                                                                                                                                 Yes    No 
 
 
   
SECTION 8. STILLBIRTH (If not a stillbirth, please go to Section 9) 
      8.1. At what gestation was death confirmed to have occurred?  weeks + days  
      If known, what date was death confirmed?  // 
 
      8.2. Was the baby alive at onset of care in labour?   




SECTION 9. NEONATAL DEATH ONLY 
       9.1. Was spontaneous respiratory activity absent or ineffective at 5 minutes?    Yes  No 
If a baby is receiving any artificial ventilation at 5 minutes, the assumption is absent/ineffective activity: a 0 Apgar score indicates 
absent activity.  
 
 
       9.2. Was the heart rate persistently <100bpm? ( i.e. heart rate never rose above 100bpm before death)  
                                                  Persistently <100bpm Rose above 100bpm 
      
       9.3. Was the baby offered *active resuscitation in the delivery room?                                             Yes  No 
        (*active resuscitation includes BMV, PPV, intubation, cardiac massage) 
 
 
        9.4. Was the baby admitted to a neonatal unit? (Includes SCBU and ICU)                                          Yes  No 
        9.5a. Was the baby transferred to another unit after birth?                                                                   Yes  No 
                  If yes please answer 9.5 b 
        
        9.5 b. Date and Time of Transfer to other unit after birth:    Date //         Time : 
 
   
        9.6. Date and Time of Death:                                                    Date //       Time : 
 
        9.7. Place of Death*:            Labour Ward               Neonatal Unit                 Ward          Theatre         
                                                In Transit                     Paediatric Centre           Home     
 
                                                           Name of unit:_____________________________________________ 
 
*This question refers to where the baby actually died, e.g. ‘ICU, ‘at home’ or ‘in transit’. 
 Babies are deemed to have died ‘at home’ if there are no signs of life documented in the home even if resuscitation is attempted. 
 A baby is deemed to have died ‘in transit’ if signs of life are documented prior to transfer but the baby was either declared dead on arrival to  
the hospital or showed no subsequent signs of life in the hospital, despite attempted resuscitation.. 
  
SECTION 10. POST-MORTEM INVESTIGATIONS  
       10.1. Was this a coroner’s case? If yes, please complete question 10.2.                                                   Yes   No  
10.2. Has the post-mortem report been received from the coroner’s office?                                   Yes   No 
                                                                                                                                                    
10.4. Was a post-mortem performed?                  Yes                        No 
         If no, please complete question 10.5. 
10.5. Was a  post-mortem offered?                                                                                                   Yes  No 
 
10.6. Were any of the following procedures carried out after death?  
               Please tick all that apply    
         MRI                      X-Ray                  CT           External Examination          Genetic testing         
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SECTION 11. CAUSE OF DEATH AND ASSOCIATED FACTORS - STILLBIRTH & NEONATAL DEATH  
  11. Please TICK ALL the maternal or fetal conditions that were present during pregnancy or were  
associated with the death.  PLEASE REFER TO THE REFERENCE  MANUAL. 
 
        11.1.1. MAJOR CONGENITAL ANOMALY:   
 
Central nervous system         Cardiovascular system      Respiratory system  Gastro-intestinal system    
Musculo-skeletal anomalies   Multiple anomalies          Urinary tract        Metabolic diseases      
 
 Other major congenital anomaly, please specify ________________________________________________________________ 
 
 Chromosomal disorder*, please specify ________________________________________________________________ 
      
* In the event of a chromosomal disorder how was the diagnosis made? 
           Clinically                               Genetic analysis *                  Ultrasound                 
                                                      *See reference manual 
11.1.1 (b) Was the diagnosis of major congenital anomaly confirmed/suspected before delivery by a Consultant Fetal  
Medicine Specialist?        No         Yes, in your unit    
                                                      Yes, in another unit, please specify name of unit   _________________________________           
        11.1.2. HYPERTENSIVE DISORDERS OF PREGNANCY: 
 
Pregnancy induced hypertension    Pre-eclampsia  HELLP syndrome     Eclampsia  
 
        11.1.3. ANTEPARTUM or INTRAPARTUM HAEMORRHAGE:    
 
Praevia   Abruption    Other, please specify  _________________________________ 
 
        11.1.4. MECHANICAL:    
Cord compression:  Prolapse cord  Cord around neck    Other cord entanglement or knot 
Uterine rupture: Before labour During labour 
Mal-presentation: Breech                     Face  Compound  
 Transverse Other, please specify  ___________________________________  
        Shoulder dystocia:  
        11.1.5. MATERNAL DISORDER:       
    Pre-existing hypertensive disease   Diabetes     Other endocrine conditions (excluding diabetes)        
    Thrombophilias   Obstetric cholestasis  Uterine anomalies                       
    Connective tissue disorders, please specify______________________________________________________________________________ 
    Other, please specify_______________________________________________________________________________________________ 
 
        11.1.6. INFECTION: (confirmed by microbiology/placental histology)   
 
Maternal infection:  Bacterial    Syphilis    Viral diseases    
 Protozoal                                        Group B Streptococcus 
                                Other, please specify organism  _______________________________________________________ 
Ascending infection: 
                                                         Chorioamnionitis    Other, please specify  _________________________________ 
        11.1.7. SPECIFIC FETAL CONDITIONS:    
Twin-twin transfusion       Feto-maternal haemorrhage    Non-immune hydrops    Iso-immunisation    
Other, please specify _________________________________________________________________________________________________  
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        11.1.8. SPECIFIC PLACENTAL CONDITIONS:   
    
PLEASE REFER TO THE REFERENCE MANUAL, PAGE 10, BEFORE COMPLETING THIS SECTION 
  
No abnormal histology reported 
        
Chorioamnionitis              →           Mild                             Moderate                          Severe 
        
 Fetal vasculitis             →          Arterial                    Venous                        Both 
       
      
  Maternal vascular malperfusion (uteroplacental insufficiency) 
     Please specify pathology:   
   Distal villous hypoplasia                     Placental hypoplasia 
        Accelerated villous maturation         Ischaemic  villous crowding         
       Placental infarction           →           Please specify approximate percentage involved _______________ 
 
    Retroplacental haemorrhage    →    Please specify approximate percentage of maternal surface involved _______________ 
   
       Fetal vascular malperfusion: 
             Please specify pathology 
        Patchy hypoperfusion              Scattered avascular villi         Thrombosis in fetal circulation    Fetal thrombotic vasculopathy      
 
          
 
     Cord pathology as sole finding 
            Please specify pathology 
         Hypercoiled cord                      Hypocoiled cord                            Meconium associated vascular necrosis   
           Vasa praevia                       Velamentous cord                  Other , please specify__________          
    
    Cord pathology associated with distal disease 
                  please specify associated distal disease:   
          Delayed villous maturation                    Thrombosis in fetal circulation                     
    
    
     Delayed Villous maturation defect  (distal villous immaturity/ delayed villous maturation)           
    
    
     Villitis     →          Low grade                 High grade                        With stem vessel obliteration 
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        11.1.9. INTRA-UTERINE GROWTH RESTRICTION DIAGNOSIS MADE:     YES   
         
          What was this based on? Please tick all that apply 
 Suspected antenatally                    Observed at delivery                         Observed at post-mortem      
 
 
        11.1.10. ASSOCIATED OBSTETRIC FACTORS: Please tick all that apply   
        Birth trauma             Intracranial haemorrhage                         Subgaleal haematoma    
                                  Fracture, please specify_____________________________________________________ 
                                  Other, please specify________________________________________________________________________________ 
 Intrapartum fetal blood sample result < 7.25       Yes     No 
 
      Polyhydramnios                  Oligohydramnios            Premature rupture of membranes     
      Prolonged rupture of membranes (> 24hours)                Amniocentesis                             
 
 



















SECTION 12.  MAIN CAUSE OF DEATH: STILL BIRTH & NEONATAL DEATHS 
 
     12.1. Which condition, indicated in Section 11 as being present, was the MAIN condition or sentinel event          
causing or associated with the death.  Please refer to the post-mortem and placental histology reports.   
        (NB “non-MAIN” conditions are best described as the “Other clinically relevant maternal or fetal conditions/ factors that were associated 
















12.2. Sources of information used to determine cause of death?  
               Please tick all that apply  









SECTION 13. NEONATAL DEATH ONLY:  NEONATAL CONDITIONS ASSOCIATED WITH THE DEATH 
 
 
       13.1. Please TICK ALL the neonatal conditions causing and associated with the death.  
                PLEASE REFER TO THE REFERENCE  MANUAL. 
 
        13.1.1. MAJOR CONGENITAL ANOMALY:   
 
Central nervous system         Cardiovascular system      Respiratory system  Gastro-intestinal system    
Musculo-skeletal anomalies   Multiple anomalies          Urinary tract        Metabolic diseases                              
  
Other major malformation, please specify ________________________________________________________________ 
 
 
Chromosomal disorder*, please specify ________________________________________________________________ 
      
* In the event of a chromosomal disorder how was the diagnosis made? 
             Clinically                                     Genetic analysis *                  Ultrasound                 
                                                              *See reference manual 
 
 
13.1.1 (b) Was the diagnosis of major congenital anomaly confirmed/suspected before delivery by a Consultant 
Fetal  Medicine Specialist?                 No          Yes, in your unit     
                                                               Yes, in another unit, please specify name of unit  ___________________  
 
        13.1.2. PRE-VIABLE: (less than 22 weeks)           
 
        13.1.3. RESPIRATORY DISORDERS:    
 
   Severe pulmonary immaturity    Surfactant deficiency lung disease Pulmonary hypoplasia Meconium aspiration syndrome    
 
   Primary persistent pulm. hypertension          Chronic lung disease / Bronchopulmonary dysplasia (BPD)   




        13.1.4. GASTRO-INTESTINAL DISEASE:    
 
Necrotising enterocolitis (NEC)    Other, please specify __________________________________________________________________ 
 
 
        13.1.5. NEUROLOGICAL DISORDER:   
 
Hypoxic-ischaemic encephalopathy (HIE)                                                  
 
*Intraventricular / Periventricular haemorrhage, please specify highest grade (0 – 4) *           
    Hydrocephalus*, please tick all that apply: 
                   * Congenital              Acquired                     Communicating                   Obstructive       Other__________________            
 
 
Other, please specify______________________________________________________________________________________________ 
 
 
        13.1.6. INFECTION:   
 
Generalised (sepsis)    Pneumonia    Meningitis    Please  specify  specific organism _________________    
    Other, specify ______________       
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        13.1.7. INJURY / TRAUMA: (Postnatal)     
  
 
             Please specify_______________________________________________________________________________________________________ 
 
        13.1.8. OTHER SPECIFIC CAUSES:   
 
Malignancies / Tumours              In-born errors of metabolism, please specify ___________________________________ 
Specific conditions, please specify___________________________________________________________________________ 
 
 
        13.1.9. SUDDEN UNEXPECTED DEATHS:   
 
Sudden Infant Death Syndrome (SIDS)        Infant death – Cause unascertained 
 
        13.1.10. UNCLASSIFIED: (Use this category as sparingly as possible)   
 
 
      13.2. Which condition, indicated in Section 13.1 as being present, was the MAIN condition causing or 
associated with the death.  Please refer to the post-mortem report.  In the absence of a post-mortem report, please 
refer to the death certificate.  
        (NB “non-MAIN” conditions are best described as the “Other clinically relevant maternal or fetal conditions/ factors that were associated 









     
      13.3. Sources of information used to determine cause of death?  
               Please tick all that apply  




SECTION 14. DETAILS OF REPORTING UNIT (Please print) 
        
   14.1. Name of reporting unit: ______________________________________________________________________ 
       14.2. Completed by 
          Name: _________________________________________________________________________________________ 
          Staff Grade: ____________________________________________________________________________________ 
          Work address: __________________________________________________________________________________ 
          _______________________________________________________________________________________________ 
          Telephone Number: ____________________     E-mail Address:_________________________ 
          Date of Notification: // 
 







Appendix F: Terminology for placental pathology 
Appendix G: Terminology for placental pathology 
Pathology category Specific placental findings 
Maternal vascular malperfusion Refers to the spectrum of findings related to shallow implantation of the 
placenta, often found in conjunction with PET and IUGR and often called 
utero placental insufficiency. Placental findings that enable this category 
to be applied are:  
distal villous hypoplasia  
accelerated villous maturation 
ischaemic villous crowding 
placental infarction  
retroplacental haemorrhage  
placental hypoplasia 
Fetal vascular malperfusion Refers to thrombosis or decreased flow in the fetal circulation. It may 
be difficult to distinguish arteries from veins in the placenta and 
pathology may be present in both. Findings consistent with fetal 
vascular malperfusion are: 
patchy hypoperfusion 
villous stromal-vascular karyorrhexis       
scattered avascular villi      
thrombosis in fetal circulation    
fetal thrombotic vasculopathy / extensive avascular villi 
Cord pathology  Cord pathology may exist by itself, or may be accompanied by evidence 
of other disease. The findings of cord pathology include: 
hypercoiled cord (Umbilical coiling index (UCI) of ≥ 0.3) 
cord stricture 
hypocoiled cord  (UCI < 0.1)             
meconium associated vascular necrosis  
velamentous or marginal (<10mm) cord insertion   
Other      
Delayed villous maturation Delayed villous maturation is the recommended term instead of distal 
villous immaturity, placental maturation defect or villous maturation 
defect. 
Chorioamnionitis The maternal and fetal inflammatory response should be staged and 
graded where possible. 
Villitis The term is used to mean villitis of unknown aetiology and assumes that 
the reporting pathologist has excluded infection where appropriate. 
Villitis is graded as either low grade or high grade and can occur with 
stem vessel obliteration. 
Other 
Note: More than one placental category may be present. 
45 Khong TY, Mooney EE et al: Sampling and definition of placental lesions. Arch Pathol Lab 
Med. 
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Guidance and Definitions for Completion of Section 11 & 12 
STILLBIRTHS AND NEONATAL DEATHS 
DEFINITION OF TERMS Subcategory 
MAJOR CONGENITAL ANOMALY 
Any genetic or structural defect arising at conception or during 
embryogenesis incompatible with life or potentially treatable but causing death 
Central nervous system   
Cardiovascular system 
Respiratory system 
Gastro-intestinal system  
Musculo-skeletal anomalies 
Multiple anomalies  
Chromosomal disorders 
Metabolic diseases  
Urinary tract 
Other 




ANTEPARTUM OR INTRAPARTUM HAEMORRHAGE 
After 20 w gestation, whether revealed or not. If associated with PET, APH will be a 
secondary diagnosis. Ignore minor degrees of haemorrhage (e.g. ‘shows’, cervical 
polyps etc). Recurrent bleeding of uncertain origin followed by preterm labour should 





Any death attributed to uterine rupture, deaths from birth trauma or intrapartum 
asphyxia associated with problems in labour such as cord compression, 
malpresentation, shoulder dystocia etc. 
Antepartum deaths associated with cord entanglement in the absence of strong 
circumstantial evidence that cord compression caused death should be classified as 
having no associated factor. 
Cord Compression  
Prolapsecord 
Cord around neck 
Other cord entanglement or knot 




Breech / Transverse 
 Face / Compound 
 Other  
Shoulder dystocia 
MATERNAL DISORDER.  
Specify hypertensive disease present before pregnancy or any other maternal disease 
or condition sufficient to jeopardise the baby such as diabetes, cardiac disease etc.  
Infection is classified separately. 
Pre-existing hypertensive disease 
Diabetes  
Other endocrine conditions 
Thrombophilias 
Obstetric cholestasis  
Drug misuse   
Uterine anomalies 
Connective tissue disorders / 
Other  
INFECTION. Confirmed by microbiology / placental histology. 
Specify maternal infections sufficient to have compromised the baby which may be 
associated with congenital infection of the baby. Trans-placental transmission may 
have occurred such as CMV, toxoplasmosis etc.  
Specify only those ascending infections that are a significant factor in death. 
Chorioamnionitis sufficient to cause preterm birth may be specified for some 
neonates but evidence of fetal infection may be required as an explanation of 
stillbirth.  
Maternal infection 
Bacterial / Viral diseases 
Syphilis  /Group B Streptoccus 
Protozoal 
Other 
Ascending infection  
Chorioamnionitis 
Other 
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Twin-twin transfusion   
Feto-maternal haemorrhage 
Non-immune hydrops   
Iso-immunisation 
Other 
SPECIFIC PLACENTAL CONDITIONS. Specific placental conditions sufficient to cause 
death or be associated with fetal compromise such as IUGR. Cord problems associated 
with compression will normally be classified under ‘Mechanical’.  
 
 
Chorioamnionitis              
Fetal vasculitis                 
Maternal vascular malperfusion  
Fetal vascular malperfusion 
Cord pathology 
 Other 
INTRA-UTERINE GROWTH RESTRICTION DIAGNOSIS MADE. IUGR may be suspected 
antenatally by abdominal circumference (AC) less than the centile threshold used to 
define IUGR locally, or decreased AC growth velocity, +/- oligohydramnios. 
 
Suspected antenatally 
Observed at delivery 
Observed at post mortem 
ASSOCIATED OBSTETRIC FACTORS. Factors recorded as Other Associated Obstetric 
Factors will be important clinical or pathological features of the pregnancy or baby but 
may not be an explanation of the death; they will often be secondary to other 
maternal or fetal conditions. Birth trauma and/or Intrapartum asphyxia should 
normally be classified primarily by the underlying cause (e.g Mechanical ). Birth 
Trauma and/or other antenatal/intra-partum factors can be recorded here either as a 


















NO ANTECEDENT OR ASSOCIATED OBSTETRIC FACTORS. Deaths with no explanation 
or significant associated factor. 
 
 
UNCLASSIFIED.  Cases where little or nothing is known about pregnancy or delivery 
and which cannot be fitted into any of the above categories.  
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Guidance and Definitions for Completion of Section 13: 
NEONATAL DEATH ONLY 
 
 
DEFINITION OF TERMS Subcategory 
MAJOR CONGENITAL ANOMALY 
 Any genetic or structural defect arising at conception or during embryogenesis 
incompatible with life or potentially treatable but causing death. 







Metabolic disorders  
Urinary tract  
Other 
PRE-VIABLE 
Babies (less than 22 weeks) who are non-viable at birth because of gestation but 
who show signs of life. 
 
RESPIRATORY DISORDERS 
Severe pulmonary immaturity will encompass those babies where structural lung 
immaturity is so gross as to mean ventilatory support is unsustainable at the outset. 
Surfactant Deficient Lung Disease may include babies with clinical or pathological 
evidence of hyaline membrane disease.  
Please note that neonatal deaths previously attributed to prematurity, would most 
often be captured under the subcategory of ‘severe pulmonary immaturity’. 
 
Severe pulmonary immaturity 
Surfactant deficiency lung disease 
Pulmonary hypoplasia 
Meconium aspiration syndrome 
Primary persistent pulmonary 
hypertension 
Chronic lung disease / BPD 
Other (includes pulmonary 
haemorrhage) 
GASTRO-INTESTINAL DISEASE 
Many babies with NEC will have associated sepsis which may be given as a secondary 
cause.  
 
Necrotising enterocolitis (NEC) 
Other 
NEUROLOGICAL DISORDER 
HIE includes those babies with severe hypoxic-ischaemic brain injury before birth. If 
possible, please specify if HIE was primarily of intrapartum or antepartum origin. 
Specify periventricular leukomalacia only if this is a significant factor in the infant 









Where possible specify the location of infection and whether due to bacteria, virus, 
fungus or other specific organism.   
If infection was the main cause of death please specify whether infection is 







INJURY / TRAUMA 
Post natal trauma only including iatrogenic injury. ‘Birth Trauma’ will usually be 
classified under neurological disorder e.g. HIE; the obstetric classification identifying 
the timing of the injury.  
 
 
OTHER SPECIFIC CAUSES 
Death due to specific fetal and neonatal conditions such as isoimmunisation or 
unexplained hydrops. Neonatal conditions will include aspiration, unexplained 







Guidance and Definitions for Completion of Section 13: 
NEONATAL DEATH ONLY 
 
 
DEFINITION OF TERMS Subcategory
MAJOR CONGENITAL ANOMALY 
 Any genetic or structural defect arising at conception or during embryogenesis 
incompatible with life or potentially treatable bu  causing death. 




Musculo-skelet l system 
Multiple anomalies 
Chromosomal disorders 
tabolic di orders  
Urin r  tract  
Oth  
PRE-VIABLE 
Babies (less than 22 weeks) who are non-viable at birth because of gestation but 
who show signs of life. 
 
RESPIRATORY DISORDERS 
Severe pulmonary immaturity will encompass those babies where structural lung 
immaturity is so gross as to mean ventilatory support is unsustainable at the outset. 
Surfactant Deficient Lung Disease may include babies with clinical or pathological 
evidence of hyaline membrane disease.  
Please note that neonatal deaths previously attributed to prematurity, would most 
often be captured under the subcategory of ‘severe pulmonary immaturity’. 
 
Severe pulmonary immaturity 
Surfactant deficiency lung disease 
Pulmonary hypoplasia 
Meconium aspiration syndrome 
Primary persistent pulmonary 
hypertension 
Chronic lung disease / BPD 
Other (includes pulmonary 
haemorrhage) 
GASTRO-INTESTINAL DISEASE 
Many babies with NEC will have associated sepsis which may be given as a secondary 
cause.  
 
Necrotising enterocolitis (NEC) 
Oth r 
NEUROLOGICAL DISORDER 
HIE includes those babies with severe hypoxic-ischa mic brain injury before birth. If 
possible, please specify if HIE was primarily of intrapartum or antepartum origin. 
Specify periventricular leukomalacia only if this is a significant factor in the infant 









Where possible specify the location of infection and whether due to bacteria, virus, 
fungus or other specific organism.   
If infection was the main cause of de th please specify whether infection is 







INJURY / TRAUMA 
Post natal trauma only including iatrogenic injury. ‘Birth Trauma’ will usually be 
classified under neurological disorder e.g. HIE; the obstetric classification identifying 
the timing of the injury.  
 
 
OTHER SPECIFIC CAUSES 
Death due to specific fetal and neonatal conditions such as isoimmunisation or 
unexplained hydrops. Neonatal conditions will include aspiration, unexplained 








SUDDEN UNEXPECTED DEATHS.  
SIDS should conform to the accepted definition. Unascertained are those 
unexpected deaths that are not explained despite a full investigation including 
autopsy, but do not conform to the accepted definition of SIDS. 
 
Sudden Infant Death Syndrome 
(SIDS) 
Infant deaths – cause unascertained 
UNCLASSIFIED.  Cases where little or nothing is known about the pregnancy or 
delivery and which cannot be fitted into any of the above categories.  
 






Appendix H: The Robson Ten Group Classification System
The 10 groups of the Robson Classification 35
35 Robson Classification: Implementation Manual. Geneva: World Health Organization; 2017. Licence: CCBY-NC-SA3.0IGO.
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